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Abstract 
The aim of this thesis was to i) study the effect of principal components of ischaemia on 
electrical activity during ventricular fibrillation and on defibrillation success, and ii) 
identify the electrophysiological mechanisms underlying these effects. 
ECG signals were recorded from isolated, Langendorff-perfused rabbit hearts to establish 
the relationship between dominant frequency and myocardial perfusion during ventricular 
fibrillation. Lower perfusion rates produced faster rates of dominant frequency decline, to 
lower steady state values. Optically mapping the anterior epicardial surface demonstrated 
heterogeneity of dominant frequency in ventricular fibrillation. During low-flow 
ischaemia, the dominant frequency reduction was restricted to the left ventricle. 
Application of individual ischaemic components during ventricular fibrillation 
demonstrated that raised [K+]EC, but not hypoxia or acidic pHEC, reproduced the ischaemic 
reduction of dominant frequency in the ECG, pseudoECG and over the left ventricular 
epicardial surface. In contrast, minimum defibrillation energies were increased by hypoxia 
and acidic pHEC, and not by raised [K+]EC. 
The dominant frequency heterogeneity during ventricular fibrillation in low-flow 
ischaemia and raised [K+]EC was not due to differential prolongation of repolarisation or 
post-repolarisation refractoriness in the left ventricle. Monophasic action potential studies 
showed that APD90 was reduced to similar degrees in each ventricle by low-flow ischaemia 
and raised [K+]EC. Effective refractory period was not altered in either ventricle by either 
condition. Low-flow ischaemia decreased conduction velocity in the left, but not the right 
ventricle. Conduction velocities were unaltered by raised [K+]EC in either ventricle. The 
activation threshold of the left ventricle was increased in low-flow ischaemia and raised 
[K+]EC" whilst the threshold of the right ventricle was unchanged. The increased activation 
threshold was associated with decreased upstroke velocity and diastolic depolarisation. 
In conclusion, this thesis demonstrates that in ventricular fibrillation, the decreased ECG 
dominant frequency in low-flow ischaemia is predominantly due to slowing of electrical 
activity in the left ventricle, associated with an elevation in the activation threshold by 
raised [K+]EC. The differential threshold change in left compared to right ventricle, 
probably results from differential inhibition of INa. This thesis hypothesises that greater 
expression of Kir2.x in the left compared to right ventricle, as previously demonstrated in 
guinea pig, could underlie the observed electrical heterogeneity in the rabbit. 
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1 Introduction 
( 
Jane C. Caldwell, 2006 Chapter 1, 23 
The aim of this introduction is to provide an overview of the phenomena of ventricular 
fibrillation and electrical defibrillation, to describe the electrophysiological processes that 
are thought to underlie these processes, and how they are affected by acute ischaemia. 
1.1 Ventricular Fibrillation 
1. 1.1 Clinical Relevance 
1.1.1.1 Definition 
Ventricular fibrillation (VF) is a cardiac arrhythmia in which the electrical activity of the 
ventricles is chaotic and uncoordinated. This results in the loss of cardiac output and death, 
unless corrective measures are undertaken (1). Although in humans VF can be precipitated 
by a wide variety of conditions, ranging from electric shocks to drug overdoses, it is 
usually seen in the context of coronary artery disease. 
1.1.1.2 Mortality data 
Coronary artery disease is the leading cause of premature death in the UK, resulting in the 
deaths of over 105,000 people in 2004 (2). Of these, 30% died suddenly before reaching 
hospital, presumably from VF (3). VF is also a common consequence of mild to moderate 
left ventricular systolic dysfunction (4, 5). 
1.1.1.3 Treatment 
Surviving VF depends on the quick re-establi~hment of a rhythm compatible with 
perfusion, usually by the application of an electric defibrillation shock. Although the 
probability of successful outcome from defibrillation is directly related to the duration of 
the VF arrest (6), interventions to minimise this duration have not consistently shown 
improvements of survival rates. One example is the introduction of automated external 
defibrillators (AED) into public places. The use of AEDs by non-medical but trained 
individuals, shortens the time to first defibrillation shock, as it is no longer necessary to 
wait for the arrival of a paramedic crew. However, AED introduction has not resulted in 
the expected survival rate improvements (7-9). The efficacy of the "shock-first" approach 
was also brought into question by animal (10-12) and clinical research (9, 13) which 
showed that survival from more prolonged VF arrests was improved by an initial period of 
cardiopulmonary resuscitation (CPR) prior to defibrillation. To this end, the UK 
Jane C. Caldwell, 2006 Chapter 1, 24 
Resuscitation Council changed its guidelines; rather than advocating immediate 
defibrillation on diagnosis of VF, the guidelines now recommend 2 minutes of CPR prior 
to first defibrillation attempt in unwitnessed out-of-hospital arrests (14). 
1.1.1.4 Clinical VF progression 
A three-phase model of VF progression has been proposed (15, 16): - (i) an initial 
"electrical phase" (0 - 4 mins), where little metabolic deterioration occurs and immediate 
defibrillation gives the best chance of survival, (ii) an intermediary "circulatory phase" (c. 
4 - 10 mins) where the metabolic consequences of failed myocardial perfusion reduce the 
success of defibrillation, but are limited enough to be partially reversed by CPR. It should 
be noted that even when performed optimally, CPR can only restore 25% of perfusion to 
the heart (17), and is inherently hypercarbic/hypoxic if using "mouth-to-mouth" ventilation 
(18). (iii) Longer duration VF ("metabolic phase") results in systemic consequences of 
ischaemia; the release of vasodilatatory cytokines and translocation of gut bacteria leading 
to sepsis. Such sequelae prevent long-term survival even if defibrillation is successful. 
As the immediate intervention for each VF phase is different, it is important to establish 
which phase a patient is in. Trying to determine the VF phase from bystander accounts of 
duration is at best an estimate. Alternatively, the VF phase can be related to parameters 
derived from the surface ECG, which also correlate with VF duration and resuscitation 
outcome. In non-perfused VF in animal models, the amplitude of the ECG waveform 
reduces with time (19). However, the assessment of ECG amplitude is not a useful clinical 
tool as large amplitude variations can occur with differing lead placements and body 
habitus (20). Analysing the ECG in the frequency domain negates these problems. As 
shown in figure 1.1, and described more fully in chapter 2.5.1, using Fast Fourier 
Transform (FFT) to convert the ECG signal into its constituent frequencies, allows the 
identification of the dominant or peak frequency (DF), and the median frequency (MF). 
Such frequency analysis in non-perfused VF has shown that the DF, the MF and amplitude 
spectrum area (AMSA = area under frequency power spectrum) are related to the VF 
duration, and probability of successful defibrillation, in both animal and clinical studies 
(21-34). For this reason, in this thesis the time-course ofVF will primarily be examined in 
the frequency domain. 
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Figure 1.1 Frequency analysis of VF. Panel A: ECG during VF. Panel B: Power Spectrum of 
(A) created by Fast Fourier Transform (FFT). 
1.1.2 Electrophysiology of VF 
1.1.2.1 Onset ofVF 
1.1.2.1.1 Initiation of Ventricular Tachycardia (VT) 
The qualitative description of VF has a long history (for review see (35)). Using 
cinematography, Wiggers described an initial regular VT, which quickly degenerated into 
the chaotic contractions of VF (36). Electrical mapping techniques demonstrated that this 
VT is characterised either by a single spiral wave or a figure-of-eight re-entry (37). 
Precipitation of such waves requires (i) a trigger and (ii) a potential pathway to support re-
entry (38). 
(i) Triggering is thought to occur by early or delayed after-depolarisations (EADs, DADs). 
As shown in figure 1.2, these oscillations in membrane potential either occur during the 
action potential (AP), as in EADs, or immediately after it, as in DADs. Both EADs and 
DADs frequently occur in electrolyte disturbances (low [K+]EC, [Ca2+]EC, [Mg2+]EC, and 
pH) or anti-arrhythmic therapy (39, 40), and are more common in the context of heart 
failure (41, 42). 
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Figure 1.2 Triggered activities. Early After Depolarisatlons (EADs) occur prior to full 
repolarlsatlon of the action potential. Delayed After Depolarlsatlons (DADs) occur after full 
repolarlsatlon of the membrane potential. Both are associated with electrolyte disturbances, 
drug therapy and heart failure. (Adapted from (40». 
(ii) At the simplest level, re-entry is the rotation of the cardiac impulse around an 
unexcitable obstacle, resulting in repetitive activation of the heart. The frequency of 
repetition is dependant on the conduction velocity of the activation and the length of the 
pathway around the obstacle. In order for re-entry to be established there must be a) 
unidirectional conduction block, which can be anatomical or functional, and b) a match 
between the conduction velocity and the length of the potential circuit to allow re-
excitation. 
a) Unidirectional conduction block - 1. Anatomical - Disease processes that disrupt the 
myocardial fibre arrangement and/or produce interstitial fibrosis can result in anatomical 
conduction block (e.g. chronic myocardial infarction) (43). Figure 1.3 illustrates the 
formation of figure-of-eight re-entry at an anat()mical conduction block, and how the 
formation of re-entry is also dependant on the surrounding tissue excitability. If the tissue 
is of normal excitability, the wave simple reunites after the obstruction (Figure 1.3(i)). If 
excitability is reduced the wave-ends cannot unit, and so they become detached and form 
two counter-rotating spiral waves (Figure 1.3(ii». 2. Functional - functional blockade 
results from the dispersion of repolarisation and conduction, as determined by restitution 
dynamics. This source of heterogeneity is also important in the degeneration of VT into 
VF, and will be discussed in section 1.1.2.1.3. 
b) Re-excitation - In order to allow re-activation of the re-entry pathway by the Circling 
activation, the rotational time around the circuit must be longer than the recovery interval 
throughout the pathway. This can be accomplished either through a relatively long 
pathway, a relatively slow conduction velocity or a relatively short refractory period. 
Figure 1.3 Formation of a wavebreak (anatomical). In all panels, a wavefront (WF) Is moving 
upward to Interact with an unexcitable obstacle, shown In black. Panel A: Normal 
excitability, upon reaching the obstacle, the wavefront splits In two. The two newly formed 
wavefronts circumnavigate the obstacle, without detaching from It, and then merge into a 
common wave front that continues moving upward, apparently undisturbed by its 
Interaction with the discontinuity. Panel B: Lower excitability. The two broken wave fronts 
(wavelets) now detach from the obstacle, resulting in the formation of a singularity point (PS 
= phase singularity) at the broken end of each wavelet. This leads to two counter rotating 
vortices (flgure-of-elght re-entry). Panel C: When excitability is too low, the two broken 
waves are unable to rotate, and Instead undergo decremental conduction. (Adapted from 
(35». 
1.1.2.1.2 Degeneration into VF 
Once established, VT may degenerate into VF. For this to occur, the re-entrant wavefront 
must fragment into numerous daughter waves. This process of wavebreak occurs in the 
context of spatial heterogeneity in electrophysiological properties such as conduction 
velocity and refractoriness (Figure 1.3). Some heterogeneity exists in the structurally 
normal heart; there are differences in the electrophysiological properties depending on 
location (apex or base, left ventricle (LV) or right ventricle (RV)),. and depth in the tissue 
(epicardial through to endocardial) (44). These differences. are enhanced further by 
sympathetic stimulation (45). Heterogeneity is increased in the abnormal heart. In left 
ventricular systolic dysfunction, stretch of the myocytes by dilation causes increases in the 
magnitude and dispersion of refractoriness (46). Early in acute myocardial infarction 
, 
ischaemia causes electrophysiological changes such as slowed conduction velocity (CV), 
depolarization of the resting potential, and reduced action potential amplitude (47). These 
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alterations can occur in patches, and may interdigitate with non-ischaemic tissue, thus 
increasing heterogeneity. 
1.1.2.1.3 Restitution 
An important contributor to the development of heterogeneity is restitution. Restitution is 
the phenomenon whereby the action potential duration (APD) and CV vary according to 
the length of the preceding diastolic interval (DI = the interval between electrical 
impulses). When the heart rate increases, the DI shortens. The AP therefore reaches the 
cell in a different stage of ion channel activation/inactivation. The result is shortening of 
the APD and reduction of the CV. Thus restitution produces rate-related changes of APD 
andCV. 
Restitution is an important functional property, allowing the heart rate to increase during 
exercise without conduction blockade or consequent arrhythmias. However, the 
consequently eyer-changing nature of APD and CV can lead to heterogeneity. The kinetics 
of restitution relationships are represented by plotting APD or CV against DI (Figure 1.4). 
With APD restitution, the gradient of the curve detennines the stability of the activation. 
Figure 1.4 shows that at low activation rates (e.g. during normal sinus rhythm) the slope is 
shallow «1), whereas at higher activation rates, such as those seen in VF, the curve is very 
steep (> 1). Shallow gradients of restitution «1) reflect a' stable situation. As shown in 
figure I.5A, if the restitution slope is <I, changes in DIlheart rate produce ever reducing 
changes in APD, and the quick re-establishment of a new steady state. In contrast, steep 
gradients (> 1) result in instability. As illustrated in figure 1.5B, with restitution slopes> 1 
even small changes in DI will have a dramatic eff~ct on the APD, and r~su1t in conduction 
failure. 
Restitution kinetics vary throughout the normal myocardium (48, 49). This heterogeneity 
of repolarisationirefractoriness and CV can lead to functional unidirectional conduction 
block, and hence wavebreak (50-52). Drugs which flatten the restitution Curve (i.e. increase 
stability) have been shown to prevent the transition of VT to VF, and convert VF to VT 
(Figure 1.4) (53.-55) .. 
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Figure 1.4 APD restitution curves. Restitution dynamics are assessed by plotting APD vs. 
01. Under control conditions the slop of the curve is <1 at longer 01 (*), and >1 at shorter 01 
(*). During amiodarone administration the slope of the curve is flattened. This stabilisation 
of the restitution dynamics prevents the transition of VT to VF. (Adapted from (54)). 
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Figure 1.5 Relationship between steepness of APD restitution curve and wave stability. 
Panel A: For slopes <1, a small shift (a) that shortens 01 results in and even smaller change 
in APD. This ever-decreasing pattern of changes continues until a new equilibrium is 
established. Panel B: For slopes >1, a similar small shift (a) produces a larger change in 01 
and a subsequent greater change in APD. This amplification circuit continues until the 01 is 
too short to generate an APD (b) and conduction falls (i.e. wavebreak occurs). (Adapted 
from (56)). 
1.1.2.1.4 Cardiac memory 
Another phenomenon that is interlinked with restitution, and may also be important in VF, 
is cardiac memory. The myocardium is imprinted by the pattern of previous activations. 
That is it appears to remember what activation pattern has happened before (57). Therefore 
not only the preceding DI influences the APD, but the previous APD, and the antecedent 
DIs and APDs of several earlier cycles (58, 59). This phenomenon appears to be important 
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in maintaining VF in the fIrst few seconds, but not thereafter (59). As this thesis is 
investigating prolonged episodes ofVF, cardiac memory will not be evaluated. 
1.1.2.2 Maintenance of VF 
The mechanism of VF maintenance remains the subject of debate. Originally it was 
thought that VF was maintained by multiple wavelets; these wavelets, moving along ever-
changing pathways, resulted in wave collision (extinction) and wavebreak: (generation of 
new daughter waves) (56). More recently, an alternative mechanism of VF maintenance 
has been proposed. In this hypothesises, the driving force in VF is a single, rapidly firing 
spiral wave (or "mother rotor") lying deep within myocardium. As the activation spreads 
from this source, and encounters tissues with longer refractory periods, wavebreak: results, 
with the production of multiple wavelets as epiphenomena. Supporting this, optical 
mapping has demonstrated that (i) a relatively small numbers of drifting rotors can give 
rise to an ECG resembling VF (60), (ii) the dominant frequency (DF) of the ECG power 
spectra correlated to the cycling periodicity of the dominant/mother rotor (61 , 62) (Figure 
1.6) and (iii) in VF the electrical activity across the heart is divided into discrete DF 
domains, the fastest of which was consistently located in the anterior aspect of the LV (63). 
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Figure 1 .6 Relationship between spiral wave dynamics and EC G dominant frequency during 
VF. Panel A: In c~ntrol conditions a single wave Is shown rotating counterclockwi with 
rotation period of 54ms. Panel B: After 5 minutes of global ischaemia, a spiral wa~e w as 
shown rotating counterclockwise with rotation. p. rlod of 158ms. In the adjacent colour bar 
a h olour band corr . pO~d to 12 m of OtlVlty.R d r .pr ht th~ Qarnest activation 
and purple the latest activation. Panel c : Plot of rotation perIod against Inv rae of domln nt 
frequ~ncy (1/f) demo~strates a strong Inverse correlation between OF and rotational period 
of spiral wave dynamiCs. (Adapted from(62)). 
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Other groups have failed to demonstrate such fixed DF domains (64-66). Choi et aI. found 
that in all areas of the epicardium the frequency power spectra were broad with multiple 
peaks. This made determination of the DF equivocal, and suggested the existence of 
multiple wavelets rather than a single mother rotor (65). Instead, as shown in figure 1.7, 
they demonstrated the existence of dynamically changing frequency "blobs" that were 
short lived, and could be altered pharmacologically (66). 
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Figure 1.1 Spatiotemporal distribu~ion of VF frequen~ies as short-lived frequency blobs. By 
performing time-frequency analYSIS across the anterior surface of the rabbit heart, Choi et 
al. did not find discrete domains, but rather identified ever-changing frequency blobs. The 
illustrated colour-coded plots are of frequency (z-axis) against spatial location (x & y axes). 
(Adapted from (66». 
1.1.2.2.1 Possibility of 2 types of VF 
By demonstrating evidence to support both mechanisms of VF maintenance, Wu et al. 
proposed a unifying theory of two types of VF that occur under different circumstances 
(55, 67). Figure 1.8 shows the results of this study, where VF was optically mapped whilst 
changing the gradient of the APD and CV restitution curves independently. This was 
accomplished through increasing concentrations of methoxyverapamil, a Ca2+ and Na+ 
channel blocker. The baseline "fast" VF (type 1), consisted of multiple wandering 
wavelets, wave-wave interaction and continuous new re-entry (DF c.18 Hz, Figures 
1.8A(i), B(i) & C(i». Low methoxyverapamil concentrations inhibit the slow calcium 
inward current (ICa(L) and thus flatten the APD restitution curve. Perfusing the preparation 
with low methoxyverapamil concentrations converted the type 1 VF to VT with a 
stationary spiral wave (Figures 1.8 A(ii) & B(ii». Higher methoxyverapamil 
concentrations inhibit the fast sodium inward current (INa), thereby reducing myocardial 
excitability as well as steepening and broadening of the CV restitution curve. In the 
preparation, increasing the methoxyverapamil concentrations produced wavebreak such 
that VT now degenerated into VF (Figures 1.8A(iii), B(iii) & C(ii» . Optically this 
appeared as a single, long wavefront that failed to propagate in certain areas; wave-wave 
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interaction and generation of new re-entry were rarely observed. ECG recordings at these 
higher concentrations showed slow (type 2) VF (DF c.l2 Hz). 
As these 2 different types of VF can be attained in the same heart, it raises the possibility 
that both mechanisms (i.e. the multiple wavelets and the "mother rotor") operate but at 
different points in the progression of VF in ischaemia (68-70). 
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Figure 1.8 Two types of VF. Pa~el A: EC.~s of (i) Baseline VF (type 1), (ii) VT under low 
concentration m.ethoxyverapamll and (III) Slow (typ~ 2) VF in high concentration 
methoxyverapamll. Panel B: P0v:-'er spectra of Panel A. ThiS ~emonstrates slower OF in Hi h 
concentration methoxyverapamll. Panel C: Phase maps of (I) Baseline VF - many pOint g f 
wavebreak (black triangles) resulting from many wavelets, and (ii) Type 2 VF _ A s· sf 
singularity (White circle) with one wavebreak at area of slow conduction. (Adapted ~ng e (67)). rom 
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1.1.2.3 Progression of VF 
1.1.2.3.1 Progression of Dominant Frequency 
Under circumstances of continued coronary perfusion (i.e. cardiopulmonary bypass (71) or 
Langendorff-perfused isolated heart (46», the frequency content of the ECG signal 
increases slightly after induction, then remains stable. When coronary perfusion is not 
supported, the frequency content rapidly declines (71, 72) irrespective of its aetiology 
(22). Intermediate levels of coronary perfusion give rise to lesser degrees of frequency 
decline (73). Therefore, the effectiveness of CPR and vasopressive agents to maintain 
coronary perfusion can be correlated to the DF or MF (30). The more complicated 
relationship between DF and defibrillation threshold (DFT) will be discussed later. 
1.1.2.3.2 Metabolic consequences 
The reduced myocardial blood flow associated with a VF arrest results in a collection of 
metabolic changes. Within 10 seconds, intracellular 02 is virtually exhausted, forcing the 
cessation of aerobic metabolism, the depletion of high-energy phosphate compounds, the 
onset of anaerobic metabolism and the accumulation of metabolites (including lactic acid 
and CO2) (74). This results in both intracellular and extracellular acidosis, and 
accumulation of extracellular K+. 
The levels of acidic pHEc in VF during ischaemia are not clear. Clinical and animal studies 
have examined plasma pH, rather than interstitial pH (75-78). In isolated ferret hearts the 
pH falls to 6.78 by 10 minutes during total ischaemia in sinus rhythm (79). Whereas 
measurement of interstitial pH in the in situ pig heart during VF supported by CPR showed 
the pH to fall to 6.38 at 11 minutes (80). .' 
During ischaemia, there is an increase in passive K~ efflux due to a) increased permeability 
of the cell membrane to anion and b) the developing intracellular acidosis (81). This results 
in a substantial rise in extracellular [K+] , and depolarisation of the resting membrane 
potential (81, 82). As is the case with pH, the actual [K+]EC during VF in ischaemia is not 
clear. Again clinical and animal studies have examined plasm~ [K+] rather than the 
interstitial [K+] (83).' In the isolated guinea pig heart the [K+]EC reached I1mM after 8 
minutes of ischaemia in sinus rhythm, and 15mM after 15 minutes (81). 
I, 
,. 
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1.1.2.3.3 Possible role of transmembrane potential 
Intracellular recordings during prolonged VF have demonstrated depolarisation of the 
resting membrane and alteration of AP morphology (84). The latter change was in keeping 
with INa inhibition, which.occurs secondarily to membrane depolarisation. In this study, VF 
was induced by reperfusion after an ischaemic insult with prior baseline membrane 
potential measurement. During the first few minutes of VF, the membrane potential did not 
reach a stable diastolic level. Therefore the contribution ofVF, as distinct from ischaemia, 
to membrane depolarisation was not ascertained. 
Pharmacological inactivation of fast sodium channels, and thus inhibition of INa, results in 
slowing of the ECG DF (22, 85, 86). This suggests that membrane ~epolarisation, and 
secondary INa inhibition, could playa role in the DF decline in VF during ischaemia. 
Indeed, as illustrated in figure 1.6, optical mapping of VF during global ischaemia showed 
that the DF inversely correlated with (i) the rotational period of the epicardial spiral wave, 
and (ii) the dimensions of the central inactive core the wave rotated around (62). In fully 
perfused preparations, blockade of INa by tetrodotoxin resulted in slowing of DF and spiral 
wave rotation that was indistinguishable from that observed in global ischaemia (62). 
The pattern of the e1ectrophysiological changes that evolve with ischaemia can be 
mimicked by increasing methoxyverapamil concentrations as described above; ischaemia 
initially leads to APD shortening and flattening of APD restitution curve (87). This can 
promote spontaneous termination, which can also occur in patients with Brugada 
syndrome. Such patients, with structurally normal hearts, suffer repeated, non-sustained 
VF arrests (88, 89). To date, the genetic mutation responsible has only been identified in a 
minority of patients (c. 10%). All mutations identified have re~,ulted in reduction of INa 
(90). Unfortunately, self-termination is notthe case for the vast majority of VF arrests, 
which occur secondary to coronary artery disease or LV systolic dysfunction. Here, the 
. 
underlying heterogeneity of the disease process negates the flattening of APD restitution. 
As VF continues, the progressing ischaemia is associated with reduced excitability, and 
there is transition into slow, type 2 VF (71). 
1.1.2.4 Termination of VF 
VF arrests have 2 possible outcomes; life or death. For the first to occur, a rhythm 
compatible with (and producing) contraction must be established, either spontaneously (an 
infrequent occurrence in conditions such as in Brugada syndrome (88,89», or by electrical 
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countershock with or without phannacological assistance. If VF continues, it will 
eventually degenerate into asystole, where the myocardial electrical activity ceases, and 
death is almost inevitable (91). 
1.2 Defibrillation by electric countershock 
1.2.1 Mechanism of action 
For over a century, it has been appreciated that electric shocks have the ability to tenninate 
VF, as well as initiate it. The precise mechanism of defibrillation is not clearly understood. 
Over the past few decades conflicting theories, with supporting evidence, have be~ 
proposed by different investigators, using different expe~mental methods (for review see 
(92)). Principles that are generally accepted are: - (i) for defibrillation to be successful a 
shock must homogeneously depolarize a sufficient mass of myocardium to stop the 
fibrillation wavefronts (critical mass concept), and (ii) it must do so without launching new 
activations that re-initiate VF (93). Two main hypotheses exist for the source of such re-
initiating activations; the "critical point re-entry" hypothesis (94, 95) and "virtual 
electrodes" hypothesis (96-98). 
1.2.1.1 Critical mass concept 
Since the beginning of the '20th century, it has been known that the ability to initiate and 
maintain a heart in VF is inversely related to its size (35, 99, 100). Indeed, studies 
investigating VF using the small-dimensione~ rat heart often have to re-induce the 
.. 
arrhythmia, as self-tennination is so commonplace (101). The prerequisite for a critical 
mass of excitable myocardium to sustain VF has been predicted by computer modelling 
(102) and demonstrated experimentally in dogs (103). Perfusing individual coronary 
. arteries with potassium chloride solution (ImEq/ml) renders the subtending myocardium 
unexcitable. Simultaneous perfusion of the left anterior descending (LAD) and the left 
circumflex arteries reduces the mass of excitable myocardium below this critical mass 
threshold, so that VF is no longer sustained (103). Similarly, successfully defibrillation 
needs only to prevent wavefront propagation within a critical mass. Thereafter the 
remaining excitable myocardium is too small to sustain VF. 
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1.2.1.2 "Critical Point re-entry" mechanism 
During established VF, a countershock imposes an electric field on the myocytes that 
prolongs their refractory period, and hence prevents the wavefront propagation. The extent 
of refractory prolongation experienced by a myocyte is determined by (i) its location 
within the electric field and (ii) its excitation state at the point of shock application. 
(i) Depending on the electrode size and placement, certain areas of the ventricular 
myocardium will only experience low voltage changes in their membrane 
potential. After an unsuccessful countershock, activation occurs in such low 
potential areas (areas of critical local field strength), and result in VF being re-
initiated (94, 104). 
(ii) Within the area of critical local field strength, the interval between the AP 
upstroke and the subsequent defibrillation shock (known as the coupling 
interval) also determines the probability of successful defibrillation (104). 
Normalised coupling intervals <40% of the mean fibrillation cycle length 
produce longer post-shock refractory periods, and are therefore more likely to 
result in successful defibrillation (105). Thus there is also a critical level of 
recovery. 
The "critical point re-entry" mechanism hypothesises that after countershocks of 
insufficient strength re-entry will occur at the intersection of the critical local field strength 
and the critical level of recovery. A countershock of sufficient strength will produce a 
unifonn prolongation of refractoriness throughout the ventricular myocardium, irrespective 
of the timing of the shock (104, 106, 107). 
1.2.1.3 "Virtual Electrode" mechanism 
Over the past decade, the validity of the "critical point re-entry" mechanism has been 
challenged. This hypothesis fails to explain all activation patterns that have been observed 
after an unsuccessful defibrillation. For, instance, it cannot explain focal, patterns of 
activation (108, 109), re-entry after a prolonged period of electrical quiescence (known as 
the isoelectric window) (109, 110) or re-entry in close proximityto the electrodes where 
the field strength is high (96). A hypothesis which can explain all these observations is the 
"Virtual Electrode" mechanism (for review see (111». 
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The concept of the virtual electrode (VE) arose from bidomain modelling of cardiac tissue 
during extracellular unipolar stimulation (112). These simulations predicted that a single 
polarity electrode would simultaneously produce dog-bone shaped regions of 
depolarisation and hyperpolarisation as a result of the differential intracellular-to-
extracellular conductivity. These predictions were verified experimentally, with 
depolarisation being attributed to the actions of a virtual cathode, whilst hyperpolarisation 
was induced by a virtual anode (Figure 1.9A) (113). Bipolar stimulation results in more 
complex patterns of virtual electrodes (114-116). As shown in figure 1.10, the virtual 
electrode pattern depends upon on the relative orientation of the dipole and the myocardial 
fibres. 
For electrical field stimulation, theoretical (117) and experimental studies (118) resulted in 
.' 
virtual cathodes and anodes across the myocardium (Figure 1.11 A). The position of these 
virtual electrodes was determined by the field configuration and the tissue structures. 
Within the virtual cathode, positive polarisation results in prolongation of activation and 
refractoriness (Figure 1.9B). In contrast, the negative polarisation of the virtual anode 
shortens the activation and the refractory period (Figure 1.ge). Where there is close spatial 
approximation of the virtual electrodes, the virtual cathode activation propagates to 
stimulate the now partially excitable virtual anode tissue. This stimulation is known as 
break-excitation (Figure 1.9D). The wave of break-excitation propagates slowly, as the 
virtual anode is not fully excitable. Therefore enough time elapses to allow full recovery of 
the virtual cathode region, ·which can now be re-excited. This leads to re-entry around a 
shock-induced phase singularity (Figure 1.11), and thus the re-initiation of VF (96, 98). 
Shock strengths that induce such phase-singularities are said to be within the heart's 
window of vulnerability. The highest shock strength that will induce such a phase 
singularity is known as the Upper Limit of Vulnerability (ULV) (119, 120). 
-1 
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Figure 1.9 Virtual electrodes in unipolar stimulation. Panel A: Virtual electrode polarisation 
during anode (+) and cathode (-) stimulation. The change in polarity of the surrounding 
myocardium is represented in grey-scale, with virtual anodes in white and virtual cathodes 
in black. Note the dog-bone shape to the polarity. Panel B: Effect of virtual cathode 
stimulation on AP. There is positive polarisation, which results in prolongation of AP, 
repolarisation and thus the refractory period. Panel C: Effect of virtual anode stimulation on 
AP. The negative polarisation results in shortening of the AP, repolarisation and thus the 
refractory period. Panel 0: Effect of virtual anode close to virtual cathode. The partially 
repolarised tissue can now be re-excited by the propagating activation from the virtual 
cathode. This results in re-entry and thus failure of defibrillation. (Adapted from (121». 
Under this hypothesis, defibrillation is successful when the shock is greater than the UL V. 
Here, the shock is of sufficient strength to restore full excitability to the myocardium 
underlying the virtual anode. The break-excitation now propagates rapidly, and returns to 
an unexcitable virtual cathode. At this point the break-excitation fails to propagate, and 
thus re-entry cannot occur. 
1.2.2 Assessment of defibrillation energies 
Owing to the chaotic nature ofVF, identical experimental conditions can result in variable 
electrical activity at the point of defibrillation. This variable electrical activity results in 
variable defibrillation energies, and thus their assessment has a probabilistic component 
(122, 122). To allow for this, the defibrillation threshold (DFT)' is defined as the energy 
that successfully defibrillates a certain percentage of VF episodes; e.g. the DFTso is the 
energy that successfully defibrillates 50% of VF episodes. Accurate detennination of 
DFTso requires a complex protocol involving several short runs of VF (123). It is not 
possible to use this protocol in conjunction with long runs (- 1 0 minutes) of VF without 
causing deterioration of the experimental preparation. 
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A simpler measurement of defibrillation energy is the Minimum Defibrillation Energy 
(MDE) (73). In this measurement hearts are defibrillated by a step-up protocol, and the 
MDE is determined as the energy that successfully converts the heart to sinus rhythm. This 
measurement does not take into account the probabilistic nature of defibrillation. 
A B 
+40 
-40 
mV 
Figure 1.10 Virtual electrodes on bipolar stimulation. The pattern of virtual electrodes 
polarisation is dependent on the orientation of the dipole with respect to the myocardial 
fibres. Panel A: Dipole perpendicular to the longitudinal axis of the fibres produces an 
interweaving trefoil pattern. Panel B: Dipole parallel to the long axis of the fibres produce 
simpler patterns. (Adapted from (116)). 
A B 
• ·70 mV +10 520 ms 630 
Figure 1.11 Shock-induced phase Singularity. Panel A: Isopotential map after application of 
monophasic shock. A virtual electrode polarisation pattern is produced with a virtual 
cathode (VC) and virtual anode (VA) in close proximity. Panel B: Isochronal activation map 
of post shock activation. The break-excitation spreads from the virtual cathode to the virtual 
anode. As this propagation is slow full recovery of the virtual cathode has occurred and 
thus re-entry around a shock-induced phase singularity can occur. (Adapted from (121)). 
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1.2.3 Factors affecting successful defibrillation 
Successful defibrillation is, influenced by variables of the shock and the patient. 
1.2.3.1 Countershock characteristics 
waveform 
electrode configuration and 
The ability of a countershock to polarise sufficient myocardium, with sufficient strength, is 
influenced by the electrode configuration. In general, the electrode configuration that gives 
the smallest area oflow potential gradient results in the lowest defibrillation threshold (94). 
Throughout this thesis the electrode configuration was unchanged, and thus was not a 
source of defibrillation energy variation. 
Historically, external defibrillators delivered monophasic impulses similar to that of figure 
1.12A. Electronics required to produce such impulses are simpler than those required to 
make the impulse bidirectional (biphasic) (Figure 1.12B). However, monophasic 
countershocks require relatively high voltages to defibrillate successfully. On repeated 
application such voltages can damage the myocardium, and thus cause post resuscitation 
cardiac failure. Although extremely high voltage electric shocks have been shown to 
damage the myocardium (124), the shock voltages used clinically cause only transient, 
completely reversible dysfunction (125). Similarly, repeated low voltage shocks in the rat 
accentuated diastolic dysfunction (impaired myocardial relaxation), but not systolic 
dysfunction (94). 
A B 
Figure 1.12 Defibrillator waveforms. Panel A: Monophasic waveform. Panel B: Biphaslc 
waveform. 
Mechanisms postulated to explain the greater effectiveness of the biphasic waveform are: -
(i) Critical point mechanism - As explained above, the "critical point re-entry" mechanism 
hypothesises that countershocks of insufficient strength will result in re-entry at the 
intersection of the critical level of recovery and the critical local field strength. In 
accordance with this theory, biphasic shocks should be more effective if they extend 
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refractoriness or increase field strength compared to equivalent strength monophasic 
shocks. Figure 1.13 shows the direct comparison of monophasic and biphasic waveforms 
of equal strengths on the action potential duration (APD). This shows that biphasic 
waveforms of lower voltage are able to produce equivalent APD prolongation to 
monophasic waveforms of higher voltages (126, 127). In terms of critical field strength, it 
has been suggested that a) electrical impedance is reduced during the second/reversed 
polarity phase - this aids current flow, and reduces the area below "critical field strength" 
(128) and b) the biphasic waveform is better able to stimulate the myocardium by effects 
on sodium channels (128). This second phenomenon may explain why biphasic waveforms 
are especially effective in prolonged VF (129). In early VF, cells are reactivated soon after 
their refractory period is over. In longer duration VF, the myocytes experience electrical 
diastole after the refractory period (post-repolarisation refractoriness) "(130). In electrical 
diastole, cells must first be excited for the countershock to prolong their refractoriness. 
Biphasic waveforms achieve this more efficiently, as the first phase acts to excite the cells 
(127). 
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Figure 1.13 Transmembrane recordings from Isolated myocytes. Panel A: Monophasic 
stimulation at voltages (i) just below and (II) just above excitation threshold. Panel B: 
Biphasic stimulation at same voltages. (i) subthreshold voltage now triggers an action 
potential and (II) suprathreshold voltage results in more prolonged APD. (Adapted from 
(127» 
(ii) VE mechanism - this hypothesis more eloquently explains why monophasic shocks 
require greater energies than biphasic shocks. As explained in the VE hypothesis above, 
for monophasic shocks, successful defibrillation requires the shock to be greater than the 
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ULV, so that a phase-singularity is not produced. With biphasic shocks, the second part of 
the wavefonn reverses the first-phase polarisation. This removes the substrate of re-entry 
so that a phase singularity can no longer be produced (96). 
1.2.3.2 Patient characteristics - arrest duration/ischaemia 
As previously stated, the likelihood of successful defibrillation diminishes with time in 
out-of-hospital VF arrests. The influence of metabolic changes on the ability to defibrillate 
has been investigated in porcine models. However, these studies have not yielded 
consistent results. In one study, increased myocardial PC02, rather than acidosis, 
correlated with the haemodynamic efficacy of the resuscitation effort, and the consequent 
success of defibrillation (80). In another study, hypercarbia and hypoxia independently 
reduced the success of defibrillation (75). In a third, hyperkalaemia and ionised 
hypocalcaemia were associated with prolonged resuscitation efforts and unsuccessful 
defibrillation (83). None of these studies examined the underlying mechanism for the 
reduced defibrillation success. Nor did they relate the metabolic changes to VF frequency. 
1.2.3.3 Paradox of relationship between OF and OFT 
Both clinical studies and animal studies using in situ hearts, have correlated OF with 
defibrillation success, such that below a certain OF threshold, the likelihood of successful 
defibrillation is diminished (23, 30, 131). However, the relationship between OF and 
defibrillation threshold (OFT) is not a simple one. In the isolated Langendorff-perfused pig 
heart, reducing the perfusion rate not only reduced the OF, but also reduced the OFT 
compared to fully perfused controls (73). Barton et al. hypothesised that the lower OF 
reflected more synchronised and homogeneous electrical activity within the ischaemic 
myocardium. By reducing myocardial excitability and increasing refractoriness, ischaemia 
was proposed to enhance the electrical organisation. They predicted that this increased co-
ordination facilitated defibrillation, and hence the reduced OFT. Similarly, the level of 
temporal coherence between orthogonal ECG recordings has been correlated to 
defibrillation success (132). Patwardhan et al. showed that higher levels of temporal 
coherence were associated with greater defibrillation success in dogs (132). 
However, evidence to the contrary also exists. Chen's proposal of a slower, type 2 VF in 
ischaemia outlines that the reduced excitability produces wavebreak of the emerging post-
shock wavefronts with consequent re-initiation of VF (68). Furthennore, a study in pigs 
demonstrated that more irregular ECGs in VF were associated with greater defibrillation 
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success (133). Therefore, the relationship between DF and DFT merits further 
characterisation. 
1.3 Techniques for studying electrophysiology of VF 
Through the decades, VF has been studied using different techniques in different models. 
Each of these methods has advantages and disadvantages, as summarised in table1.1. 
1.3.1 Intact vs. isolated 
The major advantages of intact animals over isolated preparations are (i) they closely 
mimic human cardiac arrests and (ii) all of the hormonal influences are intact. The 
influence of autonomic stimulation in VF is complex. Sympathetic output appears to 
facilitate VF initiation by steepening the restitution kinetics (87) and increasing the 
dispersion of refractoriness (134, 135). In agreement with this beta-blockers are associated 
with a) spontaneous defibrillation during ischaemic-induced VF in isolated rabbit hearts 
(136) and b) reduced cardiac deaths from VF in the context of myocardial infarction in 
humans (137). 
However, intact sympathetic innervation can complicate and confound the investigation of 
VF. Studies measuring VF intervals as a marker of refractory period have shown 
tremendous variation in the effect of sympathetic ganglion stimulation at different sites in 
different animals (135). Puzzlingly, sympathetic stimulation increased the dispersion of 
refractoriness in some hearts, yet decreased it in .others. The influence of direct autonomic 
stimulation on dominant frequency of VF is as yet unknown. Standard processes to isolate 
the heart result in it being denervated. Although this denervation prevents the investigation 
of VF during autonomic activation, it minimizes inter-heart variation. Other advantages of 
the isolated heart preparation are (i) variables such as P02, pH and [K+]EC may be 
controlled individually and (ii) a wider range of observational techniques can be utilised 
(Table 1.1). 
1.3.2 Global ECG 
As the fluids of the body act as good electrical conductors, the electrical activity of the 
heart can be detected via electrodes on the body's surface. The electrical signal recorded 
between two surface electrodes is the extracellular algebraic summation of the action 
potentials (APs) of all the myocardial fibres of the heart (138). Figure 1.14 illustrates how 
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the various components of the surface ECG anse from the spread of activation and 
repolarisation throughout the heart. Owing to this global nature, the spatial resolution of 
the ECG is very low. 
Method . Location Can be Maximum Spatial 
used in number of resolution 
vivo? simultaneous 
recordings 
.Global ECG - Yes I low 
Single cell Transmural No 1 cell 
microelectrode on 
dissociation 
Floating Surface. No ~ 3 cell 
microelectrode Transmural 
on wedge 
preparation 
MAP Surface Yes ~ 1 2 cm 
Optical Superficial No I OOs - IOOOs fl.II1 - cm 
mapping 
Table 1.1 Summary of techniques for investigation of VF (adapted from (44». 
SA node 
Atrial myocytes 
AV node 
Bundle of His 
Bundle branches 
Pukinje fibres 
Ventricular myocytes 
ECG 
o 200 400 
Time (ms) 
Temporal 
resolution 
Hi.gh 
High 
High 
High 
High 
Figure 1.14 Origins of the ECG. The transmembrane AP for the SA node, the AV node, other 
parts of the heart's conducting system, atrial muscle and ventricular muscle are illustrated 
with reference to the surface ECG. The 'p ' wave corresponds to the activation and 
repolarisation of the atrial myocytes. The QRS complex corresponds to the spread of 
activation across the ventricles. The ST segment occurs due to the electronegative 
summation of the ventricular AP plateaux, and the T wave results from the sequential 
repolarisation of the ventricular myocytes. (Adapted from (138». 
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In clinical studies, the only method available to analyze VF is the surface ECG. Such 
recordings are non-invasive and are easily obtained; at cardiac arrests external 
defibrillators store the ECGrecordings. However, these ECG recordings give a very 
general picture of the electrical activity of the heart, as a maximum of three leads, or axes 
of the heart, are recorded. Studies of intact animals, without thoracotomy to expose the 
heart, are subject to the same limitations. 
In this thesis, a single lead global ECG was acquired from 2 electrodes mounted in the 
walls of the optical mapping chamber (Figure 2.2A). The time-course of the DF of this 
global ECG during VF was compared with previous clinical and animal studies. 
1.3.3 Microeiectrode 
Glass micro electrodes impale a single cell. By comparing t~e intracellular potential to a 
reference extracellular electrode, the absolute membrane potential is measured. Such 
transmembrane recordings give a clearer appreciation of the cellular electrophysiological 
changes that occur during VF. 
Traditional microelectrode techniques require a stable intracellular impalement to measure 
the membrane potential. Maintaining the microelectrode tip in the intracellular space can 
be difficult in multi-cellular preparations, and is impossible in the contracting whole heart. 
Therefore, traditional microelectrode techniques can only be performed on multi-cellular 
preparations that are unable support VF (cf. critical mass hypothesis). The technique of the 
floating microe1ectrode was adapted to allow ericardial transmembrane recordings from 
isolated whole hearts (81, 139) or in situ hearts (140). Rather than trying to maintain one 
stable intracellular impalement, the electrode is suspended from above (Figure 2.16) and 
allowed to make a series of repeated (or floating) impalements (141). The lack of stability 
of impalement limits the number of simultaneous measurements. Another limitation of this 
method is that only the epicardial surface of the isolated whole heart can be examined. 
In this thesis, floating microelectrodes were used to assess the precise changes in LV 
epicardial transmembrane potential during VF. 
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1.3.4 Monophasic Action Potentials 
In the early 1980s, Franz developed a contact electrode catheter that recorded Monophasic 
Action Potentials (MAPs) (142). Although the source of these signals is debated (143-14S), 
Franz's hypothesis of their origin is sti1llargely accepted (146). 
The Franz contact electrode consists of 2 electrodes; one at the tip, in contact with the 
underlying tissue, and a second, placed more proximal on the catheter. As shown in figure 
1.1S, the pressure of the contact electrode causes fixed low-level depolarisation of the 
underlying tissue. Therefore, during diastole, there is a steady flow of current from the 
surrounding non-depolarised tissue to the low-level depolarised tissue underlying the 
electrode (Figure 1.1SA). On activation, the surrounding tissue becomes more depolarised, 
and thus the current flow is reversed, producing the MAP upstroke and plateau (Figures 
1.1SB & C). As the surrounding tissue repolarises, the currents are again reversed to the 
original diastolic situation (Figure 1.ISD). 
Although unable to measure the actual membrane potential, MAPs have been shown to 
accurately reflect the repolarisation time-course of the transmembrane AP compared to 
adjacent glass micro electrodes (147). In' contrast, the upstroke velocity of the MAP is 
slower than the transmembrane AP (146). This is due to the larger number of cells that 
MAP electrodes records from compared to glass microeletrodes. The number of cells that 
influence the transmembrane AP is determined by the space constant. Although the 
microelectrode impales a single cell, the resultant membrane potential is influenced by the 
electrical activity of the surrounding cells. The degree of electrical influence of a 
surrounding cell depends on its distance from the impaled cell. The influence decreases 
exponentially with distance and is described by the space constant. 'Typical space constants 
in the rabbit ventricle are 0.1 - O.3mm (148). This equates to a SO% drop in the electrical 
potential influence at 200J..l111. In contrast, MAP electrodes have tip diameters of 1-2mm, 
and spheres of electical influence beyond that. Precise space constants have not been 
determined for MAP electrodes, but spheres of influence are thOUght to be <5mm (146). 
Advantages of MAP recordings are (i) non-reliance on stable impalement, (ii) a greater 
number of recordings are possible, which with increasing computer power allows surface 
maps to be constructed, and (iii) although contact electrodes are only influenced by the 
very surface layers of the epicardium (149), intramural needle electrodes can penetrate 
further (135). Disadvantages of MAP recordings are (i) the inability to record absolute 
potentials and (ii) the need to isolate the electrical apparatus during defibrillation (92) 
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therefore producing a short window of time during which electrical activity cannot be 
observed. 
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Figure 1.15 Hypothesis of genesis of MAP recording by contact electrode. Panel A: Late 
electrical diastole. The myocytes intracellular potential Is -90mV. There is fixed 
depolarisation (grey shading) of the tissue underlying the contact electrode (black 
indentation). Thus a potential gradient exist between the normal surrounding tissue and the 
fixed depolarised tissue under the contact electrode. This results in an extracellular current 
flow from the normal tissue (circular lines with arrow). Panel B: Early electrical systole. The 
tissue under the electrode remains fixed. Depolarisatlon of the activation side tissue now 
reverses the current resulting In the MAP upstroke. Panel C: Mid systole. As the activation 
spreads all the surrounding tissue Is now more depolarlsed than the reference area. This 
results in the MAP plateau. Panel 0: Early diastole. As the activation wave recedes from the 
MAP the surrounding tissue returns to pre-activation potentials and the current reverts to 
that in A. (Adapted from (146), TAP = Transmembrane Action Potential). 
In this thesis, MAP recordings were used to assess alterations in repolarisation and 
refractoriness simultaneously in the LV and RV. Repolarization and refractoriness cannot 
be measured directly during VF, therefore both parameters were assessed during epicardial 
pacing. 
1.3.5 Optical mapping 
Optical mapping allows the simultaneous recording of the electrical activity of hundreds to 
tens of thousands of sites on a cardiac surface (For review see (150,151)). Hearts are first 
loaded with a voltage-sensitive fluorescent dye (such as RH237) that integrates into the 
myocyte membrane. After being excited by short wavelength light, the dye fluoresces at 
longer wavelengths. The spectral characteristics of this fluorescence are altered by the 
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membrane potential. Figure 1.16 shows how membrane depolarisation results in a shift of 
RH237's fluorescence spectrum to shorter wavelengths. This spectral shift affects the 
amplitude of the fluorescence as measured beyond a fixed long wavelength cut-off. 
Therefore membrane depolarisation results in a relative fall in fluorescence at longer 
wavelengths. On membrane repolarisation, the spectrum returns to its original 
characteristics, resulting in an increase in fluorescence back to pre-activation levels. 
_ Polarised 
~F 
Figure 1.16 Diagram of voltage-sensitive spectral shift. Depolarisation produces a reduction 
In fluorescence at the red end of the spectrum e.g. RH237. (Adapted from (152». 
The nature of the optical action potential (AP) is different from the transmembrane AP 
recorded by a microelectrode. The optical AP reflects the activation of a group of cells that 
are defined by the photodiode size, the magnification and the depth of field. For the optical 
apparatus used in this thesis, this equated to a volume of 0.8 x 0.8 x 0.09mm "" 0.056mm2 
on the epicardial surface (Chapter 2.4). The surface cells have equal influence on the 
optical AP. The electrical influence from underlying cells is harder to define. As discussed 
above, the number of cells that influence the transmembrane AP is determined by the space 
constant with typical space constants in the rabbit ventricle is 0.1 - O.3mm (148). This 
equates to 50% drop in electrical potential influence at 200J..Lm. Thus the number of cells 
influencing the optical AP is far greater than the number affecting the transmembrane AP 
as recorded by microelectrode. 
For this reason, as shown in figure 1.17, the optical AP upslope is slower than the 
simultaneous transmembrane AP. Cells adjacent to each other do not activate 
simultaneously, but rather activate in rapid succession as the wave of excitation spreads. 
The extent of upstroke slowing depends on the number of cells influencing the membrane 
potential recording. In optical mapping the extent of this smearing is determined by the 
spatial resolution of the optical system. The spatial resolution is determined by a 
combination of the optical magnification, and the number of recording sites on the 
detector. The optical magnification is a limiting factor on the spatial resolution as 
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increasing magnification reduces signal quality (153). As shown in figure 1.18, fluorescent 
light is collected from fewer and fewer cells as the optical magnification is increased. 
Therefore, at higher magnifications optical signals have lower amplitudes, and are poorer 
quality as the signal-to-noise ratio falls (Figure 1.19). 
Figure 1.17 Comparison of microelectrode and optical upstroke. The raw data illustrated 
was recorded under control conditions whilst pacing at basic cycle length 180ms. The 
upstroke velocity of a LV optical Signal (Chapter 7.3.2) Is slower as It represents the 
summation of the activation of hundreds of thousands of cells from a volume of .., 
0.056mm2. In comparison, the electrotonic influence on transmembrane recordings from a 
floating microelectrode (Chapter 9.3) Is more limited. 
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Figure 1.18 Influence of magnification In optical mapping. Panel A: Plot of magnification vs. 
spacial resolution - the spatial resolution, r, varies as Inverse with the degree of optical 
magnification. Panel B: Plot of magnification vs. pixel area - the surface area of tissue 
Imaged onto each photo element decreases with Increasing optical magnification (pixel area 
= a x b). Panel C: Plot of magnification vs. cells per pixel- the estimated number of cells 
that contribute to the signal focused onto any Individual detector reduces with Increasing 
magnification. (Adapted from (153». 
Jane C. Caldwell, 2006 Chapter ~, 50 
Movement during myocardial contraction alters the site that the detector is focused on, and 
therefore changes the signal fluorescence for reasons unrelated to the membrane potential 
(movement artefact). Although electro-mechanical uncoupling agents can be used to 
reduce or even eliminate movement, evidence is growing that they alter the 
electrophysiological properties that are being studied (139, 154, 155). Therefore in this 
thesis the use of electro-mechanical uncoupling agents was avoided where possible. 
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Figure 1.19 Voltage resolution and slgnal-to-noise ratio (SNR). Plotting voltage resolution 
vs. spatial resolution shows how the voltage resolution, and signal fidelity fall as the spatial 
resolution is Increased (I.e. as the pixel area Is decreased). This occurs because fewer cells 
are contributing to the optical action potential signal, whilst system noise and illumination 
remain constant. (Adapted from (153». 
Previously it was thought, that similar to contact electrodes, optical recordings originated 
from only the very surface layer of the epicardium. Evidence now shows that optical 
measurements may penetrate deeper. Using a trapsparent mapping array, Knisley et al. 
compared simultaneously the excitation intervals of optical and" extracellular electrical 
recordings, and demonstrated that the differences between them could be attributed to 
deeper optical interrogation and the accompanying fibre rotation (149). This 'depth of 
field' effect is an additional complication, but its dependency on the optical properties of 
the set-up allows it to be quantified using standard optical equations (156). For the 
photodiode array (PDA) based optical set-up used in this thesis (Figure 2.4): -
Depth ofField = 1000J..lm/[(7 x NA x magnification) + Aexl2(NAi] 
= 1000/[(7 x 1.4 x 1.2) + 0.535/2x1.42] 
=90J..Lm (NA = Numerical Aperture) 
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This depth of field is sufficiently shallow to exclude a major influence from deeper 
myocardial layers. 
A major advantage of optical mapping is that the lack of electrical contact with the heart 
allows continuous recording during defibrillation (157). 
1.4 Aims and hypothesis 
The aims of this thesis were: -
(i) To verify in the isolated rabbit heart the slowing of the ECG dominant 
frequency during VF under conditions oflow-flow ischaemia. 
(ii) To investigate the spatiotemporal pattern of this electrical slowing using optical 
mapping. 
(iii) To investigate which components of ischaemia are responsible for the slowing 
of the ECG dominant frequency, and whether they produce the same 
spatiotemporal patterns as observed in VF during low-flow ischaemia. 
(iv) To assess which components of ischaemia reduce the likelihood of successful 
defibrillation by increasing the energies required to defibrillate. 
The hypothesis at the outset was that a single component of ischaemia would be identified 
as being responsible for slowing the ECG dominant frequency, and that the same 
component would increase the energies required to successfully defibrillated VF. 
· 52 
2 Methods 
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2.1 Preparation for Langendorff perfusion 
Male New Zealand White rabbits, weighing 2.5 - 3.0kg, were sacrificed by tenninal 
anaesthesia using an intravenous cocktail of 0.5ml/kg Euthatal (sodium pentobarbitone 200 
mg/kg, Rhone M6rieux) and 500 IU of heparin. The hearts were rapidly excised, 
transferred into chilled Tyrode's solution to transiently stop contractions, then mounted 
onto an aortic cannula and perfused retrogradely (Langendorff mode, Figure 2.1). The 
Tyrode's solution was composed of (units = mM) Na+ 134.5, Mg2+ 1.0, K+ 5.0, Ca2+ 1.9, 
cr 101.8, SO/- 1.0, H2P04- 0.7, HC03- 20, acetate (CH3COO) 20 and glucose (C6HI206) 
50. This high glucose concentration prevented osmotic swelling with its incumbent 
electrophysiological changes (Prof. Guy Salama, Personal communication & (158)). The 
solution was filtered through a 5J.Ul1 filter (Whatman) prior to use. With the exception of 
acidic pH protocols, the solution pH was maintained at 7.4 by bubbling with a 95% 02/5% 
CO2 gas mixture (BOC, UK). The solution perfusing, and surrounding the heart, was 
maintained at 37°C by a glass-column heat exchanger connected to a thennostat-controlled 
water bath (Figure 2.1). Using a Gilson Minipuls 3 peristaltic pump, the Langendorff 
perfusion was rate controlled rather than pressure controlled. A standard perfusion rate of 
40ml/min was used in all but low-flow ischaemia experiments. A transducer connected to 
the aortic cannula monitored the perfusion pressure. Experimentation was discontinued 
when pressures rose above 70mmHg; typical starting pressures were approximately 
45mmHg. 
2.2 Pacing and ECG 
Pacing was achieved by connecting the relevant electrodes to a Digitimer DS2 stimulator. 
This provided a constant voltage, square pulse of 2ms width. The timing of the pulse was 
computer controlled using locally developed software (Dr FL Burton, University of 
Glasgow). The pacing protocols for each experimental protocol are outlined in the relevant 
chapter. 
In the optical experiments, global ECG signals were obtained using electrodes mounted 
within the chamber walls (Figure 2.2A). Signals from these electrodes were amplified by a 
MAP amplifier (custom built by Dr. Mark Watts, Glasgow Royal Infinnary), before being 
relayed to an oscilloscope (Nicolet Instrument Corporation, Wisconsin, USA.) to allow 
real-time viewing, and to the photodiode array (PDA). During optical experiments, the 4 
comer channels of the PDA were reserved for recording the ECG and pacing stimuli 
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traces. In MAP and microelectrode experiments no ECG recordings were taken. In these 
experiments, pacing stimuli were recorded in a separate channel via the relevant amplifier. 
2.3 VF induction 
Experimentally VF can be induced in many ways, each with its advantages and 
disadvantages. 
(i) The most clinically relevant method of VF induction is through regional 
ischaemiaJreperfusion. Regional ischaemia can be induced by external ligation 
of the Left Anterior Descending artery (LAD) (22). This method requires 
almost complete occlusion of the artery, which is technically difficult. 
Furthermore VF does not automatically follow the ischaemic challenge. 
(ii) The application of a low-voltage stimulus during the vulnerable period of 
repolarisation (Le. the T wave) can induce VF by increasing repolarisation 
heterogeneity (159). This method requires the application of a strong enough 
stimulus at a precise time-point of the APD. Having 2 variables (amplitude and 
timing) reduces the reliability of this method, such that several attempts are 
often required to induce VF (160). 
(iii) A more reliable method ofVF induction is the application of a high-voltage DC 
shock (160). However, this shock can cause damage to the heart, and 
secondarily to myocardial stunning, results in slowing of the VF frequencies 
immediately post induction (161), Dr F !3urton, Personal Communications). 
(iv) VF induction by burst pacing does not damage the heart, or result in stunning. 
Therefore, this method of induction was preferred due to its lack of effect on 
VF frequencies (162) and lack of damage to the preparation. Compared to 
"Shock-on-T" induction (ii), burst pacing is more likely to induce VT (162). In 
such cases, VT was immediately detected on the ECG, and VF induced by a 
second burst-pacing salvo of 50Hz for 8s. 
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Figure 2.1 Langendorff perfusion apparatus 
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2.4 Defibrillation 
Although VF can be defibrillated chemically (163, 164), electrical defibrillation is the 
standard practice in the clinical setting. In this thesis, hearts were defibrillated using an 
external cardiac defibrillator (Ventak ECD 2815, CPL, St Paul's, MN, USA). This 
defibrillator has a 140)lF capacitor, 80% fixed tilt with 1st phase 60% of total duration. In 
this external defibrillator, the wavefonn duration is automatically adjusted to resistance 
load. The typical resistance of a rabbit heart was -480, which gave rise to wavefonn 
duration of -14ms. Shocks were delivered via custom-made stainless steel paddles (Figure 
2.2A). The defibrillation paddles cradled the heart and reduced motion artefact. These 
paddles were fixed with respect to the front-plate and the area of optical interrogation. As 
the interrogation area was standardised using the left anterior descending artery (LAD) as a 
landmark, the paddle position on the heart was relatively constant. The orientation of initial 
electrode polarity was also kept constant. 
2.5 Optical mapping 
Epicardial membrane potentials from the anterior surface of the heart were acquired using 
an optical mapping array. Langendorff-perfused hearts were positioned into the custom-
made Perspex chamber shown in figure 2.2. The heart's exterior surface was maintained at 
37°C by allowing the coronary sinus effluent to fill the chamber. The contractile motion of 
the heart was reduced during optical recordings by (i) cradling it between the defibrillation 
electrodes and (ii) transiently applying gentle compression against the front-plate by 
sliding forward the back piston (Figure 2.2). 
The hearts were loaded with a 100)l1 bolus of the voltage-sensitive, fluorescent dye RH237 
(Molecular Probes) (Figure 2.3), dissolved in DMSO (1mglml). This bolus was 
administered into the coronary circulation by slow injection through the bubble trap "Dye 
port" (Figure 2.1). When RH237 is excited at 514.5nm, depolarisation by an action 
potential produces a fractional fluorescence decrease of approx. 2 - 6% (165). This 
highlights that a large component of the optical signal is due to background fluorescence 
(166). This background component was removed by software subtraction prior to data 
analysis. 
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Figure 2.2 Photographs of the optical mapping chamber. Panel A: Photograph of the front 
elevation of Perspex chamber. This shows the defibrillation electrodes that cradled the 
heart, and the wall-mounted electrodes that record the ECG. Panel B: Photograph showing 
the side elevation. Sliding forward the back piston allowed transient compression of the 
heart against the frontplate. 
Figure 2.4 illustrates how the anterior surface of the heart was illuminated with light from 
4 x 75W tungsten-halogen bulbs passing through 535 ± 25JUTI interference filters (Comar 
Instruments) (Figure 2.4). Fluorescent light emitted from the epicardial surface was 
collected with a camera lens (Nikon 85mm, f1: 1.4) and focused through a 695nm long-
pass filter onto a 16 x 16 PDA (C4675-102, Hamamatsu Photonics). As the 4 corner 
channels were reserved for ECG and pacing signals, optical signals were acquired by 252 
of 256 diodes. Each diode had a sensing area of 0'95mm x 0·95 mm. The distance 
between the centres of adjacent diodes, or pitch, was 1·1 mm. The magnification of the 
optical system was x 1·2. Therefore each diode detected light from an epicardial area of 
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O'8mm x O·8mm. Data was digitised at 1kHz, stored onto disk, and analysed offline using 
software written in IDL (Interactive Data Language, Research Systems Inc.). Photographic 
images of the epicardial area of interrogation were taken using a charged-coupled device 
(CCO). This CCD was perpendicular to the PDA, and at the same focal distance. The CCD 
and PDA were precisely aligned using a patterned black/white square print and a mirror. 
As the alignment was crucial for the correct identification of the RV IL V border, it was 
verified at the start of each experimental day. At the end of each experimental day, the 
location of the RV IL V boundary was confirmed by suture placement; the RV was incised 
and sutures inserted at the junction of the RV free wall and the inter-ventricular septum. 
Figure 2.3 Chemical structure of RH237 
A second critical element was the adjustment of the focal plane so that light was collected 
from the epicardial surface. This was achieved by adjusting the focus to give a sharp edge 
to the epicardial fat streaks on the heart's surface. 
Tungsten-halogen lamp 
Excitation filter 
535nm Emission filter >695nm 
Chamber q: 
Heart 
PDA 
cco RH237 
Figure 2.4 Diagram of the optical mapping set-up. 
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2.6 Analysis of VF 
2.6.1 Frequency analysis of VF 
Traditional spatiotemporal cardiac mappmg involves (i) identification of the local 
activation time, usually taken as the time of dV /dtmax of the AP upstroke (167), and (ii) 
subsequently plotting the spread of activation across the field of interest (48, 168). This 
creates a map of ever expanding contour lines (Isochronal mapping). Whilst ideal for 
analysing simple, repetitive rhythms, this method cannot be used to analysis the chaotic 
activity that occurs in VF. One approach to analysing complex rhythms like VF is to break 
the pattern into smaller constitutive parts, such as frequency (169). This can be 
accomplished using the mathematical tool of Fourier Transform, whose equation is 
outlined in figure 2.5. 
00 
s (t) = ~ J S (w)e"'" du; 
-00 
Figure 2.5 Fourier Transform equation 
In 1807, Baron Fourier developed his mathematical formula to describe the temporal 
dispersion of heat around an iron anchor ring (170). The resulting Fourier Transform 
breaks down any time-based waveform into a series of sinusoidal waves, each with its own 
magnitude, frequency and phase. As shown in figure 2.6, plotting the amplitude of each 
sinusoidal wave against frequency creates a frequency power spectrum. 
With the development of computers and software" a more efficient approach to Fourier 
analysis, known as the Fast Fourier Transform (FFT), was developed by Cooley and Tukey 
(171). By reducing the number of calculations more than 200 fold, this process is faster but 
at the cost of some data restrictions (172): - (i) The waveform to be analysed must consist 
of 2n data points. In this thesis 4098 data points were used; 4s of I kHz recordings (4000 
points) extended by 98 zero-pad points. (ii) Incomplete sinusoidal cycles lead to inaccurate 
interpretation of the frequencies involved. This is prevented by applying a window 
weighting function that tapers the data to zero. In this thesis, the Hamming window was 
applied to all raw VF signals prior to FFT analysis. FFT power spectra were derived from 
ECG and optical pixel signals. From the VF optical data, the power spectra of the 252 
pixels were summated to give a global power spectrum. This global power spectrum is 
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commonly known as the pseudoECG (psECG) (61, 173). The psECG reflects the average 
electrical activity ofVF within the epicardial area examined. 
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Figure 2.6 The Fourier Transform illustrated (adapted from (172». Panel A: The signal and 
power spectrum are of a 5kHz pure tone. The single sine wave produces a power spectrum 
consisting of a single line. Panel B: The signal and power spectrum for combined pure 
tones of 5 and 10kHz at same amplitude and phase. The power spectrum of this wave has 2 
lines of equal length. Panel C: the combination of fundamental (5kHz), first harmonic 
(10kHz) and second harmonic (20kHz) at equal amplitude and In phase give 3 lines of equal 
length on the power spectrum. Panel 0: A typical ECG signal In VF produces a more 
complex power spectrum. However, there is a clear peak (or dominant) frequency. 
From the FFT frequency power spectrum, statistical parameters can be derived and used to 
quantify the electrical activity of VF: - (i) Dominant Frequency (DF) - identified as the 
largest peak on the power spectrum, the DFis a measure of the predominant rate of 
activation. For the ECG, this reflects the predominant ventricular activation rate, whereas 
for optical signals, DF reflects the predominant activation rate within the confines of that 
pixel (174). As well as being equivalent to the ventricular fibrillation cycle length of 
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electrical mapping studies (4, 46, 135), the ECG-derived time-course ofDF in VF has been 
well characterised in human and animal studies (21-24, 30). (ii) Median Frequency (MF)-
The time-course of this measure of the average electrical activity has also been well 
characterised in human and animal VF studies (24-33). 
For this thesis, both DF and MF were analysed in all the VF experiments. As the time-
course and spatiotemporal patterns were identical in all conditions, only DF data is 
presented in this thesis. 
2.6.2 Amplitude analysis in VF 
During VF, the peak-to-peak amplitude of the ECG and optical signals was detennined 
using locally developed software (Dr Francis Burton). This software first filtered the raw 
signal by polynomial subtraction, high pass (50Hz) and low pass (3Hz) filters. As shown in 
figure 2.7, the VF peaks were then identified as the points where dV/dt changed orientation 
(i.e. from +ve to -ve or vice versa). The difference in y value between 2 consecutive peaks 
was taken as the action potential amplitude. 
2.6.3 Analysis of conduction velocity 
2.6.3.1 Apparent conduction velocity In VF 
In VF, the apparent conduction velocity was derived using software developed by Dr F. L. 
Burton (4, 46). This program first detects the activation front as dV/dtmax in each pixel. 
These activation times are compared between adjacent pixels to establish wave direction. 
The wavefront velocity is calculated at the centre point of each 2 x 2 pixel squares. This 
.-
process was repeated for all activations during the 4s datasets of VF. From these datasets, 
the mean and modal apparent CV was calculated. 
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Figure 2.7 Illustration of peak identification in ECG, optical and mlcroelectrode recordings. 
Panel A: Illustrates the signals after filtering (polynomial subtraction, low and high pass). 
Panel B: shows peak identification as the change In direction of dV/dt. Amplitude was 
measured as the peak-to-peak excursion. 
Figure 2.8 illustrates how in VF the patterns of wavefront propagation observed on the 
epicardial surface could result from simple linear conduction across epicardium or from 
more complex spiral waves in underlying intramural myocardium. Owing to the two-
dimensional nature of optical mapping, it is impossible to determine the true direction of 
propagation in VF. For this reason, conduction velocity was also assessed during epicardial 
pacing. 
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Figure 2.8 illustration of the different possible pathways of epicardial activation. Panel A: In 
VF, epicardial activity Is chaotic. The activation could originate from intramural rotors or 
multiple epicardial wavelets. Here a clock-wise rotating Intramural rotor Is Illustrated. 
Currently it is not possible to differentiate the VF activation pathways from the optically 
mapped epicardial surface. Panel B: In epicardial pacing, the activation wavefront changes 
from epicardial to intramural propogation owing to the non-uniformity of Intramural fibre 
orientation (175). This results In apparent acceleration of conduction. This diagrammatic 
representation shows how the epicardial CV changes with the direction of activation. Again 
the orientation of the underlying wavefront is Indiscernible from the epicardial surface. 
2.6.3.2 Conduction velocity from epicardial pacing 
Normally conduction velocity (CV) is determined during epicardial pacing rather than 
during spontaneous activity, atrial pacing or endocardial pacing. Stimulating the 
epicardium directly allows epicardial conduction to be assessed without potential artefact 
from transmural conduction. A Imm hole was drilled into the front-plate of the optical 
mapping chamber to allow epicardial stimulation with a bipolar "platinum electrode. 
Bipolar stimulation was used in preference to unipolar to produce more reliable point of 
first activation. 
In this thesis, the method for calculating epicardial CV was based on work by Bayly (176). 
(i) Activation times (time of dV/dtmax) were detected in each pixel using software 
developed in IDL (Interactive Data Language; Research Systems) by Dr Bum-Rak Choi 
(Pittsburgh, USA) (Figure 2.9A). (ii) From this activation matrix a series of polynomial 
curves were fitted to the epicardial activation times. (iii) From these curves two-
dimensional velocity vectors were generated (176) (Figure 2.9B). Processes (ii) and (iii) 
were performed using software developed by Dr Francis Burton in MatLab 7.0 (The 
MathWorks Inc, Natick, MA.). 
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There are several potential pitfalls in using velocity vectors to generate a representative 
assessment of the epicardial CV: - (i) Stimulating the epicardium with a bipolar electrode 
does not produce a single activation point. Rather it produces complex patterns of virtual 
electrodes from which the activation spreads (114-116) (Figure 1.10). Therefore, the CV 
must be assessed beyond these virtual electrodes. (ii) Epicardial stimulation activates 
deeper structures that can result in faster conduction than the epicardium (purkinje fibres, 
intramural cusps (175)). This faster activation can breakthrough onto the yet unexcited 
epicardial surface (Figure 2.8B). Therefore, CV must be assessed within a certain 
perimeter to avoid contamination by intramural breakthrough conduction. (iii) Conduction 
does not spread uniformly across the myocardium. Rather there is anisotropy, with faster 
, conduction along the length of the myocardial fibres (longitudinal CV) and slower CV 
perpendicular to this (transverse CV) (177). Therefore, the angle at which CV is assessed 
will also affect the value obtained. To avoid these pitfalls, and remove observer error, the 
CV was assessed by 3 different approaches: -
1. Radial- Figure 2.9 demonstrates the radial analysis ofCV. The stimulation point 
was identified as the central point of activation (* in Figure 2.9A). This was confirmed as 
the bipolar electrode location through CCD imaging. From this stimulation point, the CV 
was assessed around a 5mm radius (Figure 2.9A). Plotting CV against the angle of 
incidence allowed determination of the peak CVs around the 5mm radius (Figure 2.9C). 
These were identified as the longitudinal CV s. Depending on the bipolar, electrode 
location, the 5mm radius circle could cross the RVILV boundary. Therefore the 
longitudinal CV was assessed along the activation axis travelling away from the septum. 
Transverse CV s were identified as the CV s perpendicular to the longitudinal axis. As 
neither of these axes crossed the ventricular boundary, the transverse CV was determined 
as the average of the two CV s perpendicular to the longitudinal CV. .. 
2. Linear - Figure 2.10 outlines the linear approach to CV determination. On the 
isochronal activation map a line was drawn from the stimulation point (*) through the most 
distant point on each isochrone in a direction away from the septum (Figure 2.10A). The 
CV, as derived from the incident velocity vectors, was plotted along the length of this line 
(Figure 2.1OB(i)). Near to the bipolar stimulation point, the complex virtual electrodes 
produced prevent accurate determination of the velocity vectors. This leads to extremely 
variable and fast CV on the line-plot. At the distal regions edges of the line plot, intramural 
breakthrough again leads to artificially high and variable CV vectors. Between these points 
the plot had a low CV plateau which reflected the epicardial longitudinal CV. The 
longitudinal CV was taken along this plateau at a distance as close to 5mm from the 
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stimulus point as possible. Two lines were drawn perpendicular to this line (Figure 2. 1 OA) 
and were used to assess the transverse CV in an identical manner (Figures 2.10 B (ii) & 
(iii)). 
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" Figure 2.9 Illustrations of CV calculation from epicardial pacing and the radial approach to 
CV assessment. Panel A: Isochronal activation map with stimulation point ( ) and circle of 
5mm radius for radial CV assessment. The arrow indicates 0° on panel C. Panel B: 
Illustration of 20 velocity vectors derived from the activation times of Panel A as per (176, 
176). Panel C: Plot of CV around the 5mm radius. 0° is indicated on panel A. The plot then 
works anticlockwise around the circle for a full revolution. The two peak CVs in this trace 
reflect the longitudinal velocities. The longitudinal CV was measured on activations 
travelling away from the RVlLV boundary (dotted red line at 337°). Transverse CV was 
calculated as the mean of the two CV values at the pOints perpendicular to the longitudinal 
CV (dotted red lines at 67° and 247°). 
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Figure 2.10 Illustration of linear approach to CV assessment. Panel A: Isochronal activation 
map with stimulation point ( ), line for longitudinal CV (i), and 2 lines perpendicular (II), (ill) 
for transverse CV. Panel B: Plots of velocity along the lines in panel A as derived from local 
velocity vectors (Figure 2.9B). (i) Longitudinal CV plot. Between the artificially high CV from 
pacing stimulus and intramural conduction there is a relatively stable plateau (c. 3 - Scm 
from stimulus pOint). Longitudinal CV was measured from this plateau as near to Scm as 
possible. (ii) & (iii) show the 2 linear velocity used to calculate transverse CV in an identical 
manner. 
3. Point - Figure 2.11 displays the point CV approach to determining transverse 
CV. The local velocity vectors of figure 2.9B can be illustrated as a colour-coded map 
(Figure 2.11). This shows that there are 2 areas of more homogeneous CV along the same 
axes as the transverse CV. Five CV measurements were taken from each of the 
homogeneous areas, and the mean used as a further method to assess transverse CV. 
Both radial and linear strategies were open to observer error in the selection of the 
stimulation point. In addition, the linear approach relied on the correct selection of the 
angle of incidence. Therefore the radial method produced more consistent longitudinal and 
transverse CV results, and was used in most situations. 
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Figure 2.11 Point method for assessing CV. The local velocity vectors are represented in a 
colour-coded scale in this 20 maps. The boxes highlight areas of relatively homogeneous 
CV that are on the axes of transverse conduction. From each area 5 values of CV were taken 
and the average velocity calculated. 
2.7 Monophasic action potential 
The Langendorff-perfused hearts were placed within optical mapping Perspex chamber but 
in reversed antero-posterior orientation, and with the back-piston being replaced by a tight-
fitting "Sylgard" silicone plastic disc (Dow Company, USA) as shown in figure 2.12. 
Through the hnm hole in the "front-plate", now in contact with the posterior aspect of the 
heart, the RV was stimulated using a platinum bipolar electrode (Figure 2.l2A). Two Franz 
contact electrodes were placed against the anterior surfaces of the LV and the RV 
respectively through tight punctures in the "Sylgard" disc (Figure 2.l2B). Signals from the 
contact electrodes were amplified (custom built by Mark Watts, Glasgow Royal 
Infirmary), and subsequently digitalised at 1kHz (16bit) by a National Instruments data 
acquisition board (NJ 6130E, National Instruments Inc., Tx, USA) within a PC. Signals 
were stored to disc for offline analysis. 
2.7.1 MAP duration and restitution 
APD restitution can be determined by 3 different methods: - (i) S1S2 protocol - a train of 
approx. 10 impulses at resting physiological cycle length, is followed by a single impulse 
at a shorter cycle length. This protocol is highly influenced by the cardiac memory of the 
physiological cycle length, and thus will not be influenced by the continuous adaptation to 
faster activations as occurs in VF (51 , 178). (ii) Simulated VF - hearts are paced for 50 
impulses with a randomly selected sequence of cycle lengths as observed in VF. At the end 
of the 50 impulses, a 300ms pause allows full repolarisation, so that APD can be measured. 
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This process is repeated 30 times to allow the plotting of a restitution curve (51) (Figure 
2.13). This protocol is not suitable for comparing APD in different circumstances as a) the 
randomly selected pacing intervals affect cardiac memory differently, therefore giving 
variable APDs for a single DI as clearly shown in figure 2.13 , and b) the time taken to 
perform the protocol is too long to assess the dynamic situation of low-flow ischaemia. 
(iii) Steady state protocol - Hearts are paced with a sequence of 50 impulse salvos of set 
cycle length. The cycle length is reduced from one salvo to the next, and between each 
salvo there is a 500ms pause. The APD is measured from the last cycles at each cycle 
length. This protocol induces reproducible cardiac memory, and creates restitution slopes 
comparable to that of simulated VF (51). Therefore, in this thesis, steady state protocols 
were used to assess APD and restitution. 
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Figure 2.12 MAP recording. Panel A: Bipolar platinum electrode stimulating posterior aspect 
of RV. Panel B: Two Franz contact electrodes recording from the anterior aspect of the RV 
and LV. The LAD, indicated by yellow dotted line, guided the electrode placement. 
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Figure 2.13 APO restitution as assessed by simulated VF. As the preceding 01 is chosen 
randomly, the APO Is variably affected by cardiac memory. This explains how a single 01 
can produce 2 different AP095• (Adapted from (51, 51)}. 
APD was measured using locally developed software (Dr Francis Burton). The MAP 
upstroke was identified as the dV/dtmax and MAPD5o, MAPD75 and MAPD90 were 
calculated as shown in figure 2.14. 
dV/dtmax 
Plateau ' . : . 
Baseline· . 
Repolarisation 
50% 75% 90% 
t. I I \~ t~' 
i 
100 ms 
Figure 2.14 Assessment of MAPO. Activation point was identified as dVldt max. 
Repolarisation was assessed from MAP plateau with respect to Baseline. MAP050, MAP075 
and MAP090 were measured as time from activation to 50%, 75% and 90% repolarlsation. 
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2.7.2 Effective refractory period 
Hearts were prepared as for MAP recording. To assess ERP, the ventricle was stimulated 
through one contact electrode, whilst recording capture through the other contact electrode 
(Figure 2.12B). Thus to assess LV ERP, stimuli were delivered thought the electrode in 
contact with the LV, whilst the electrode in contact with the RV detected whether or not 
the stimulus had produced a propagating AP. The situation was reversed to assess RV 
ERP. The ERP was assessed using an SlS2 protocol, whereby the ERP was identified as the 
shortest S2 interval that produced a propagating AP (Figure 2.15). All stimuli were 
delivered at twice the diastolic pacing threshold as assessed at basic cycle length (BeL) 
30Oms. 
Stimulus 
artefact S1 
I 
Stimulus 
artefact S2 
100 ms 
Figure 2.15 Illustration of 8182 protocol to assess ERP. After 10 81 impulses at Bel = 300ms, 
a shorter 82 was delivered. ERP was determined as the shortest 82 to produce an action 
potential. 
2.8 Floating microelectrode 
Hearts were prepared for Langendorff perfusion, with the additional insertion of an 
intraventricular latex balloon within the LV. The balloons were placed whilst the heart was 
non-contractile in chilled Tyrode's solution. This ensured that no air entered into the 
coronary circulation. Balloons were inserted . through a pulmonary vein, and then 
manoeuvred across the left atrium and mitral valve into the LV. Prior to micro electrode 
impalement the balloon was gently inflated to reduce contractile motion. Care was taken 
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not to over inflate the balloon and stretch the LV; the perfusion pressure was used as a 
guide to wall stretch. 
Microelectrode experiments were performed within a Faraday cage. Hearts were placed 
within a chamber similar to that used for optical recording, but adapted for microelectrode 
impalement of the LV surface by boring a O.5cm diameter hole in the Plexiglas front-plate. 
After placement of RV hook electrodes, the chamber was rotated by 90° to allow access to 
the anterior surface of the heart with vertical microelectrodes (Figure 2.16). 
Microelectrodes were pulled from borosilicate glass (WPI, Sarasota, FL) using a P-97 
Flaming/Browning pipette puller (Sutter Instruments, Novato, CA). The microelectrodes 
were filled with 2M potassium chloride solution, before the tips were mounted onto silver 
chloride coated silver wire. The tips were secured in place, on the wire, by a drop of candle 
wax. The total resistance of the floating microelectrode was 20 - 25Mil. Impalements of 
the LV epicardial surface were made under stereomicroscopic observation (Zeiss, 
Germany). Membrane potential signals were recorded via a Microprobe Model 750 (WPI, 
Sarasota, FL) with reference to a nearby silver chloride coated silver wire. Real-time 
signals were visualised both on oscilloscope (Nicolet Instrument Corporation, Wisconsin, 
USA), and on the computer monitor. Signals were digitalised at 1kHz (l2bit) by a data 
acquisition board (DT2801 Data Translation Inc, MA, USA) and stored to disc. In 2 
experiments, the raw analogue signals were recorded to VHS tape (VC-M23HM, Sharp 
electronic corp., NJ, USA) and digitised at 10kHz (12bit) through Digidata 1320 working 
with Clampex software (Axon Instruments Inc., CA, USA). 
2.9 Statistical analysis 
Throughout this thesis data are expressed as mean ± Standard Error of the Mean (SEM). 
Significance testing was performed using Instat3 (GraphPad Software Inc., USA). In VF, 
ANOV A was used to test the significance between VF protocols, and paired t-test was 
used to compare significancies between the ventricles of the same heart. Repeated 
ANOVA was used to assess changes in APD, ERP, dV/dtmax, pacing threshold and CV 
produced by low-flow ischaemia or hyperkalaemia, as these comparisons were made 
within the same heart under control and experimental condition. 
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Figure 2.16 Microelectrode apparatus. Panel A: Illustration of microelectrode apparatus. 
Panel B: Photograph of heart within the chamber, and a microelectrode ready to impale. 
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3 VF frequency in ischaemia 
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3.1 Introduction 
Previous work has shown that during VF, the changes of the ECG dominant frequency 
(DF) with time are determined by whether the heart is perfused or not. If the heart is fully 
perfused, the ECG DF is maintained (71, 73), whereas if the heart is not perfused, the ECG 
DF declines (22, 72, 73). The effect of intermediate levels of perfusion on ECG DF time-
course has not been well characterised. In situ experiments have simply compared the ECG 
DF time-course in CPR supported animals to those with no CPR support (25). Similarly, 
isolated heart experiments have only examined a single low-flow perfusion rate along with 
full perfusion and no perfusion (73). Therefore, experiments were undertaken to observe 
the effect of intermediate perfusion on ECG DF time-course during VF in the isolated 
Langendorff-perfused rabbit heart. 
In VF during full perfusion, spatiotemporal heterogeneity of the electrical activity has been 
described in the isolated guinea pig heart (63). In this study, optical mapping demonstrated 
that the LV DF increased with time, whilst RV DF remained unchanged. The purpose of 
the work described in this chapter was to determine the spatiotemporal organisation of VF 
during ischaemia. Prior to investigating the spatiotemporal organisation of VF during 
ischaemia using optical mapping, the model used in this thesis was validated by 
demonstrating identical heterogeneity during full perfusion to that reported in the literature 
(63). 
3.2 Method 
Animals were sacrificed and hearts Langendorff perfused as describe<;l in chapter 2.1. A 
pair of platinum hook electrodes was placed in the posterior aspect of the RV, well 
removed from the optical investigation area. After a period of stabilisation of 
approximately 20 minutes, hearts were loaded with 100,.11 RH23 7, and VF induced by burst 
pacing (50Hz for 8s). All hearts were perfused at 4OmI/min for the first 60s ofVF. During 
this interval, 4s epochs of ECG and optical recordings were taken every 30s. During 
control protocols, 40mllmin perfusion was maintained throughout. In experimental 
protocols, the perfusion rate was reduced at 60s to 10ml/min, 6ml/min, 4mllmin or 
Oml/min. From 60s onwards, ECG recordings' continued every 30s, whereas optical 
recordings were reduced to every 60s to prevent over-compression of the heart. After 600s, 
VF was terminated by defibrillation (Chapter 10). During experimental protocols, the 
epicardial temperature was maintained at 37°C by superfusing the chamber as follows. 
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Using the same water bath and Tyrode's solution, a second glass-column heat exchanger 
and Gilsen pump continuously replenished the solution surrounding the heart via a port on 
the top-plate. To control for any confounding influence of degradation of the preparation, 
equal proportions of 1 st and 2nd runs were performed for each protocol. It should also be 
noted that movement contaminated optical recordings in the initial experiments, and thus 
only the ECG data was analyzable. Chamber modifications removed this contaminant 
(Chapter 2.4). 
As discussed fully in chapter 2.5.1, ECG and pixel signals were analysed in the frequency 
domain. FFT was used to create frequency power spectra, which allowed identification of 
the peak, or dominant frequency (DF), and the median frequency (MF). The power spectra 
of all 252 pixels were summated to create a global optical power spectrum, or pseudoECG 
(psECG) as it is commonly known (61, 173). Across the epicardial surface, during VF the 
spatiotemporal distribution of DF and MF was visualised by creating colour-coded maps. 
The colour scale of these maps, from blue-black (5Hz) through to pink-white (30Hz), 
represented the DF or MF in that pixel at that given time-point. As both DF and MF 
showed identical time-courses and spatiotemporal distributions, only DF results are 
presented. 
A small series of non-perfused protocols was performed in hearts with chronic myocardial 
infarcts. Preparation and characteristics of this model are well described (179-181). In 
brief, adult male New Zealand White rabbits underwent a left thoracotomy under general 
anaesthesia. The marginal branch of the left circumflex coronary artery was ligated to 
produce an ischaemic area of 30 - 40 % of the LV. Animals were studied 8 weeks after 
coronary ligation. 
3.2. 1 Statistical analysis 
Significance testing was performed using ANOV A of mean dominant frequency fractional 
change at 480s. P values are stated within the text. 
Due to the variable location of the LVIRV boundary within the area of interrogation, mean 
ventricular frequencies were determined as the av~rage DF from standardised squares of 3 
x 3 pixels. Paired t-test was used for significance testing between ventricles of the same 
heart and ANOV A was used to make comparisons between protocols. 
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3.3 Results 
3.3.1 ECG OF time-course with varied perfusion 
As shown in figure 3.1, following VF induction the ECG DF increased during the 60s 
control period of all experiments. After 60s, in control protocols the ECG DF continued to 
increase, reaching a peak at 180 - 210s (fractional change = 1.36 ± 0.07, p<O.OOl 
compared to baseline), before slightly slowing, and stabilising to values higher than those 
observed immediately post induction (fractional change = 1.23 ± 0.07, p<0.05 compared to 
baseline). In experimental protocols, perfusion rate reduction was associated with an 
immediate decrease in ECG DF. This ECG DF decline progressed until stabilising at a new 
slower DF steady state. This steady state was achieved by 480s (Figure 3.1). The initial 
rates of decline, and the steady state DF value, were dependent on the degree of perfusion 
reduction. The lower the perfusion rate, the quicker the ECG DF declined, and the lower 
the steady state value. Within this steady state period, all experimental ECG DFs were 
statistically different from control, but not from one other. Unperfused protocols were not 
included in this comparison, as none of the hearts remained in VF until the 480s analysis 
time-point. 
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Figure 3.1 Time-course of ECG OF with varying perfusion rates as expressed by fractional 
change of starting OF. The mean starting OF was 13.2 ± 0.2 Hz. The number of protocols per 
perfusion rate is shown within parenthesis. During the first 60s, the OF of all preparations 
Increased. During 40ml/min, this Increase continued, reaching a -peak at 180s, before 
Slightly slowing and stabilising. On reduction of perfusion rate, the OF declined to reach a 
!!.ew steady state. The steady state value was dependant on the level of perfUSion (**p<0.01, 
p<0.001 compared to 40ml/min fractional change at 480s). 
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On complete cessation of perfusion, VF spontaneously converted to a regular ventricular 
escape rhythm within 240s. During this total global ischaemia, the mean ECG DF 
immediately prior to conversion was 5.7 ± 0.2Hz. Commencing standard perfusion during 
this escape rhythm resulted in the return of sinus rhythm. During 4ml/min perfusion (n = 
9), over 50% of protocols underwent such spontaneous conversion. During 6ml/min 
protocols, no such spontaneous conversion occurred. Thus 6ml/min was the lowest 
perfusion rate that consistently maintained VF for 600s in non-infarcted hearts. 
Figure 3.2 shows that in the 8-week infarct model, complete cessation of perfusion was not 
associated with spontaneous conversion. In contrast, VF continued for 600s. In total global 
ischaemia, the ECG DF dropped to 4.3 ± O.4Hz in infarcted hearts. This was significantly 
lower than the ECG DF of 5.7 ± 0.2Hz (p<0.05) that occurred-prior to conversion in non-
infarcted hearts. In infarcted hearts, the optical signal amplitude from the infarcted tissue is 
greatly reduced (182). In her thesis, Walker compared the optical signal amplitude across 
the anterior surface of the infarcted heart. She showed that in the infarct zone the signal 
amplitude was at best only 30% of the amplitude of the optical signals from the non-
infarcted tissue (182). This amplitude reduction increases the signal-to-noise ratio during 
VF, and therefore prevents reliable FFT interpretation from the infarct zone. The size of 
the infarct produced in this model is variable (181). In the four infarcted hearts used in this 
chapter the infarct was extensive. Thus there was insufficient non-infarcted LV tissue on 
the anterior heart surface to allow assessment of LV IR V heterogeneity. 
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Figure 3.2 Time course of ECG OF in non-infarcted hearts (n = 4) and 8-week infarct model 
hearts (n = 4) during total global ischaemia. Spontaneous conversion occurred within 240s 
of perfusion cessation in stock hearts. The mean ECG OF immediately proceeding 
conversion was 5.7 ± 0.2Hz. In contrast, in 8-week Infarct model hearts, VF continued for 
600s after perfusion cessation. The lowest mean ECG OF during this period was 4.3 ± 0.4Hz. 
This was Significantly lower than the ECG OF at conversion In non-infarcted hearts (p<0.05). 
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3.3.2 Optical measurements in VF during control and low-flow 
ischaemia 
In VF, during control (40 ml/min) and low-flow ischaemia (6mllmin), the optical psECG 
DF displayed similar changes with time as observed in ECG recordings (Figure 3.3). 
However, the absolute DF values and fractional changes were slightly higher in the psECG 
compared to ECG in control, and consistently lower in psECG than ECG in low-flow 
ischaemia. This disparity is probably due to having a greater proportion of LV than RV 
within the flat anterior surface recording area (approx. 2:1) (see below). Better 
representation of the RV was impossible due to the curved nature of the epicardial surface. 
As previously described for the ECG, there was an increase in psECG DF during the 60s 
control period immediately post VF induction. After 60s, in control experiments the 
psECG DF continued to increase to a peak: at 280s (fractional change = 1.52 ± 0.14, p<O.OI 
compared to baseline), before stabilising at slightly lower values (fractional change = 1.27 
± 0.l9, p = NS compared to 280s and baseline). In low-flow ischaemia, the reduction of 
flow to 6mllmin was associated with a steep decline in psECG DF. The psECG DF 
stabilised at a lower DF (fractional change = 0.50 ± 0.10, p<O.OOI compared to baseline). 
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Figure 3.3 Time-course of psECG OF during control (40mVmln) and low-flow Ischaemia 
(6ml/min), expressed as the fractional change of starting OF. The mean starting OF was 13.4 
± 0.2Hz, and 7 protocols were performed In each condition. Ouring the first 60s, the psECG 
OF increased. In control experiments, this increase continued, reaching a peak at 280s, 
before Slightly slowing and stabiliSing. In low-flow, Ischaemia, the psECG OF declined to a 
slower steady state OF (**p<0.001 compared to control at 480s). 
As clearly demonstrated in figure 3.4 and table 3.1, the spatial distribution of DF during 
VF was not homogeneous. DF heterogeneity developed in a progressive manner, and was 
well established by 480s. This corresponds to the steady state period observed in the ECG 
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and psECG DF time-courses. During control conditions, there was marked increase in the 
fractional DF of the LV to 1.62 ± 0.13. This was significantly different from the RV 
(p<0.001), where the fractional DF increased to 1.16 ± 0.04. In VF during low-flow 
ischaemia, the DF changed in an opposite fashion (Figure 3.4 & Table 3.1). There was 
marked fractional DF reduction within the LV to 0.58 ± 0.08. This was significantly 
different from the RV fractional DF (p<0.01), which again remained unchanged at 0.94 ± 
0.07. 
Dominant Frequency of VF (Hz) 
Site/Time LV/Os RV/Os LV/480s RV/480s 
40ml/min (n = 7) 16.7 ± 1.4 13.4 ± 0.9 26.1 ± 1.9** 15.6 ± 1.3 
6mllmin (n = 7) 15.2 ± 1.0 13.4 ± 0.9 8.6 ± 1.0** 12.3 ± 0.8 
Table 3.1 Ventricular OF during control (40ml/min) and low-flow ischaemia (6ml/min). In both 
conditions LV OF changed significantly compared to starting frequencies (**p<0.01). RV 
frequencies were unchanged. 
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Figure 3.4 OF maps during VF in control (40ml/min) and low-flow ischaemic (6ml/min) 
conditions. The colour-coded maps display the OF in each pixel at the stated time-point. The 
dotted white line indicates the RVlLV boundary. The white squares indicate the 
standardised 3 )( 3 regions from which the mean OF was derived. The maps demonstrate 
typical spatiotemporal organisation of OF at Os and 480s during VF in control (40ml/min) 
and low-flow ischaemic (6ml/min) conditions. At Os, all pixels displayed a similar OF of 12-
14Hz. As VF progressed in control conditions, the LV OF increased. In contrast in VF during 
low-flow ischaemia the LV OF decreased. The RV OF remained relatively unchanged in both 
control and low-flow ischaemic conditions. 
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To verify the sharp transition of OF at the RV/LV boundary, and ensure no further 
heterogeneity more distant from the boundary, the LV and RV were optically mapped 
individually during control VF. In figure 3.5, the OF maps of the individual ventricles 
demonstrate that OF is relatively homogeneous within each ventricle. OF was compared 
between similarly spaced 3 x 3 pixel regions, but within the same ventricle (Figures 3.4 & 
3.5). There was no significant difference in the fractional DF time-course between 2 
regions within the same ventricle during control VF (LV, upper left 1.34 ± 0.07, lower 
right 1.46 ± 0.1; RV, upper left 1.12 ± 0.07, lower right 1.08 ± 0.01, Figure 3.5). This 
indicates that the spatiotemporal heterogeneity of DF observed during VF in control and 
low-flow ischaemia occurs between the ventricles, and not within the LV or RV. 
A 
Figure 3.5 Investigation of the sharp transition of OF at the LV/RV boundary. Optical 
mapping was performed during control VF with the interrogation area placed in the LV or 
RV. The heart diagram illustrates the areas of interrogation with the arrows indicating the 
relevant OF map at 480s. The black ~otted line indicates the RVlLV boundary, and the white 
squares the standardised 3 )( 3 pixel regions used to derive the mean ventricular OF. Panel 
A: RV interrogation. Across the RV, the OF remained homogeneous at 12 - 13Hz. Panel B: 
Standard area of interrogation across the RVlLV boundary. This highlights the sharp 
transition in OF at the boundary. Panel C: LV interrogation. The OF was homogeneous 
across the LV at 20 - 25Hz. This confirms the sharp transition of OF at the RV/LV boundary, 
and the lack of further heterogeneity. 
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3.4 Discussion 
3.4.1 Time-course of VF OF with varied perfusion 
The dependence of the VF frequency time-course on myocardial perfusion is suggested by 
previous research in pigs (26, 28, 30). In these VF studies, CPR was combined with 
intravenous injections of saline, epinephrine or vasopressin, to produce varied degrees of 
peripheral vasoconstriction. More potent peripheral vasoconstriction diverted flow away 
from the peripheral circulation, thus giving better myocardial perfusion, and was 
associated with higher ECG MF. In the isolated Langendorff-perfused swine heart, the 
relationship between myocardial flow and VF frequency was confirmed (73). After an 
initial period where VF was not perfused, perfusion was comnitmced at either control flow 
rate or 10% of the control flow rate. At the end of non-perfusion period of VF, the ECG 
had a slow DF of 3.6 ± I.4Hz. On perfusing at the control rate, the ECG DF increased to 
10.8 ± 1.1Hz. However, commencing perfusion at 10% control rate the ECG DF only 
increased to 4.5 ± 1.1 Hz. The experiments in this chapter demonstrate that the relationship 
between myocardial perfusion and VF frequency holds for the Langendorff-perfused rabbit 
heart as well. These experiments show that lower myocardial perfusion rates produce more 
rapid declines in the ECG DF, and lower ECG DF at steady state. 
The ECG and psECG OF time-courses were similar to each other both in control 
(40ml/min) and low-flow ischaemic (6ml/min) conditions. The decrease in the ECG DF in 
ischaemia reflects a reduction in global myocardial activation rate. In comparison, the 
decrease in the psECG DF reflects reduced activation in the epicardium alone. Reduced 
epicardial activation rates during ischaemic VF 'have previously been documented by 
electrical mapping (135). Here, as ischaemia evolved, the time between epicardial VF 
activations increased. Optical mapping has correlated this reduction in epicard~al activation 
during ischaemic VF to slowing of the rotation of epicardial re-entrant cycles (62). 
3.4.2 Spontaneous VF conversion in zero-flow ischaemia 
The conversion of VF to a more regular rhythm during profound global ischaemia has 
previously been documented in rabbits (62, 72) and rats (101). Such spontaneous 
conversion is uncommon in larger animals, including humans. Theoretical explanations for 
this difference are (i) the need for a critical mass of myocardium to support VF and (ii) the 
different electrophysiological substrates of VF in clinical compared to experimental 
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settings. In the clinical setting, regional ischaemia and scarred infarcted tissue play a role 
in sustaining VF. 
3.4.2.1 Critical Mass 
For over a century it has been appreciated that large hearts sustain VF more readily than 
small hearts (99, 100). Garrey confirmed the need for a critical mass to maintain VF by 
sectioning ventricles from various animals (183). On shaving pieces of tissue from an 
already fibrillating ventricle, he noted that pieces less than 4cm2 were unable to maintain 
VF. More recently, Zipes et al. demonstrated the same phenomenon in dog. Here the mass 
of excitable myocardium was reduced by bolusing 10ml of potassium chloride solution 
(1mEq/ml) down the relevant the coronary artery. Tissue perfu.sed with this' concentration 
of potassium chloride become depolarised, and thus are rendered unexcitable. 
Simultaneously perfusion of the left anterior descending (LAD) and the left circumflex 
arteries reduced the amount of excitable myocardium below the critical mass required for 
VF maintenance (103). 
Computer modelling suggests that both "mother rotor" and ''multiple wavelets" 
mechanisms ofVF maintenance require a critical mass of excitable myocardium (102). For 
a "mother rotor" to be supported, the myocardium must be larger than its core size. In the 
case of multiple wavelets, an even greater mass is required for the break-up of the irregular 
wanderings of the numerous wavelets (102). During global ischaemia, the internal, non-
excitable core of re-entrant cycles expands (Figure 1.6) (62). Thus the area required for 
each re-entrant cycle increases. Conversion occurs when the area required expands beyond 
the limits of the available tissue. 
Although the heart failure model used this chapter is associated with increased ventricular 
size (wet heart weight infarct 13.0 ± 0.5, sham 10.4 ± 0.3 from (180», the increase is only 
25%. If during global ischaemia, the re-entrant core enlargement occurred in a temporally 
linear fashion, one would predict that infarct hearts would spontaneously convert around 
300s. Instead, there was no spontaneous conversion in infarcted hearts. Interpreting the 
ECG DF as in inverse marker for core enlargement (62), suggests that internal core 
expansion does not occur in a temporally lineru: fashion during total global ischaemia 
(Figure 3.2). However, comparing the reciprocals of ECG DF in a) non-infarct hearts prior 
to conversion (1/5.7 = 0.18) and b) the lowest DF in infarct hearts (114.3 = 0.23) indicates 
that the internal core enlarged approximately 36% more in infarcted hearts than non-
infarcted hearts. This suggests that critical mass alone may not be the only factor 
·=1 
------------
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detennining the lack of spontaneous conversion in 8-week infarct hearts in VF during total 
global ischaemia. 
3.4.2.2 VF substrate 
A second important factor in VF maintenance is the underlying electrophysiological 
substrate of the ventricle. Past research indicates roles for restitution and repolarisation 
heterogeneity in VF maintenance. Pharmacological interventions that flatten restitution 
curves, and thereby reduce heterogeneity, convert VF into VT (53, 54, 184). Ischaemia, 
with its similar effect on APD restitution curve (185), would also be expected to convert 
VF to VT as observed in non-infarcted hearts. Although ischaemic-driven flattening of 
APD restitution curve does not progress homogenously throughout the heart (see Chapter 5 
and (186», this heterogeneity must not be sufficient to maintain wavebreak, and thus VF in 
the non-infarcted heart. Dispersion of repolarisation is increased in the 8-week infarct heart 
model as compared to the nonnal heart (187, 188). This could make the substrate 
sufficiently heterogeneous to maintain VF, even in the context of ischaemic flattening of 
restitution. 
3.4.3 Spatiotemporal Organisation 
Current literature describes 2 different patterns of spatiotemporal arrangement in perfused 
VF: - (i) apex-to-base distribution of DF (65, 189) and (ii) ventricular-based heterogeneity 
(63, 190). 
3.4.3.1 Apex-to-base OF distribution 
Using optical mapping in the guinea-pig heart, Choi et al. measured activation intervals 
and frequencies in perfused VF (65). They demonstrated that in apical region of the hearts, 
the APD was shorter, and was associated with shorter activation intervals and faster VF 
frequencies. In contrast, basally the APD was longer, and was associated with longer VF 
activation intervals and slower VF frequencies. The areas selected for this apexlbase 
comparison were not specified in this paper. The area examined optically was on the 
anterior heart surface, and spanned the LV IR V border in a manner similar to this chapter 
(Figures 3.5B & 3.6A). This means that the apex area was predominantly LV, and the base 
predominantly RV. Indeed, the APD maps in this paper show the shortest APD (and thus 
presumably faster DF) to be in the LV, and the longest APD in the RV (Figure 3.6B). The 
paper goes on to perfonn circumferential VF mapping for a limited period, and localises 
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the slowest DF to posterior-RV. It is therefore possibility that any discrepancy between the 
findings of Choi et al. and this chapter are merely due to different definitions. 
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1.2cm 
190 
150 
(ms) 
Figure 3.6 Apex-to-base repolarisation. Panel A: Area of interrogation on anterior surface of 
rabbit heart used by Choi et al. This area is identical to the standard region examined in this 
thesis (Figure 3.58). Panel 8: Isochronal map of APD across the anterior surface. The APD 
is shortest in the LV and longest in the RV. At the lower end of the septal zone interrogated 
there is a quick transition from short to long APD (Adapted from (65». 
A second paper that documents apex-to-base DF gradients uses Continuous Fourier 
Transform (CFT) to produce more precise DF maps (189). Using optical mapping in 
rabbits, Joel et al. studied the DF distribution generated by CFT compared to FFT. These 
higher definition maps show a gradient from apex-to-base in the LV, however, a sharp 
transition from LV to RV was still demonstrated. In this chapter, DF maps created using 
FFT showed no such gradient within either the LV or the RV, identifying instead a sharp 
transition between LV and RV DF. 
3.4.3.2 Ventricular OF Heterogeneity 
Ventricular heterogeneity in VF is well established (for review of this topic see (191)). 
Electrical mapping of VF shortly after induction revealed higher frequencies in the LV 
compared to the RV in both pig and dog (192, 193). Similarly in the guinea pig, optical 
mapping ofVF during full perfusion demonstrated higher LV than RV frequencies, with a 
sharp transition between the 2 regions (63). Identical ventricular-based heterogeneity has 
been demonstrated in this chapter; LV frequencies dramatically increased in VF during full 
perfusion, whereas those of the RV were unchanged. 
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Investigating the underlying mechanism of this ventricular-based heterogeneity, Samie et 
al. demonstrated a larger outward background conductance in LV compared to RV 
myocytes (63). This larger outward conductance would be predicted to allow faster 
repolarisation, and thus the development of faster LV frequencies. Using low concentration 
barium chloride to selectively block IKl, the enhanced outward background conductance 
has been attributed to the ventricular heterogeneity of Kir2.x expression (190). Here, 
Warren et al. demonstrated increased mRNA expression of Kir2.l (x1.97 ± 0.45) and 
Kir2.3 (x 1.47 ± 0.08) in LV compared to RV myocytes. They proceeded to demonstrate in 
the whole heart that IKI blockade prevented the development of faster LV frequencies 
(190). While in single cells, IKI blockade removed the differential magnitude of outward 
background current between the RV and LV myocytes (190). 
A second mechanism proposed to underlie the spatiotemporal DF heterogeneity in fully 
perfused VF is the differential LV-to-RV response to osmotic swelling (158). In this study, 
the APD and DF distribution were assessed whilst perfusing isolated guinea-pig hearts 
with either iso-osmotic or hypotonic solutions. The iso-osmotic solution contained 5mM 
Glucose and 45mM Mannitol, whereas in the hypotonic solution, Mannitol was omitted. 
After 20 minutes of hypotonic perfusion, a sharp LV-to-RV transition was observed in (i) 
the APD during pacing, with a marked reduction in LV compared to RV APD and (ii) the 
epicardial DF during VF, with a marked increase in LV DF. During iso-osmolar perfusion 
a gradual apex-to-base gradient of APD and DF was observed, but with a definite LV -to-
RV transition, albeit with a lower amplitude step. Choi et al. proposed that the source of 
this differential LV response to tonicity was the 27% greater expression of CIC-3 in LV 
compared to RV, as demonstrated by fluorescent antibody labelling. CIC-3 is one of 
several proteins responsible for producing ICL,voh a volume-regulated c~loride current that 
become activated upon cell swelling (194). Activation of ICL,vol produces APD shortening 
and diastolic depolarisation, as its reversal potential (Ek) is -60 to -40m V (195, 196). 
Therefore, a greater relative magnitude of ICL,vol in the LV compared to the RV, would be 
expected to produce greater LV-to-RV APD shortening, and allow development of faster 
LV-to-RV DF. On blocking ICL,vol with 10J.1M indanyloxyacetic acid-94, Choi et al. 
demonstrated a reduction in the LV DF, however, the RV DF also decreased, and a sharp 
transition between LVIRV remained. 
The activation of ICL,vol is unlikely to be an important factor In the heterogeneity 
demonstrated in this chapter as:- (i) the Tyrode's solution used contained 50mM Glucose, 
giving same tonicity as the iso-osmolar solution used by Choi et al. (Prof Guy Salama, 
Personal communication). (ii) The tonicity-induced alterations only developed after 20 
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minutes. It is possible that the increased metabolic demands of VF would result in greater 
cellular glucose extraction, thus rendering the solution hypotonic during VF. The DF 
heterogeneity in this chapter was fully established by 7 minutes, a time-point too early to 
be secondary to hypotonic alterations. (iii) Microelectrode impalement of the LV in VF 
during full perfusion with standard Tyrode's solution failed to demonstrate diastolic 
depolarisation (Chapter 9). 
In this chapter, optical assessment of VF during low-flow ischaemia displays ventricular 
heterogeneity, where the LV DF markedly decreased, whilst the RV DF remained 
unaltered. Such maintenance of RV frequency in non-perfused VF has previously been 
implied (21, 22). Here, Carlisle et al. positioned a contact electrode onto the RV 
endocardial surface in dogs. Their results show that during globally ischaemic VF, the DF 
in the RV unipolar electrode was maintained, whilst the DF of the surface ECG decreased. 
A recent publication by Wu et al. describes an identical pattern of DF distribution to that 
demonstrated in this chapter, but in VF during global ischaemia rather than low-flow 
ischaemia (69). 
The reduction in LV DF reflects decreased cellular activation rates in the LV compared to 
the RV during low-flow ischaemia. Theoretically, several electrophysiological mechanisms 
can produce a reduced activation rate, namely (i) prolongation in repolarisation (ii) 
prolongation of post-repolarisati~n refractoriness, (iii) reduced conduction velocity or (iv) 
raised activation threshold. A differential alteration of at least one of these 
electrophysiological mechanisms may account for the LV-to-RV DF heterogeneity during 
VF in low-flow ischaemia. 
. 
The differential LV-to-RV expression of Kir2.1 and Kir2.3 could underlie a heterogeneous 
electrophysiological response to low-flow ischaemia. However, LV-to-RV differences in 
the expression of other ion channels have been noted in a range of species (197, 198); these 
may also contribute to the ventricular differences in DF observed during VF. 
Another possible explanation for any electrophysiological heterogeneity is differential 
perfusion of the LV compared to the RV. Studies in dogs (199) and rats (200) have shown 
differential control of vascular tone in the right an~ left coronary systems. In the dog, Quail 
demonstrated lesser degrees of vasodilatation in the left then right coronary systems by 
using increased aortic pressure to precipitate vasodilatation (199). It is thus possible that 
during low-flow ischaemia, there is a lesser degree of vasodilatation in the LV than the 
RV. One would expect such differential vasodilatation to result in more profound 
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ischaemia in the LV compared to the RV. Although this could account for the ventricular 
heterogeneity in low-flow ischaemia, it would not explain the similar pattern of DF 
distribution in total global ischaemia (69). Therefore, it is less likely that differential 
perfusion plays a predominant role 
88 
4 VF frequency & isolated ischaemic 
components 
Jane C. Caldwell, 2006 Chapter 4, 89 
4.1 Introduction 
It is clear that in VF, low-flow ischaemia produces a reduction in ECG and psECG DF. 
This decline in the global VF measurements is associated with a profound reduction in the 
LV DF. Ischaemia is a complex interaction of substrate depletions, metabolite 
accumulations and their sequelae. Although the outcome of prolonged ischaemic VF 
arrests is determined by such systemic sequelae as cytokine release and gut bacterial 
translocation, within the first 10 minutes the predominant influences are the local 
consequences of circulatory interruption: hypoxia, acidic pHEc, raised [K+]EC and energy 
substrate depletion (15). The influence of these individual ischaemic components on global 
and spatiotemporal DF progression during VF has not been clearly delineated. By altering 
the composition of the perfusing solution, it was possible to test the contribution of 
individual ischaemic components to the time-course ofDF in low-flow ischaemia. 
4.2 Methods 
The protocols for VF induction, recordings and defibrillation were identical to those 
previously outlined in chapter 3.2. In all protocols, perfusion rate was maintained at 
40mVmin. In control protocols, standard Tyrode's solution was perfused throughout. In 
experimental protocols, experimental solutions were introduced after 60s ofVF. As shown 
by figure 4.1, there was a further 100s delay before this change reached 90% transition at 
the heart, due to the intervening tubing and bubble traps. The 90% transition time was 
determined through diluted black food colouring and spectrophotometry (Figure 4.1). 
Standard Tyrode's solution was adapted to represent individual ischaemic components as 
discussed in chapter 1.2.3. All Douglas bags were prepared using a Penlon Gas Mixer 
(Abingdon, Berks) and solutions bubbled by Dymax 30 (Charles Austin p~ps" Byfleet, 
Surrey). Experimental solutions were composed of: -
Hypoxia - bubbling standard Tyrode's with 5% C02/95% N2 Douglas bag mixture. 
Acidic pH EC - pH 6.7 - bubbling standard Tyrode's with 20% C02/80% 02 from a BOC 
mixed gas cylinder. 
- pH 6.3 - bubbling standard Tyrode's with 20% C02/80% 02 Douglas bag 
mixture. 
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Raised [K+]EC - 8mM & lOmM 
The isolated heart model employed relies on 50mM glucose to maintain osmotic pressure, 
and thereby reduce cellular swelling. Reduction of glucose to 20mM affected preparation 
integrity, and therefore data reliability. Introduction of Dextran 70 or albumin as osmotic 
substitutes did not improve preparation survival. Therefore further investigation into 
reduced energy substrate was abandoned. To control for any confounding influence of 
preparation degradation, equal proportions of 1 st and 2nd runs were performed for each 
protocol. 
10 -.................................. . 
................ ................................. 90% 
0.1---
o 60 120 180 240 300 
Time after changeover (s) 
Figure 4.1 Solution transition time. This figure plots the change in the absorbance of aortic 
cannula effluent with time after switching clear solution to diluted black food-colouring 
solution. This demonstrates the delay In solution transition experienced by the heart. 
As outlined in the chapter 2.5.2, ECG and pixel signals were analysed in the frequency 
domain using FFT. The frequency power spectra created allowed identification of the peak, 
or dominant frequency (DF), and the median frequency (MF). The power spectra of all 252 
pixels were summated to create the global optical power spectrum, or psECG. Across the 
, .. 
epicardial surface, the spatiotemporal arrangement of the DF and MF during VF was 
visualised by creating colour-coded maps. The colour scale of these maps represented the 
DF or MF in that pixel at that given time-point. As both DF and MF showed identical time-
courses and spatiotemporal arrangements, only DF results are presented. 
4.2.1 Statistical analYSis 
Significance testing was performed on the mean DF fractional changes at 480s using 
ANOVA. Due to the variable location of the LVIRV boundary within the area of 
interrogation, mean ventricular frequencies were determined as the average DF from 
standardised squares of 3 x 3 pixels (Figure 4.4). Paired t-test was used for significance 
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testing between ventricles of the same heart and ANOV A was used to make comparisons 
between protocols. 
4.3 Results 
4.3.1 Hypoxia 
As shown in figure 4.2, the initial marked increase in ECG and psECG DF observed during 
VF in control conditions did not occur in VF during hypoxia. In control conditions, ECG 
DF peaked at 180 - 21 Os, with a fractional change of 1.31 ± 0.07. For the same time-point, 
the ECG DF fractional change in hypoxic conditions was significantly different at 1.07 ± 
0.02 (p<0.0001). Similarly, in control conditions, the psECG DF fractional change reached 
a peak of 1.51 ± 0.14 at 240s, whilst the concurrent psECG DF fractional change in 
hypoxia was significantly lower at 1.08 ± 0.04 (p<0.0001). Rather than a marked initial 
increase, there was a more gradual rise in the ECG and psECG DF during VF in hypoxic 
conditions. By the 480s assessment point, the ECG DF fractional change during hypoxia of 
1.19 ± 0.12 was indistinguishable from the change of 1.23 ± 0.06 observed during control 
conditions (Figure 4.2(i». Similarly, the psECG DF fractional change in hypoxia of 1.24 ± 
0.10 was no different from the in control change of 1.26 ± 0.19 (Figure 4.2(ii)). In hypoxia, 
the ECG and psECG DF were significantly faster than frequencies observed in VF during 
low-flow ischaemia. In low-flow ischaemia, at the 480sassessment point, the ECG DF 
fractional change had dropped to 0.75 ± 0.13 (p<0.001 compared to hypoxia, Figure 
4.2(i)), whilst the psECG DF fractional change dropped to 0.50 ± 0.10 (p<0.01 compared 
to hypoxia, Figure 4.2(ii)). 
Assessment of the spatiotemporal VF organisation during hypoxia was hampered by the 
profound effect hypoxia had on signal amplitude (see Chapter 8). However, as shown in 
figure 4.4 and detailed in table 4.1, hypoxia had no significant effect on the DF 
spatiotemporal organisation compared to VF during control. By 480s, the RV DF fractional 
change had minimally increased to 1.18 ± 0.09. This was not different from the RV DF 
fractional change in control conditions of 1.16 ± 0.04. The LV DF fractional change 
markedly increased in hypoxia to 1.47 ± 0.23 at 480s. This was indistinguishable from LV 
DF fractional change increase of 1.62 ± 0.13 observed in control conditions, but was 
significantly different from the LV DF fractional change decrease of 0.58 ±.0.08 that 
occurred in VF during low-flow ischaemia (p<0.001). 
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Figure 4.2 OF time-course during hypoxia compared to control (40ml/mln) and low-flow 
ischaemia (6ml/mln): • (i) ECG and (II) psECG. At 480s, both global assessments showed no 
significant difference between OF in hypoxia compared to control. At 480s, both the ECG*** 
and psECG" OFs were significantly faster than low-flow Ischaemia (***p<0.001, .. p<0.01). 
Dominant frequency of VF (Hz) 
SitelTime LV/Os RV/Os LV/48Os RV/480s 
4Oml/min(n = 7) 16.7 ± 1.4 13.4 ± 0.9 26.1 ±1§~ 15.6 ± 1.3 
Hypoxia (n = 5) 14.7 ± 1.0 12.4 ± 0.5 21.9 ± 1.0) 14.7 ± 0.9 
pH6.7(n=7) 15.4 ± 1.3 13.5 ± 1.0 20.0 ± l.i~ 17.8±1.1 
pH 6.3 (n = 4) 16.6 ± 1.0 12.6 ± 0.6 22.0 ± 2.4 16.7 ± 1.0 
6ml/min (n = 7) 15.2 ± 1.0 13.4 ± 0.9 8.6 ± 1.0# 12.3 ± 0.8 
8mMKT(n= 5) 16.5 ± 1.9 13.0 ± 0.7 9.2 ± 1.0# 12.5 ± 1.5 
10mMKT(n = 4) 17.5 ± 1.5 14.7 ± 0.7 7.7 ± 1.4# 7.7±2.0-
Table 4.1 Ventricular OF during VF In various Individuallschaemlc components compared to 
control and low-flow Ischaemia. In hypoxia and pH 6.7, LV OF Increased to levels 
Indistinguishable from those In control conditions - (40mllmin)$, whereas raised [K]EC 
produced LV OF lowering that was indistinguishable from low-flow ischaemia (6mllmin)'.ln 
pH 6.3, LV OF was significantly lower than control (p<0.05) but hl~her than low-flow 
(p<0.001). RV OF was significantly reduced by 10mM [K1EC ~ ( p<0.001). and $ mark LV OF 
that were not significantly different. 
In summary, hypoxia did not reproduce the global or spatiotemporal DF alterations that 
were observed in VF during low-flow ischaemia. 
4.3.2 Acidic pHEC 
In VF under acidic pHEc conditions, the ECG and psECG DF demonstrated great 
variability in their early time-courses (Figure 4.3): All acidic pHEc time-courses stabilised 
by the 480s assessment point. At 480s, in pH 6.7 the ECG DF fractional change rose by a 
factor of 1.19 ± 0.08, and the psECG DF by 1.28 ± 0.06. In pH 6.3, the ECG DF fractional 
change rose by a factor of 1.22 ± 0.04, and the psECG by 1.30 ± 0.10. These changes were 
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not significantly different from each other, or from those observed in the control pH 7.4, 
where ECG DF fractional change rose by 1.23 ± 0.06, and psECG DF by 1.26 ± 0.19. 
There was also no difference between the effects of acidic pHEc and hypoxia on the global 
DF assessments during VF. In keeping with these findings, both severities of acidic pHEc 
were associated with ECG and psECG DFs that were significantly higher than during low-
flow ischaemia. In VF during low-flow ischaemia, the fractional change in ECG DF was 
0.75 ± 0.13 (p<0.05 compared to both levels acidic pHEc), and the change in psECG DF 
was 0.50 ± 0.10 (p<0.001 compared to pH 6.7, p<O.OI compared pH 6.3). 
(i) 
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• ~ 1.0 
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O. 
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pHS.7(e)*** 
pHS.3(.t.)** 
4Oml/min(.) 
. t ·1 6mlhn'.I.' 
480s 
Figure 4.3 Time-courses of OF during VF with acidic pHEc (pH 6.7 & pH 6.3) compared to 
control (pH 7.4, 40ml/mln) and low-flow Ischaemia (6mllmln): - (I) ECG OF - At 480s, neither 
pH 6.7 nor pH 6.3 were significantly altered the ECG OF compared control. Whereas at 480s, 
the ECG OF was significantly faster In both pH 6.7 and 6.3 than In low-flow Ischaemia 
(*p<0.05 compared to both levels of acidic pHEc). ,(II) psECG OF - Again at 480s neither 
acidic pHEc significantly altered psECG OF compared to contr~: In both eH6.i"and 6.3" the 
psECG OF was significantly faster than in low-flow Ischaemia ( p<0.OO1, p<0.01). 
In contrast to the global DF measurements, the spatiotemporal DF organisation during VF 
under acidic conditions was significantly different from both control and low-flow 
ischaemia (Figure 4.4, Table 4.1). Under acidic pHEc, the LV DF tended to increase by a 
lesser degree than that observed in control (pH 7.4). In control, the LV DF fractional 
change increased to 1.62 ± 0.13 at 480s, whereas in pH 6.3, the LV DF fractional change 
increased to 1.32 ± 0.12 (p<0.05). In pH 6.7, LV, DF fractional change increase to 1.41 ± 
0.07 was not significantly different from control. However these fractional changes were 
significantly different from the decrease in LV DF observed in low-flow ischaemia, where 
the LV DF decreased to 0.58 ± 0.08 (p<0.001 compared to pH 6.7 & 6.3). 
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Figure 4.4 Typical OF maps during VF in low-flow ischaemia, raised [K+]EC, hypoxia and acidic pHEC taken at Os and 480s. Grey-dotted line illustrates RV/LV 
border and white squares the standardised 3 x 3 pixel areas used to derive mean ventricular OF. Colour scale represents OF in each pixel. Raised [K+]EC 
reproduces changes of ischaemia whereas hypoxia and acidosis are more reminiscent of control conditions (Figure 3.4). 
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Also distinct from low-flow ischaemia and control, there was a tendency for RV DF to 
increase in acidic conditions (Figure 4.4, Table 4.1). At 480s, the RV DF remained 
unchanged in low-flow ischaemia with a fractional change of 0.94 ± 0.07. In comparison, 
under acidic conditions the RV DF was significantly increased by a factor of 1.35 ± 0.06 in 
pH 6.7 (p<0.01), and 1.33 ± 0.10 in pH 6.3 (p<0.05). Although these RV DF increases· 
under acidic pHEC tended to be higher than the control change of 1.16 ± 0.04, the 
difference did not reach significance. During acidic conditions, the LV DF tended to 
increase by more than the RV DF, but this difference was not significant (Table 4.1). 
Therefore acidic pHEC had an equalising effect on the distribution ofDFin VF. 
In summary, acidic pHEC did not reproduce the decline observed in global DF assessments 
in VF during low-flow ischaemia. Although acidic pHEC affected the spatiotemporal 
organisation of VF, it did not reproduce the DF distribution observed during low-flow 
ischaemia. 
4.3.3 Raised [K'"}EC 
In contrast to control, hypoxia and acidic pHEC, raised [K+]EC produced profound reduction 
of the ECG and psECG DF. In figure 4.5, the ECG and psECG DF in raised [K+]EC clearly 
follow the corresponding DF changes during low-flow ischaemia. It should be noted that 
there was a time delay in the reduction of OF during VF in raised [K+]EC compared to low-
flow ischaemia. This relates to intrinsic differences in delay of application for each 
parameter. Reducing the perfusion to 6mVmin was immediatley ef{!ective at the epicardial 
surface, whereas raising the solution [K+] experienced the 90s transistion delay as detailed 
in figure 4.1. By the 480s assessment point the ECG DF decreased fractionally to 0.76 ± 
0.03 in 8mM [K+]EC, and 0.51 ± 0.09 in 10mM [K+]EC. These fractional changes could not 
be distinguished from that observed in low-flow ischaemia, where the ECG OF decreased 
to 0.75 ± 0.13 (Figure 4.5(i». ECG OF fractional reductions in raised [K+]EC were 
significantly different from:-
(i) control conditions, where the DF increased by a factor of 1.23 ± 0.06 (vs. 8mM 
[K+]EC p<O.OI, vs. 10mM [K+]EC p<O.OOI) 
----------------------~.------------
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(ii) hypoxia, where the DF increased by a factor of 1.19 ± 0.12 (vs.8mM [K+]EC p<0.05, 
vs. lOmM [K+]EC p<O.OOI) 
(iii) pH 6.7, where ECG DF increased by a factor of 1.19 ± 0.08 (vs. 8mM [K+]EC p<0.05, 
vs. IOmM [K+]EC p<O.OOI) 
(iv) pH 6.3, where the ECG DF increased by a factor of 1.22 ± 0.04 (vs. 8mM [K+]EC 
p<0.05, vs. IOmM [K+]EC p<O.OOI). 
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Figure 4.5 Time-course of ECG OF and psECG OF during VF In raised [K+]EC (OmM and 
10mM) compared to control (40mVmin) and low-flow Ischaemia (6mVmln). (I) ECG OF - In 
both OmM [K+]EC** !nd 10mM [K1EC - the ECG OF was significantly reduced compared to 
control (**p<O.01, p<O.001). In contrast, the degree of ECG OF reduction could not be 
distinguished from that observed in VF during low-flow Ischaemia. (Ii) psECG - Although 
both OmM and 10mM .. slowed the psECG OF compared to control, at 400s, only 10mM. 
reached significance ( p<0.01). The reduction of psECG OF produced by both [K1 was 
Indistinguishable from the psECG OF reduction that occurred during VF in low-flow 
ischaemia. . 
In raised [K+]EC, the psECG DF decreased fractionally to 0.73 ± 0.05 in 8mM [K+]EC, and 
0.50 ± 0.09 in 10mM [K+]EC. These fractional changes were indistinguishable from each 
other, and from that observed in VF during low-flow ischaemia, where the psECG DF 
decreased to 0.50 ± 0.10 (Figure 4.5(i». In lOmM [K+]EC, psECG DF reduction was 
significantly different from control, where the DF fractional change increased to 1.26 ± 
0.19 (p<0.001). The psECG DF decrease in 10mM [K+]EC was also significantly different 
from (i) hypoxia, where the DF fractional change increased to 1.24 ± 0.10 (p<0.01), (ii) pH 
6.7, where psECG DF fractional change rose to 1.29 ± 0.10 (p<O.OI) and (iii) pH 6.3, 
where the psECG DF fractional change increased to 1.30 ± 0.10 (p<0.01). In comparison, 
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the decrease in psECG DF in 8mM [K+]EC was only significantly different from the 
increase observed during pH 6.3 (p<0.05). 
During perfusion with IOmM [K+]EC, all hearts spontaneously converted to a regular 
ventricular escape rhythm before 600s. Isolated protocols perfonned using higher KCI 
concentrations spontaneously converted at earlier time-points: 15mM [K+]EC converted 
before 180s, while 12mM [K+]EC converted at 300s. 
The spatiotemporal organisation of VF in 8mM [K+]EC was indistinguishable from that 
observed in 6mVmin low-flow ischaemia (Figure 4.4, Table 4.1). In 8mM [K+]EC, there 
was a marked fractional reduction in LV DF to 0.67 ± 0.04. This was indistinguishable 
from the LV DF fractional reduction to 0.58 ± 0.08 observed during low-flow ischaemia. 
The RV DF was unchanged by perfusion 8mM [K+]EC with a fractional change of 0.95 ± 
0.03 at 480s. Again this was indistinguishable from the unchanging RV DF fractional 
change of 0.94 ± 0.07 observed in low-flow ischaemia. In 10mM [K+]EC, one protocol 
converted before 480s. Hearts still in VF at 480s in 10mM [K+]EC, showed equally marked 
DF slowing in the LV and RV. In the LV the DF fractional change of 0.46 ± 0.01 was 
indistinguishable from low-flow ischaemia, whereas in the RV, the DF fractional change 
was lowered to 0.53 ± 0.12 (p<0.01 compared to RV fractional change in low-flow 
ischaemia). 
At 480s, the fractional reduction in LV DF observed in 8mM [K+]EC (0.67 ± 0.04) was 
significantly different from the fractional increase in LV DF observed under control 
conditions (1.62 ± 0.13, p<O.OOI). Similarly, the fractional reduction of LV DF produced 
by 10mM [K+]EC (0.46 ± 0.01) was significantly different from control (p<0.00 1) 
In summary, perfusing VF with 8mM [K+] solution reproduced the global and 
spatiotemporal DF alterations that were observed in VF during low-flow ischaemic 
conditions. 
4.4 Discussion 
This chapter demonstrates that the marked ECG and psECG DF reduction observed in VF 
during low-flow ischaemia is reproduced by raising [K+]EC, and not by imposing hypoxia 
or acidic pHEC. Raising [K+]EC to 8mM also reproduced the spatiotemporal DF 
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arrangement observed In low-flow ischaemia, with differential lowering of LV DF. 
Hypoxia and acidic pHEc did not reproduce this spatiotemporal DF organisation. 
4.4.1 Hypoxia 
In VF during hypoxia, the global assessments of DF increased more gradually than in 
control. However, at steady state there was no significant difference between the two 
conditions. There was also no significant effect of hypoxia on VF spatiotemporal 
organisation compared to control conditions. 
The first electrophysiological effects of hypoxia to develop is a pr<:>found and highly 
reproducible APD shortening (201-204). The exact cellular mechanism of this early APD 
shortening is unclear (205). Although the hypoxia-induced shortening can be blunted by 
increased glucose concentrations (206), and exaggerated by glycolytic inhibition (207), the 
ATP level only drops low enough to activate IKATP after more prolonged periods of 
hypoxia than those examined in this chapter (208). The APD shortening associated with 
hypoxia would be predicted to increase the DF during VF. This was not observed. 
Other electrophysiological adaptations to hypoxia, such as diastolic depolarisation, AP 
amplitude reduction and slowing of the upstroke velocity, are less consistently 
demonstrated in the literature. Most studies showed only minimal effects, or effects only 
after prolonged periods of hypoxia (202, 209, 210), whereas Morena et al. demonstrated 
profound, early changes (211). This variation appears to depend on the [K+]EC. In standard 
[K+]EC, diastolic potential and upstroke velocity are virtually unchanged by hypoxia (202-
204, 209, 210). However in raised [K+]EC ,hypoxia produ~ed marked diastolic 
depolarisation, AP amplitude reduction and upstroke velocity slowing (203, 204). The 
relationship between hypoxia and [K+]EC is bidirectional, with hypoxia producing a net 
efflux of K+ (212). Thus, one may expect that more prominent changes were observed in 
experimental preparation that allowed K+ accumulation, and that minimal changes would 
occur in preparations with continued perfusion. Therefore in the isolated Langendorff-
perfused rabbit heart, one would predict only marginally greater K+ accumulation in fully 
perfused, hypoxic VF than in control. This may explain the apparent lack of effect of 
hypoxia on DF demonstrated in this thesis. 
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4.4.2 Acidic pHEC 
Despite having virtually identical global DF assessments at steady state, the spatiotemporal 
DF organisation in VF under acidic pHEc was significantly different from that observed in 
control. Compared to control conditions, there was a tendency for LV DF to be reduced, 
and RV DF to be increased. This qualitatively different effect of acidic pHEc on the LV 
compared to the RV is difficult to explain. 
Acidic pH has many effects on myocyte electrophysiology (213, 214) and on excitation-
contraction coupling (215). Application of acidic pH produces a shot-term reduction in 
calcium transient amplitude, which is then followed by increases to amplitudes greater than 
those observed at baseline (215). This adaptation of the·· Ca2+ transient to acidic pH is 
thought to result from complicated modulations of (i) L-type Ca channels, (ii) the 
ryanodine receptor (iii) the sarcoplasmic Ca2+ ATPase (SERCA) and (iv) the Na+-Ca2+ 
exchanger. It is possible that the profound effects of acidic pH on calcium dynamics 
influence voltage dynamics, and hence affects the DF in VF. At present, the interaction 
between voltage and calcium dynamics during VF is not well understood. Initial studies 
suggest that at VF induction, there is complete dissociation of voltage and calcium 
oscillations (216, 217). 
Published data on the effect of acidic pH on electrophysiological properties are conflicting. 
For example, in one study, APD prolongation was more pronounced in respiratory than 
metabolic acidosis (220). In another study, there was marked APD prolongation in 
metabolic acidosis, but no prolongation in respiratory acidosis (218). Acidic-induced APD 
shortening has also been observed (219). It is po~sible that differ~tial LV-to-RV APD 
alterations could underlie the effect of acidic pH on the spatiotemporal DF organisation in 
VF. For instance an LV APD prolongation and RV APD shortening could account for 
lowering of the LV DF whilst increasing the RV DF. To date there is no evidence of to 
support this theory. 
At the pH levels used in this chapter, acidosis has been shown to produce both diastolic 
depolarisation, and an associated reduction in the AP upstroke velocity (218, 220, 221). 
One would predict that diastolic depolarisation should bring the resting membrane 
potential closer to the AP activation threshold. However, acidosis also alters the voltage 
dependence of INa, such that the AP threshold shifts to more positive values. These pH 
dependent alterations do not occur in parallel, so that slight acidification decreases the gap 
between diastolic potential and AP threshold, whereas more profound acidification 
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increases the gap (213). If the LV and RV were to experience different degrees of 
metabolic stress during VF, then different levels of acidification could occur in the LV 
compared to the RV when both ventricles are being perfused at the same rate, with the 
same solution. If the LV experienced greater metabolic stress, this could result in more 
severe acidification of the LV compared to the RV. Such alterations could reduce the AP 
activation threshold in the RV, whilst increasing it in the LV, and thus explain the 
increased RV DF, and lowered LV DF compared to control. At present, there is no 
evidence of heterogeneity between the ventricles in the degree of metabolic stress 
experienced during VF. 
Acidosis-induced diastolic depolarisation is thought to result from extracellular potassium 
accumulation (222). Such K+ accumulation is thought to be secondary to IKI inhibition. The 
relationship between IKI and acidic pH is biphasic, with low-level acidification (pH 7.2 -
6.0) enhancing the current, whilst higher levels (pH 6.0 - 5.0) suppress it (219). In VF, the 
ongoing metabolic stress could produce acidification greater than that predicted by solution 
imposition alone. As described above, one could hypothesise that acidification would be 
more severe in the LV than the RV, with subsequent differential effects on IK1 . Indeed, 
acidic pH has also been shown to produce an initial hyperpolarisation prior to 
depolarisation in both respiratory (223) and metabolic acidosis (219). Another 
consideration is the possible ventricular heterogeneity of Kir2.x. The effect of such 
heterogeneity on such a complex relationship cannot be predicted. 
As acidic pH did not reproduce spatiotemporal DF distribution of VF during low-flow 
ischaemia, investigation into these complex potential mechanisms was not pursued. 
4.4.3 Raised [K'"jEC 
This chapter's demonstration of EeG DF slowing when [K+]EC is raised is in keeping with 
research in the in situ canine heart (22). In this previous study, VF was induced by 
different methods, and the initial EeG DF recorded post induction. VF induction by 
intravenous potassium chloride infusion prod!.lced an initial EeG DF of 4.8 ± 0.8 Hz. This 
was significantly slower than the EeG DF on burst pacing induction of 9.9 ± 0.7Hz. The 
study also suggested a less prominent effect of raised [K+]EC on the RV. On VF induction 
by potassium chloride, an endocardial RV unipolar electrode displayed higher DFs 
immediately after initiation (8.3 ± 1.0Hz) than the surface EeG (4.8 ± 0.8 Hz) .. 
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Similar results have been shown in the isolated guinea pig heart (224). Here Warren et al. 
induced VF by burst pacing, and perfused all preparation with 4mM [K+]EC for the first 5 
minutes. After 5 minutes, the perfusate [K+] was raised to 7mM or IOmM. On increasing 
the [K+] to 7mM, the LV DF fell from 21 ± 2 to 17 ± 3Hz, whilst the RV DF rose from 13 
± 1 to 15 ± 1. Switching from 4mM to IOmM resulted in maintenance ofRV DF at 12 ± 1, 
and reduction of LV DF from 16 ± 3Hz to 14 ± 2Hz. The results of Warren et al. are subtly 
different from those presenting in this chapter. Increasing [K+] to 8mM reduced the LV DF 
from -16Hz to -9Hz, whilst the RV DF remained unchanged at -13. On increasing [K+] to 
10mM the both the LV and RV DF reduced to -7.7Hz. The subtle disparity of these could 
represent species differences, as different species demonstrate different cardiac 
repolarisation (for review of species repolarisation see (225)). Temporal differences may 
also explain the disparity; Warren et al. did not indicate the time of DF assessment (224). 
Biological variation, as suggested by the lack of similarity in LV DF in 4mM, may also 
have caused the disparity. More difficult to explain is why the different levels of increased 
[K+] concentrations had different effects on the DF heterogeneity in VF. As yet the cause 
for this remains unclear. 
Warren et al. suggested that the LV-to-RV DF heterogeneity observed in raised [K+]EC was 
a result of differential LV-to-RV expression of Kir2.x (224). Raising [K+]EC is known to 
alter the conductivity of Kir2.x in a subtype-dependant manner. In raised [K+]EC, the 
outward current of Kir2.1 is increased, whilst the reversal potentials (Ek) of both Kir2.1 
and Kir2.3 experience a rightward shift to less negative voltages (226). Such alterations in 
Ek result in diastolic depolarisation of the cell membrane in the presence of raised [K+]EC 
(Chapter 9 & (202, 227)). Diastolic depolarisation is a classic consequence of ischaemia 
(140, 228), and has been directly linked to the local [K+]EC (81). This highlights the key 
role of raised [K+]EC in ischaemia, and suggests involvement of Kir2.x ventricular 
heterogeneity in the spatiotemporal organisation ofischaemic VF. With greater LV Kir2.x 
expression, one would predict that the diastolic depolarisation would be greater in the LV 
than the RV, assuming homogeneous ventricular milieu of all other channels. To date such 
preferential LV diastolic depolarisation has not been demonstrated. 
Raised [K]EC will produce a rightward shift of Ek in all cardiac K+ currents; namely IKr, IKs, 
IKATP and kto. Heterogeneous expression of the channels responsible for these currents 
could also produce differential diastolic depolarisation. At present, there is a lack of 
research into the ventricular distribution of K+ channels in the rabbit, including Kir 
channels. In dogs, IKto and IKs are heterogeneous, with greater RV than LV current strength. 
Such heterogeneity should produce greater RV diastolic depolarisation in raised [K+]EC. 
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Also in dogs, IKr, IKl and lKATPhave been shown to have equal LV-to-RV magnitude (229). 
Thus canine IKl distribution is dissimilar to that observed in the guinea pig. Owing to such 
wide species variation, infonnation about rabbit K+ channel expression cannot be inferred 
from other species (review see (197)). 
As with low-flow ischaemia, the isolated reduction in LV DF reflects decreased cellular 
activation rates in the LV compared to the RV in the presence of raised [K+]EC. Similarly, . 
several electrophysiological mechanisms could be responsible for reducing the LV 
activation rate in this isolated fashion: - (i) differential LV-to-RV prolongation in 
repolarisation (ii) differential LV-to-RV prolongation ofpost-repolarisation refractoriness, 
(iii) differential LV-to-RV reduction in conduction velocity and (iv) differential LV-to-RV 
elevation of the AP activation threshold. These different mechanisms are explored in 
chapters 5 - 7. 
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5 Monophasic action potential duration and 
restitution in low-flow ischaemia & raised [K+]EC 
Jane C. Caldwell, 2006 Chapter 5, 104 
5.1 Introduction 
As previously demonstrated, in VF during low-flow ischaemia the ECG and psECG DF 
decreased with time (Chapter 3). This DF decline was reproduced by raising [K+]EC, and 
not by hypoxic or acidic conditions (Chapter 4). Optical mapping showed that the decrease 
in DF was heterogeneous, with a marked decrease in the LV DF, whilst the RV DF 
remained unchanged. This reduction in DF reflects decreased activation rates in the LV 
compared to the RV. Theoretically, several electrophysiological mechanisms can decrease 
activation rates: - (i) prolonged repolarisation; (ii) prolonged post-repolarisation 
refractoriness; (iii) raised activation threshold and (iv) reduced conduction velocity. This 
chapter documents the investigations into the first of these potential mechanisms, 
prolonged repolarisation. To account for the differential slowing of LV DF, but not RV 
DF, would require differential prolongation of repolarisation in the LV compared to the 
RV. Thus the LV APD would be longer than the RV APD. Although previous research 
documents APD shortening in ischaemia and raised [K+]EC (230), a relative difference in 
LV -to-RV repolarisation time may still contribute to the differential LV DF slowing. 
5.2 Methods 
As described in chapter 2.7, Langendorff-perfused hearts were positioned in a chamber 
adapted to allow epicardial pacing of the posterior RV surface with a bipolar electrode. 
Simultaneous RV and LV MAPs were recorded using two Franz contact electrodes placed 
against the R V and LV anterior epicardial surfaces. As discussed in chapter 2.7, APD 
restitution can be assessed by several methods. In this chapter, the APD restitution was 
assessed using a steady state protocol, with the' APD being measured from the last 5 
activations of 50 paced beats salvos (51). The pacing stimulus strength was set at twice the 
diastolic threshold as assessed at a Basic Cycle Length (BCL) 300ms. Using this stimulus 
strength, salvos ofBCL 250,200, 175, and 150ms were applied. Beyond this, the BCL was 
decreased by IOms until 13Orns, and then by 5ms until loss of 1: 1 capture. This protocol 
was performed in control conditions (5mM [K+]EC, 40mVmin perfusion rate) before the 
imposition of experimental conditions. Experimental conditions consisted of (i) flow rate 
reduction to 6ml/min (low-flow ischaemia) (n = 6), (ii) Tyrode's solution containing 8mM 
[K+] (n = 5) or (iii) Tyrode's containing 10mM [K+] (n = 4). The restitution protocol was 
repeated at 6 minutes (360s) and 10 minutes (600s) after the imposition of experimental 
conditions. 
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Using locally developed software, the activation point was identified as the maximal rate 
of depolarisation (dV/dtmax) on the MAP upstroke. MAPD90 was calculated as time from 
the activation point to 90% repolarisation (Figure 5.1) (231). Restitution curves were 
plotted against BCL (51, 232) and Diastolic Interval (01) (51, 52, 233). As the curves 
remained approximately parallel, comparisons between conditions and ventricles were 
made at BCL 300ms, 150rns and 125ms, and between the fractional changes ofMAPD9o at 
BCL 300ms. The significance was tested by repeated ANOV A. 
dV/dtmax 
Plateau·· :. 
Baseline· . 
Repolarisation 
90% 
~ 
100 ms 
Figure 5.1 Assessment of MAPD90• Activation point was Identified as dV/dtmax. The 
percentage repolarisation was assessed from MAP plateau with respect to baseline. MAPDgo 
was measured as the time from activation to 90% repolarlsatlon. 
5.3 Results 
5.3.1 40m/lmin VS. 6m/lmin 
Figure 5.2 demonstrates that pacing at BCL <13Orns produced alternate-beat APD 
variation in both ventricles under control conditions. This phenomenon, ,known as 
alternans, created zig-zagging of the curve at short DI in the plot ofMAPD90 vs. DI as seen 
in figures 5.3A(i) & B(i). Such zig-zagging can be eliminated by plotting scattergrams of 
APD vs. DI, and subsequently fitting to y = Yo + Ae(x-xo)/t using Origin (Originlab 
Corporation, MA, USA) (Figures 5.3A(ii) & B(ii» (234). 
At longer DIs, there was great variation between the hearts, such that RV MAPD90 could 
be longer than LV MAPD90 or shorter as in the experiments illustrated in figure 5.3. At 
shorter DIs, the curves overlapped in all experiments. Shorter DIs are more in keeping with 
the faster activation rates that occur in VF. The exact DIs produced by the pacing protocol 
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differed between experiments. Therefore the summary results from all 6 experiments were 
plotted against BeL (Figure S.4A). This showed that in control conditions, the LV and RV 
APD restitution curves were not significantly different. In keeping with this, at BeL 
300ms the LV MAPD90 of 132 ± 3ms was not different from the RV MAPD90 of 133 ± 
3ms (Figure S. SA), at BeL lSOms the LV MAPD90 of 101 ± 4ms was no different from the 
RV MAPD90 of RV of 105 ± 4ms (Figure 5.5B), and at BeL 125ms both LV and RV 
MAPD90 were 89 ± 4ms. 
LV 
300ms 125ms 
RV 
Figure 5.2 MAP recordings from the anterior epicardial surface of the lV and RV. Pacing at 
BCl <130ms resulted In alternate-beat APD variation (alternans) in both ventricles. 
Illustrated are recordings of RV & lV at BCl 300ms & 125ms. 
After 6 minutes of low-flow ischaemia (6ml/min), the stimuli failed to capture 1: 1 at BeL 
shorter than lSOms. In some experiments, the RV restitution curve shifted upwards to 
longer APD for a given DI, and the LV restitution curve to shift downwards to shorter 
APD for a given DI (Figure S.3A). However, in other experiments both the LV and RV 
APD were prolonged, and in 1 of the 6 experiments was the LV APD was more prolonged 
than the RV (Figure 5.3B). With this considerable variation in the degree of shifting, the 
mean LV and RV restitution curves after 6 minutes of low-flow ischaemia were not 
significantly different from each other, and were not significantly different from control 
restitution curve (Figure S.4A). In keeping with this, at BeL 300ms after 6 minutes oflow-
flow ischaemia, the LV MAPD90 of 136 ± l1ms was not significantly different from the 
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RV MAPD90 of 133 ± 13ms. As shown in figure 5.5A, neither of these MAPD90 were 
different from the control LV MAPD90 of 132 ± 3ms or RV MAPD90 of 133 ± 3ms at 
BCL 300ms. Similarly, figure 5.5B shows that at BCL 150ms there was no difference 
between the LV MAPD90 of 93 ± 4ms and the RV MAPD90 of 95 ± lOms in low-flow 
ischaemia or with the control LV MAPD90 of 101 ± 4ms and RV of 105 ± 4ms. 
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Figure 5.3 MAP090 restitution curves during low-flow ischaemia. There was great variation 
between experiments. Panel A: Result from one experiment where RV APO prolonged in 
ischaemia and LV APO shortened (i) Mean MAP090 of last 5 beats plotted against mean 01 
for those last 5 beats. This results in a zig-zag pattern at lower 01. (ii) 1st order exponential 
fits from scatter plots of the same experiment. Both plots show progressive reduction of LV 
MAP090 with low-flow ischaemia. RV MAP090 was prolonged especially at longer 01. 
Prolongation was longer at 6 minutes than 10 minutes in this experiment. Panel B: 
Experiment where both RV and LV were prolonged with LV more prolonged than RV. (i) 
Mean MAP090 of last 5 beats. (ii) 1st order exponential fit of from scatter plots of the same 
experiment. 
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In the experiment illustrated in Figure 5.3A after 10 minutes of low-flow ischaemia, the 
RV restitution curve returned towards control values. whereas the LV curve shifted to even 
shorter values. This pattern was extremely variable between hearts. Thus plotting the mean 
LV and RV restitution produced overlapping curves (Figure 5.4A). Again in keeping with 
this at BeL 300ms. the LV MAPD90 of 131 ± 10ms was not different from the RV 
MAPD90 of 136 ± 5ms (Figure 5.5A). and at BeL 150ms the LV MAPD90 of 94 ± Ims 
was not different from the RV MAPD900f92 ± lOms (Figure 5.5B). 
A 6ml/min B 8mM C 10mM 
- -II) II) 
.§. e 
-11 c1 1 Q Q. Q. 
c( c( 
:e :e 
80 
60 .L...--..-...,...~""T'""'~""--:'r': 
150 200 250 300 
Key 
BCL(ms) 
-- LV control 
LV 6 minutes 
. . . . LV 10 minutes 
1 
-II) e 
-
c1 1 
~ 
150 200 250 300 
BCL(ms) 
Q. 
~ 
-- RV control 
RV6 minutes 
. RV 10 minutes 
80 
150 200 250 300 
BCL(ms) 
Figure 5.4 Mean MAPD90 restitution plots. Panel A: MAPD90 restitution in low-flow ischaemia (6mllmln) compared to control. Although there was progressive shortening of LV MAPD90, 
this did not reach significance. Mean RV APD did not change. Panel B: MAPD90 restitution In 
SmM [K+] solution compared to control. Mean LV and RV APD progressively shortened to 
reach significant levels. Panel C: MAPD90 restitution In 10mM [KJ solution compared to 
control. As with SmM, 10mM [KJEC showed progressive and significant shortening in both 
ventricles. 
The percentage changes in MAPD90 were examined. This showed that after 10 minutes of 
low-flow ischaemia at BeL 300ms the LV MAPD90 was unchanged at 90% ± 9%. and the 
RV MAPD90 was unchanged at 100% ± 13%. At BeL 150ms both LV and RV MAPD90 
were unchanged at 97 ± 6%. This suggests that differential prolongation of repolarisation 
in the LV compared to the RV was not the mechanism underlying reduced LV DF in low-
flow ischaemia. 
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A BCl300ms 
LV 
Control Low flow 
RV 
Control Low flow 
B BCl150ms 
LV 
Control Low-flow 
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RV 
Control Low-flow 
Figure 5.5 MAPD90 In control (e) and low-flow Ischaemia (6mVmin).Panel A: Bel 300ms -
Neither the lV nor the RV MAPD90 was significantly shortened by low-flow Ischaemia 
(6mVmln). There was no significant difference between the'RV and l V MAPD90 In control or 
low-flow Ischaemia. Panel B: Bel 150ms - Again neither the lV nor the RV MAPD90 was 
significantly shortened by low-flow Ischaemia (6mVmln), and there was no significant 
difference between the lV and RV MAPDgo In either control or low-flow Ischaemia. 
5.3.2 5mM [K'JEC VB. 8 & 10mM [K'JEC 
In both 8mM and IOmM [K+]EC protocols, 1: 1 capture could not be achieved with BCL 
<15Oms. The restitution plots in figure 5.4 clearly show that MAPD90 was shortened by 
raised [K+]EC in a manner that was both time and concentration dependant. This shortening 
was only reached significance in 10mM [K+]EC and after 10 minutes (Figure 5.6). 
Looking at the results in more detail, after 6 minutes of perfusion with 8mM [K+] solution, 
the LV MAPD90 was 117 ± 2ms at BCL 30Oms, whilst the RV MAPD90 was 121 ± 4ms. 
These were not significantly different from the respective baseline MAPD90 in the LV of 
128 ± 5ms, and RV of 133 ± 6ms. After 6 minute~ of perfusion with 10mM [K+] solution, 
the LV MAPD90 reduced to 115 ± 5ms as assessed at BCL 30Oms, whereas the RV 
MAPD90 decreased to 119 ± Ilms. Compared to respective baseline LV and RV MAPD90, 
these were no significant changes. Assessing the MAPD90 at BCL 150ms also gave no 
significant change in either level of raised [K+]EC in either ventricle. In 8mM [K+]EC, the 
LV MAPD90 of 86 ± 2ms was not different from that in control conditions of 90 ± 2ms, 
and the RV MAPD90 of 91 ± 4ms was unchanged from the control RV MAPD90 of 98 ± 
2ms. Similarly, in IOmM [K+]EC the LV MAPD90 of 81 ± 7ms and the RV MAPD90 of 90 ± 
2ms were unchanged compared to baseline. 
After 10 minutes of perfusion with 8mM [K+] solution, the LV MAPD90 was 118 ± 3ms at 
BeL 30Oms, and the RV MAPD90 was 122 ± 4ms. These ventricular MAPD90 were not 
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significantly shortened compared to baseline values (Figure 5.6A). After 10 minutes of 
perfusing with 10mM [K+] solution, the LV MAPD90 had reduced to 113 ± 3ms * at BeL 
300ms, whilst the RV MAPD90 was III ± 6ms*. Both of these ventricular MAPD90 were 
significantly reduced compared to baseline (Figure 5.6A, *p<0.05). Assessing the MAPD90 
at BeL 150ms also gave rise to significant changes in 10mM [K+]EC but not in 8mM [K+]EC 
(Figure 5.6B). In 8mM [K+]EC, the LV MAPD90 of84 ± Ims was not different from that in 
control conditions of 90 ± 2ms, and the RV MAPD90 of 90 ± 1 ms was unchanged from the 
control RV MAPD90 of 98 ± 2ms. In contrast, in 10mM [K+]EC the LV MAPD90 of 77 ± 
3ms" and the RV MAPD90 of 87 ± 3ms** were significantly shortened compared to 
baseline (*p<O.OI). 
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Figure 5.6 MAPDoo in control (C), SmM [K1EC and 10mM [K1EC' Panel A: BCl 300ms -
Compared to control (C), the lVand RV MAPDoo were significantly shortened by 10mM[K1EC 
(*p<O.05 compared to control) but not SmM [K1EC' In both SmM and 10mM [K+]EC, there was 
no significant difference between the lV and RV MAPDoo. Panel B: Bel 150ms - eo!!,pared 
to control (e), LV and RV MAPDoo were significantly shortened by 10mM [K+]EC ( p<O.Ol 
compared to control) but not by SmM [K+]EC. In SmM [K1EC the LV and RV MAPDgo were not 
significantly different from each other. Whereas in 10mM [K1EC, the LV MAPDoo was 
significantly shorter than the RV MAPDoo(p<O.05 lV vs. RV). This is not documented on the 
plot for clarity). 
Although there was significant reduction of the MAPD90 in both ventricles in 10mM 
[K+]EC, there was no significant difference in the concurrent RV-to-LV MAPD90. There 
was also no difference in the relative change in MAPD90 as experienced by each ventricle 
under raised [K+]EC as shown by percentage change in MAPD90 compared to baseline. 
After 10 minutes of perfusion in 10mM [K+] solution, at BeL 300ms the LV MAPD90 
underwent a percentage reduction to 88 ± 2%, which was not significantly different from 
the RV MAPD90 percentage change of 83% ± 2%. Similarly at BeL 150ms, the LV 
MAPD90 underwent a percentage reduction to 88 ± 3%, which was not significantly 
different from the RV MAPD90 percentage change of93% ± 3%. 
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In summary, both the LV and RV MAPD90 were significantly reduced after 10 minutes 
perfusion in IOmM [K+] solution. There was no difference in the percentage reduction 
experienced by each ventricle. 
5.4 Discussion 
In order to explain the differential LV-to-RV DF reduction in VF during low-flow 
ischaemia and raised [K+]EC, repolarisation would have to be differentially prolonged in the 
LV compared to the RV. Thus the LV MAPD90 would need to be differentially prolonged 
compared to the RV MAPD90. This chapter demonstrated no significant reduction in LV or 
RV APD during low-flow ischaemic conditions. There was also no significant difference 
in the LV-to-RV APD during low-flow ischaemia. Although IOmM [K+] solution produced 
significant shortening of the APD, there was no difference in the degree of APD shortening 
between the LV and the RV. Nor was there any difference in the absolute values of the LV 
APD compared to the RV in either 8mM or IOmM [K+] solutions. 
Previous investigations of MAPD dispersion during global ischaemia in the isolated rabbit 
heart showed differential alterations in the LV and RV restitution curves (186). Kurz et al. 
positioned 2 contact electrodes against the RV and LV epicardial surface in a manner 
similar to that used in this chapter. APD restitution was assessed by SlS2 protocol at 
baseline before the perfusion rate was reduced to 2.5ml/min, and APD restitution re-
assessed after 2, 5 and 9 minutes. At baseline, there was no significant difference between 
the RV and LV APD. In response to global ischaemia, there was an initial APD 
prolongation, which was followed by APD shortening in both ventricles. The time-course 
of this APD alteration was different between the ventricles. In the LV, the APD' 
prolongation lasted for 2 - 5 minutes, whereas in theRV the APD prolongation lasted 5 - 9 
minutes. This produced divergent restitution curves, with LV APDs -lOOms longer than 
RV APDs after 5 minutes of ischaemia. At the DF assessment point of 480s used in this 
thesis this would mean that the RV APD would be prolonged compared to LV. This is 
opposite from the differential alteration required to explain LV DF slowing compared to 
RV. 
In this chapter, the results from 1 experiment followed the same pattern as described by 
Kurz et al. (186). This is illustrated in figure 5.3A. Over the 6 experiments, the patterns of 
restitution altered in a highly variable fashion (Figure 5.3). Therefore, the mean of all 6 
experiments showed no significant difference in APD restitution curves between the 
ventricles. One possible explanation for the discrepancy between the results of Kurz et al. 
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(186), and of this chapter, is the different perfusion rates used. In this chapter, the flow rate 
was reduced to 6ml/min, whereas Kurz et al. imposed more severe ischaemic conditions by 
reducing the flow to 2.5ml/min. One would predict that in the less severe ischaemic 
conditions of this chapter, the APD alterations would occur more gradually. Such a 
situation could produce a near unity of LV and RV APD; having reached its most 
prolonged values, the shortening LV APD could intersect with the prolonging RV APD at 
approximately the same value. Indeed, in lout of 6 experiments the LV APD was more· 
prolonged than baseline and RV supporting this theory (Figure 5.3B). 
There is no evidence in the literature for differential APD alterations of the LV compared 
to the RV in raised [K+]EC. The only evidence of any heterogeneity in th~ heart comes from 
single cell work. This showed that in raised [K+]EC there was differential alteration of the 
APD dependent on the mural level within the LV (235). The subepicardial myocyte APD 
is more prolonged in 8.1mM [K+]EC than the subendocardial myocyte. 
In summary, differential alteration in repolarisation does not account for the slowing of the 
LV DF compared to the RV in VF as observed in both low-flow ischaemia and raised 
[K+]EC. 
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6 Effective refractory period, pacing threshold 
and dV/dtmax in low-flow ischaemia and raised 
[K+]EC 
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6.1 Introduction 
Previous chapters have described how Dominant Frequency (DF) is reduced during VF in 
low-flow ischaemia and raised [K+]EC in the ECG, the psECG and over the LV epicardial 
surface. In contrast, the RV DF was unchanged during VF in low-flow ischaemia and 
raised [K+]EC. Theoretically, several mechanisms could account for the reduction of DF in 
the LV but not the RV in low-flow ischaemia and raised [K+]EC. These mechanisms are (i) 
relative prolongation of LV repolarisation, (ii) relative prolongation of LV post-
repolarisation refractoriness, (iii) relative elevation of the LV activation threshold and (iv) 
relative reduction of LV conduction velocity. Chapter 5 demonstrated that LV 
repolarisation is not prolonged compared to RV in either low-flow ischaemia, or raised 
[K+]EC. This chapter investigates the role of relative LV-to-RV changes of post-
repolarisation refractoriness and activation thresholds in low-flow ischaemia and raised 
[KiEC. 
6.1.1 Prolongation of post-repolarisation refractoriness 
In ischaemia, the Effective Refractory Period (ERP) extends beyond full repolarisation 
(236-238). This is known as post-repolarisation refractoriness. If during low-flow 
ischaemia and raised [K+]EC, there is differential prolongation of the LV post-repolarisation 
refractoriness compared to the RV, this may explain the differential LV DF slowing during 
VF in low-flow ischaemia and raised [K+]EC. Traditionally, the ERP is assessed by 
establishing the pacing threshold voltage at intervals well beyond post-repolarisation 
refractoriness, and then setting the pacing stimulus voltage at twice this threshold. The 
ERP is identified as the longest S2 interval not to propagate during an S1S2 pacing protocol 
(239) 
6.1.2 Raised threshold for activation 
An action potential (AP) is triggered if the membrane potential depolarises above a certain 
potential or threshold. At this point, there is activation of the fast Na+ current (INa), and an 
AP is propagated. In sinus rhythm and regular pacing, the peak systolic potential on 
activation is constant. This is not the case in VF. Figure 6.1 shows the considerable 
variation of the peak systolic potential that occurs during VF. If there were heterogeneity 
of the activation threshold potential throughout the myocardium, one would predict 
heterogenous activation rates. For instance, activations from an area where the potential 
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difference between the threshold and resting potentials is small may not cause sufficient 
depolarisation to trigger activations in a region where the potential difference is larger. 
Thus a relative increase in LV activation threshold, compared to the RV, could explain the 
differential lowering of the LV DF compared to the RV in low-flow ischaemia and raised 
[K+]EC. In this chapter, the pacing threshold was measured as a surrogate for AP activation 
threshold. 
The activation threshold can be increased either by increasing the magnitude of the 
background outward current, or by reducing INa. The possibility of INa reduction was 
assessed by measuring the maximum MAP upstroke velocity (240). As discussed more 
fully in chapter 1.3.4, the upstroke of MAP recordings is influenced by more cells than in 
transmembrane recordings, and thus the upstroke velocities"are slower. In the canine heart, 
the typical ventricular MAP upstoke velocity of 7V/s is much slower than the 
transmembrane upstoke velocities of 200-300V/s (146). Therefore changes in the MAP 
upstroke velocity give indirect assessments of INa. 
-80 
400ms 
Figure 6.1 Transmembrane recordings during VF. ,There Is considerable variation in the 
degree of systoliC depolarlsatlon between activations. 
6.2 Methods 
Hearts were prepared as per chapter 5. To assess the LV ERP, the heart was paced through 
the MAP electrode in contact with the LV, and any propagating activation detected via the 
MAP electrode in contact with the RV. To assess the RV ERP, the roles of pacing and 
detecting were reversed without repositioning the MAP electrodes. In each electrode, the 
pacing threshold was determined as the lowest voltage to capture 1: 1 at BeL 300ms. The 
ERP was assessed by an S1S2 protocol using a 2ms duration stimulus set at twice the 
pacing threshold voltage. The S182 protocol consisted of eight beats at BeL 300ms (81), 
followed by a single stimulus at a shorter intervals (82) (Figure 6.2). The 8182 interval was 
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initially set at 150ms, and was sequentially shortened by 5ms on subsequent stimuli trains. 
This step-wise reduction of SIS2 interval was continued until the S2 activation failed to 
propagate to the detecting electrode. The S 1 S2 interval was now returned to the last interval 
that produced a propagating activation, and the step-wise reduction resumed using 2ms 
increments. The ERP was determined as the longest S1S2 interval to not to result in a 
propagating AP. 
The pacing threshold and ERP were determined in control conditions (40ml/min, 5mM 
[K+]Ec), and after 10 minutes (600s) of experimental conditions. Experimental conditions 
consisted of (i) low-flow ischaemia (6ml/min) (n = 6), (ii) Tyrode's solution with 8mM 
[K+] (n = 5) or (iii) Tyrode's solution with 10mM [K+] (n = 5). The maximum upstroke 
velocity (dV/dtmax) was measured during the BCL 300ms (SI)' The MAP amplitudes were 
calibrated according to the known voltage signals applied through the amplifier. 
Comparisons were performed on the absolute data, and on fractional changes to reduce the 
influence of biological variation. Significance was tested using repeated measures 
ANOVA. 
Stimulus 
artefact Sl 
1 
Stimulus 
artefact S2 
100ms 
Figure 6.2 illustration of 5152 protocol to assess ERP. After ten 51 stimuli, a shorter 52 was 
delivered. ERP was determined as the shortest 52 to produce a propagating action potential. 
6.3 Results 
6.3.1 Effective Refractory period (ERP) 
As shown in figure 6.3, under control conditions the LV ERP of 123 ± 3ms was not 
significantly different from the RV ERP of 119 ± 4ms. In low-flow ischaemia, the LV ERP 
of 127 ± 7ms was not significantly different from the RV ERP of 127 ± 8ms. Neither the 
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LV ERP, nor the RV ERP was significantly different from baseline values. In 8mM [K+] 
solution, the LV ERP of 130 ± 4ms was not significantly different from the RV ERP of 
131 ± 6ms (Figure 6.3). In 10mM [K+] solution, the LV ERP of 138 ± 6ms was not 
significantly different to the RV ERP of 126 ± 4ms. In 8mM and 10mM [K+] solutions 
neither the LV ERP, nor the RV ERP were significantly different from the respective 
baseline values. 
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Figure 6.3 Plot of mean ERP in control (C), low-flow ischaemia, SmM [K+] solution and 10mM 
[K+] solution. The ERP was not significantly different between the ventricles, and showed no 
significant change compared to control in low-flow ischaemia or raised [K+]EC. Comparing 
fractional change of LV and RV ERP in low-flow ischaemia and raised [K+]EC showed no 
difference between the RV or LV. 
To ensure that there was no relative change in ERP between the ventricles in response to 
low-flow ischaemia or raised [K+]EC, the ERP fractional change was calculated for each 
ventricle. In low-flow ischaemia, the fractional change in the LV ERP of 1.03 ± 0.06 was 
not significantly different from the RV ERP fractional change of 1.10 ± 0.06. Similarly, in 
8mM [K+] solution, the fractional change in LV ERP of 0.99 ± 0.03 was not significantly 
different from the RV fractional change of 1.11 ± 0.05, and in 10mM [K+] solution, the LV 
ERP fractional change of 1.05 ± 0.02 was not different from the RV ERP fractional change 
ofl.03 ±0.01. 
Using the MAPD90 at BCL 150ms after 10 minutes of experimental conditions (Chapter 
5.3) post-repolarisation refractoriness was calculated for each ventricle in each experiment. 
Both low-flow ischaemia and raised [K+]EC produced significant post-repolarisation 
refractoriness. Figure 6.4 demonstrates that the post-repolarisation refractoriness was not 
significantly different between the LV and RV in low-flow ischaemia and 8mM [K+] 
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solution. In low-flow ischaemia the post-repolarisation refractoriness in the LV of 38 ± 
14ms was not significantly different from that of the RV of 20 ± 2ms. Similarly, in 8mM 
[K+] solution the post-repolarisation refractoriness in the LV of 43 ± 1 ms was not 
significantly different from the RV of33 ± 4ms. In contrast, in 10mM [K+] solution the LV 
the post-repolarisation refractoriness of 63 ± 3ms was significantly longer than the 32 ± 
5ms in the RV (**p<O.Ol). These results are in line with the changes in MAPD90, where 
only 10mM [K+] solution produced differential shortening of the LV MAPD90 compared to 
the RV. 
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Figure 6.4 Post-repolarisation refractoriness. Post repolarisation refractoriness was 
calculated by subtracting the MAP090 at Bel 150 from the ERP. In low-flow ischaemia and 
SmM [KJ solution the post-repolarisation refractoriness was not significantly different in the 
lV from the RV. In 10mM [K+] solution the lV post-repolarisation refractoriness was 
significantly longer than in the RV (**p<O.Ol). 
In summary, although low-flow ischaemia and raised [K+]EC produced significant post-
repolarisation refractoriness, only 10mM [K+] solution produced significantly longer post-
repolarisation refractoriness in the LV compared to the RV. This was associated by 
significant shortening of the LV MAPD90 compared to the RV. Thus there was no 
significant change in ERP in either ventricle in low-flow ischaemia or raised [K+]EC. 
6.3.2 Activation threshold 
Figure 6.5 shows how the pacing thresholds were increased heterogeneously by both low-
flow ischaemia and raised [K+]EC at BeL 300ms. In low-flow ischaemia, the LV pacing 
threshold increased by a factor of 3.5 ± 1.3 (p<0.05) which was significantly different from 
the RV (p<O.05) which only increased by 1.2 ± 0.1. In 8mM [K+] solution, the LV pacing 
threshold increased by a factor of2.6 ± 0.5 (p<0.01) which was significantly different from 
Jane C. Caldwell, 2006 Chapter 6, 119 
the RV pacing threshold (p<0.05) that remained unchanged at 1.3 ± 0.3. Similarly, 10mM 
[K+] solution, the LV pacing threshold increased profoundly by a factor of 11.4 ± 8, whilst 
the RV threshold only increased by a factor of 4 ± 2.2. However, the great variation 
masked the detection of significant differences. 
In summary, the LV pacing threshold was more markedly increased than the RV in low-
flow ischaemia and raised [K+]EC. This differential change is in keeping with the lower LV 
DF compared to the RV DF in low-flow ischaemia and raised [K+]EC. 
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Figure 6.5 Fractional change of threshold voltage required to capture the respective 
ventricle at Bel 300ms. Thresholds were elevated in the lV during low-flow ischaemia* and 
8mM [K+] solution*, whereas the RV threshold remained unchanged (*p<O.05; lV vs. RV 
fractional change). In 10mM [K+] solution, the lV pacing threshold was increased compared 
to the RV but this did not reach significance. 
6.3.3 Maximum Upstroke Velocity 
The MAP amplitude was greater in the LV than the RV, such that at baseline the mean LV 
MAP amplitude was 15.3 ± 1.5mV, whereas the mean RV MAP amplitude was 4.4 ± 
O.4mV. For this reason, LV dV/dtmax was approximately 3 times greater than RV. As 
shown in figure 6.6, at BCL 300ms, the maximum MAP upstroke velocity (dV/dtmax) was 
significantly reduced in the LV by both low-flow ischaemia and raised [K+]EC, whereas the 
RV dV Idtmax remained unchanged. In low-flow ischaemia, the LV dV Idtmax of 72 ± 24m V Is 
was significantly reduced from baseline values of 147 ± 24m Vis (p<0.001). In comparison, 
in the RV the dV/dtmax of 72 ± 6mV/s was unchanged from the baseline value of 93 ± 
33mV/s. Comparing the percentage changes in dV/dtmax, the LV was reduced to 44 ± 10% 
of baseline, whereas the RV was unchanged at RV 97 ± 19%. The difference in these 
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percentage changes did not reach significance (p = 0.06). In 8mM [K+] solution, the LV 
dV/dtmax of 81 ± 21mV/s was significantly reduced from baseline values of 218 ± 12mV/s 
(p<O.OOI). In comparison, in the RV the dV/dtmax of 27 ± 6mV/s was unchanged from 
baseline of 36 ± 6mV/s. Comparing the percentage change in dV/dtmax, the LV was 
reduced to 39 ± 10% of baseline, which was significantly different from the RV (p<0.05) 
which remained unchanged at 90 ± 22%. In 10mM [K+] solution, the LV dV Idtmax of 72 ± 
21mV/s was significantly reduced from baseline values of 218 ± 12mV/s (p<0.001). In 
comparison, in the RV the dV/dtmax of 24 ± 3mV/s was unchanged from baseline of 27 ± 
6mV/s. Comparing the percentage change in dV/dtmax, the LV was reduced to 26 ± 4% of 
baseline, which was significantly different from the RV (p<0.05), which remained 
unchanged at 87 ± 31 %. 
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Figure 6.6 Percentage change in MAP upstroke velocity during low-flow ischaemia and 
perfusion with 8mM [K+] solution or 10mM [K1 solution. In low-ischaemia, the tendency for 
the LV dVldtmax to be reduced compared to the unchanged RV dVldtmax did not reach 
significance (p = 0.06). In both 8mM and 10mM [K1 solution the LV dV/dtmax percentage 
change was significantly different from that in the RV (*p<0.05). 
In summary, there was slowing of the LV MAP upstroke compared to the R V. This 
differential upstroke slowing was associated with a differential increase in L V pacing 
threshold, compared to the RV, in low-flow ischaemia and raised [K+]EC. 
6.4 Discussion 
This chapter examined the roles of post-repolarisation refractoriness and activation 
threshold in determining the spatiotemporal DF distribution during VF in low-flow 
ischaemia and raised [K+]EC. In low-flow ischaemia and raised [K+]EC, the relative LV DF 
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slowing could be explained by either (i) a differential prolongation of the LV post-
repolarisation refractoriness or (ii) a differential increase in the LV activation thresholds. 
6.4.1 Prolongation of post-repolarisation refractoriness 
The results in chapter 5 showed no evidence of a differential prolongation of MAPD in LV 
compared to RV during low-flow ischaemia or raised [K+]EC. However, prolongation of 
ERP beyond full repolarisation (post-repolarisation refractoriness) remains a possible 
mechanism of the lower DF in the LV. Traditionally, ERP has been measured by first 
establishing the pacing threshold at intervals well beyond post-repolarisation 
refractoriness. Once established, the pacing stimulus strength is set at twice this threshold. 
The ERP is identified as the longest 8 182 interval not to' capture during an 8 182 pacing 
protocol (239). Using such a protocol, this chapter demonstrated that the ERP did not 
change in either low-flow ischaemia or raised [K+]EC. Therefore, the differential LV-to-RV 
DF slowing in VF during ischaemia and raised [K+]EC is not secondary to ERP changes. A 
similar lack of relationship between ERP and DF was demonstrated in canine atria (241). 
Here, Huang et al. observed that in atrial fibrillation (AF), the DF increased as the atria 
were dilated, whilst the ERP was unchanged. 
Although the results of Huang et al. (241) and this chapter show no correlation between 
ERP and DF, a cautionary note must be made. The determination of ERP is highly 
dependent on the pacing stimulus voltage. Using stronger pacing voltages to assess the 
same state of post-repolarisation refractoriness will allow earlier myocardial capture, and 
thus will give shorter ERP measurements. If the same stimulus strength were used 
throughout the experiment, the interpretation of E~ alteration as d,~stinct from changes in 
activation threshold becomes difficult. This difficulty of assessing and interpreting ERP in 
acute ischaemia due to the continuously changing diastolic thresholds is well known (134, 
242). To this end previous studies have shown the ERP to increase (134, 242), decrease 
(242-244) or remain unchanged (244) during ischaemia dependent on whether the stimulus 
intensity used was static or a dynamic. As the aim of the experiments in this chapter was to 
study alterations of both ERP and activation threshold in low-flow ischaemia and raised 
[K+]EC, a set high stimulus voltage was not applied, but rather the diastolic threshold was 
assessed in each circumstance, and the standard of twice this threshold used to assess the 
ERP. With this in mind, there was no relative prolongation of LV ERP compared to the RV 
ERP. Thus post-repolarisation refractoriness cannot account for relative LV-to-RV DF 
slowing in VF during low-flow ischaemia and raised [K+]EC. 
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6.4.2 Raised threshold for activation 
A differential increase in the LV activation threshold compared to the RV, could explain 
the lower LV DF in VF during low-flow ischaemia and raised [K+]EC. Differential 
elevation of the LV activation threshold means that greater current is needed to raise the 
membrane potential to threshold in the LV than the RV, and hence the safety margin for 
conduction is lower in the LV. With this lower safety margin for conduction activations 
will fail to propagate into the LV, and will therefore result in a lower LV DF. By 
measuring the pacing stimulus threshold as a surrogate for the activation threshold, this 
chapter demonstrated a relative increase in LV activation threshold compared to RV. This 
differential increase was observed in low-flow ischaemia and in raised [K+]EC. Similar 
elevations of the pacing voltage threshold have been observed by others during ischaemia 
(242,245,246) and in raised [K+]EC (247). 
Increases in the activation threshold suggest an altered balance between INa and the 
background potassium currents; either an increase in the background current or a decrease 
INa. The raised [K+]EC that occurs in low-flow ischaemia, as well as when perfusing with 
8mM or 10mM [K+] solutions, would tend to reduce background potassium currents, rather 
than increase them. As [K+]EC increases, the intracellular-to-extracellular [K+] gradient is 
reduced. This reduces the background current's driving force. Therefore, the increase in the 
LV activation threshold in low-flow ischaemia and raised [K+]EC is more likely to result 
from a reduction of INa than an increase in background current. 
The change in the maximum MAP upstroke velocity provides complementary evidence for 
INa reduction in the LV. Although the relationship between maxim~ AP upstroke velocity, 
and available sodium channels is not linear, the upstroke velocity gives a reasonable 
approximation of peak INa in conditions where non-sodium currents have minimal 
contribution (240). However, as ischaemia and raised [K+]EC depolarise the cell'membrane 
(81, 140, 202, 227), the slower ICa(L) will start to contribute to the upstroke (240). Despite 
this, maximum upstroke velocity can still be examined as an indicator of INa. In low-flow 
ischaemia, and raised [K+]EC, the maximum MAP upstroke velocity was reduced in the LV 
but not the RV. Therefore, the elevated LV activation threshold was associated with 
reduced LV upstroke velocity. 
The association between reduced INa magnitude, increased pacing threshold and reduced 
AP upstroke velocity has previously been demonstrated in non-cardiac tissues (248). Chen 
et al. showed a 42% reduction ofNa+ channel membrane density in the Na+ channel ~2-
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subunit knockout mouse. The optic nerves of these mice had reduced INa, increased 
activation thresholds, and reduced AP upstroke velocity. Interestingly, the conduction 
velocity within these nerves was maintained. 
The current literature also demonstrates that INa inhibition lowers the DF in VF (62). Here, 
Mandapati observed that low-level tetrodotoxin, a Na+ channel blocker, reduced the DF by 
reducing the rotational rate of the VF re-entrant circuits. Mandapati et al. also observed 
that the relationship between the DF reduction and reduced rotational rate in the presence 
of tetrodotoxin was identical to that observed in total global ischaemia. 
This chapter does not elucidate the mechanism of the proposed INa reduction during low-
flow ischaemia and raised [K+]EC. As the inhibition has quick onset, and is immediately 
reversed, it is unlikely to be due to altered Na+ channel density as in Chen et al. (248). The 
current literature documents depolarisation of diastolic membrane potential in ischaemia 
(140) and raised [K+]EC (81). Such depolarisation reduces the Na+ channel availability and 
increases activation threshold. Differential depolarisation of the LV diastolic potential 
compared to the RV could account for differential changes in the LV activation threshold, 
and thus the differential slowing of the LV DF in VF during ischaemia and raised [K+]EC. 
The diastolic depolarisation of ischaemia and raised [K+]EC occurs as the reversal potential 
(Ek) of K+ channels undergo positive (rightwards) shift in the presence of increasing 
[K+]EC. One of the K+ channels, Kir2.x also undergoes rightward shift of its Ek ischaemia 
and raised [K+]EC (226). As the expression of Kir2.x, and the magnitude of the resultant IKI 
current, are greater in the LV than the RV, one would predict that LV myocytes would 
experience greater diastolic depolarisation than RV myocytes in the same [K+]EC .. 
" 
Therefore differential LV-to-RV diastolic depolarlsation is theoretically possible. 
In summary, this chapter demonstrates differential elevation of the LV stimulation 
threshold compared to the RV in both low-flow ischaemia and raised [K+]EC. The 
associated differential reduction in LV dV/dtmax suggests that differential inhibition of INa 
in the LV compared to the RV may underlie this threshold elevation. It is theoretically 
possible that this differential INa inhibition is secondary to differential diastolic 
depolarisation as a result of the LV/RV heterog~neity of Kir2.x expression. 
124 
7 Alterations in conduction velocity 
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7.1 Introduction 
Chapters 3 & 4 have described how the Dominant Frequency (DF) in the ECG, the psECG 
and by optical mapping of the LV is reduced during VF in low-flow ischaemia and raised 
[K+]EC. In contrast, the RV DF was unchanged during VF in low-flow ischaemia and raised 
[K+]EC. Theoretically, several mechanisms could account for the relative slowing of the LV 
DF in VF during low-flow ischaemia and raised [K+]EC. These mechanisms are (i) relative 
prolongation of LV repolarisation (Chapter 5), (ii) relative prolongation of LV post-
repolarisation refractoriness (Chapter 6), (iii) relative elevation of the LV activation 
threshold (Chapter 6) and (iv) relative reduction of LV conduction velocity (CV). This 
chapter documents the investigations into CV heterogeneity in low-flow ischaemia and 
8mM [K+] solution. 
A relative slowing of the LV CV compared to the RV would slow the propagation of 
wavefronts from the RV into the LV. CV is altered by ischaemia (249) and raised [K+]EC 
in a biphasic manner (218), (250). Early ischaemia is associated with minor elevations in 
[K+]EC, which increase CV. More prolonged ischaemia is associated with higher [K+]EC that 
decrease CV. Therefore, differential slowing of the LV CV could be produced by either a 
relative decrease in the LV CV, or a relative increase in the RV CV. 
In this chapter, CV was assessed during VF (apparent CV (46, 189)) and during epicardial 
pacing (traditional CV). 
7.2 Methods 
7.2.1 Apparent CV measurements in VF 
Apparent CV was calculated from the VF data sets of chapters 3 & 4, using locally 
developed software (46). This software first identifies the activation times in each pixel as 
the point of dV/dtmax• The activation times of adjacent pixels were compared to determine 
the wavefront direction. Using the direction; and the activation times, the wavefront 
velocity was calculated at the junction of each group of 4 pixels. The process was repeated 
for all activation times during the 4s epochs of VF. From these data sets, the mean and 
modal apparent CV was calculated for each junction point. The results were plotted as 
colour-coded, two dimensional maps. Representative values for the LV and RV CV were 
derived from standardised squares, which were equivalent to those used to determine the 
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RV and LV DF in chapters 3 & 4. Similar patterns were observed for both the mean and 
the modal CV. As the mean CV showed less variability than modal CV, it alone is reported 
in this chapter, whilst acknowledging that modal CV is more in keeping with the "peak" 
nature ofDF. 
For the first 60s after VF induction, all hearts were perfused at the control rate of 40mllmin 
with standard Tyrode's solution. Experimental conditions were imposed from 60s onwards, 
and hearts were defibrillated at 600s. Comparisons were made between control and 
experimental conditions at Os and 480s using ANOV A. The 480s time-point was 
representative of the steady state observed in DF, and was equivalent to 420s in 
experimental conditions. 
7.2.2 Traditional measurements of CV 
Hearts were Langendorff-perfused and mounted in the optical mapping chamber as per 
chapter 2.1. A Imm diameter hole was drilled through the Plexiglass front-plate to allow 
the insertion of a bipolar platinum electrode. This electrode was used to pace the 
epicardium of the ventricles. The bipolar electrode was centralised within the optical 
recording area. Hearts were loaded with 100~ of Imglml RH237. 3~ cytochalasin D 
was used to improve the precision of activation identification by reducing motion artefact. 
This concentration of cytochalasin D has been shown not to significantly affect CV in the 
rabbit heart (231). Hearts were perfused in Tyrode's solution containing 3 ~ cytochalasin 
D for 20 minutes. The perfusate was then switched back to standard Tyrode's solution. 
Both control and experimental protocols were performed during this "washout" phase. At 
the start of each CV protocol, the diastolic pacing threshold was aS~,essed at BCL 30Oms .. 
Hearts were paced at twice this stimulus strength at BCL 25Oms, 200ms and 15Oms. Hearts 
were manipulated within the chamber to stimulate of each ventricle in turn. The CV 
protocol was performed in each ventricle during control conditions, before experimental 
conditions were applied. Experimental conditions consisted of either low-flow ischaemia 
(6ml/min, n = 4) or raised [K+]EC (8mM, n = 4). After 6 minutes (360s) in experimental 
conditions, the CV protocol was repeated in each ventricle. Performing the CV protocol in 
both ventricles took c.60s, so that the protocol was completed by 420s. The short intrinsic 
delay of this experimental procedure resulted in one of the ventricles being exposed to 
experimental conditions for a marginally longer prior to CV assessment. To ensure this 
short intrinsic delay had no confounding effect on the CV data, the sequence of the LV-RV 
recordings was reversed in alternate experiments. 
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Offline, the activation time in each pixel was identified as the point of dV/dtmax• Using 
software developed locally in MatLab (The MathWorks, Inc., MA, USA), these times were 
used to calculate the local conduction velocity (251). The conduction velocity can be 
artificially accelerated by intramural conduction or close pacing stimulus. Thus, to ensure 
the correct evaluation of conduction velocity, both transverse and longitudinal velocities 
were assessed using several different selection strategies. For full description and 
explanation of the different strategies see chapter 2.6. Briefly the strategies were: - (i) Smm 
radial velocity (Figure 2.9) - the pacing site was identified as the central activation point 
on the isochronal activation map. CV was calculated at all points around a 5mm radius 
from the pacing site. The longitudinal CV s were identified as the 2 highest velocities 
around this circle. The transverse CV was measured on the circle at points perpendicular to 
the longitudinal CV. (ii) Linear velocity (Figure 2.10) - using isochronal activation maps, 
CV was calculated along a straight line. This line was drawn from the pacing site, through 
the fasted advancing point of the wavefront. The longitudinal CV was determined as the 
value of the "low plateau" velocity· between the pacing artefact and the intramural 
breakaway conduction. Transverse CV was similarly assessed on perpendicular lines. (iii) 
Point velocity (Figure 2.11) - The CV was plotted across the epicardial surface as a colour-
coded map. This shows 2 areas of homogeneous CV along the transverse CV axes. Five 
CV measurements were taken from each of the homogeneous areas, and the mean used as a 
further method to assess transverse CV. As all strategies gave similar results only the radial 
method data is reported. 
Due to the variable location of epicardial stimulation point with respect to the 
septum/opposite ventricle, longitudinal velocity was assessed along the axis away from the 
septum. Transverse velocity was measured in both perpendicular axes then averaged. 
Comparisons between control and experimental conditions were made using repeated 
measures ANOV A. 
7.3 Results 
7.3.1 Apparent CV in VF 
As shown in figure 7.1 & table 7.1, the apparent CV was homogeneous across the 
ventricles immediately after VF induction. As all protocols were commenced in control 
conditions, there were no differences in the baseline apparent CV. During VF in control 
conditions, the distribution of apparent CV remained homogeneous (Figure 7.1, Table 7.1). 
Jane C. Caldwell , 2006 Chapter 7, 128 
At 480s, the mean percentage change of CV in the L V of 102 ± 19%, was not significantly 
different from the percentage change of CV in the RV 117 ± 19%. 
As clear from figure 7.1, during VF in low-flow ischaemia the CV changed 
heterogeneously (Table 7.1). In low-flow ischaemia, the mean CV in the LV decreased 
profoundly to 64 ± 7% (p<0.01). This was significantly different from the RV (p<0.05) 
where the CV decreased non-significantly to 89 ± 5%. 
Low flow 70cm/s 
480s 40cm/s 
10cm/s 
Figure 7.1 Apparent CV in VF. The colour-coded maps represent the CV at the junction of 4 
pixels in the photodiode array. The maps represent typical CV maps at Os and 480s in 
control, low-flow ischaemia and 8mM [K+] solution. The white dotted line delineates the 
LV/RV border, and the white squares indicate the regions used to derive the mean 
ventricular CV. At Os, the CV was homogeneous across the ventricles in all protocols. At 
480s, in control VF there was no significant change in either the LV or RV CV compared to 
Os. At 480s in low-flow ischaemia, there was profound CV reduction in the LV compared to 
Os. In the RV, CV remained unchanged. In 8mM [K+] solution, the, LV CV was marginally 
reduced, whilst RV CV remained unchanged at 480s compared to Os. 
Apparent CV Control (n = 7) Low-flow (n = 7) 8mM [~l (n = 4) 
(em/s) 
LV Os 36.5 ± 3.1 41.1 ± 3.0 35.1 ± 2.3 
LV 480s 32.9 ± 3.1 25.2 ± 1.9** 29.5 ± 3.1* 
RVOs 34.6 ± 3.1 41.3 ± 2.4 35.9 ± 1.9 
RV 480s 36.4 ± 0.6 36.7 ± 2.4 39.5±2.1 
Table 7.1 Mean apparent CV at Os and 480s. During VF in control conditions the apparent CV 
remained unchanged. During low-flow ischaemia VF, the LV CV decreased (**p<0.01 vs. 
baseline), whereas the RV CV was unaltered. During raised [K+]EC, the LV CV was slightly 
reduced (p<0.05 vs. baseline). Again the RV CV was unaltered. 
During VF in 8mM [K+] solution, there was a tendency towards a difference in CV 
between the LV and RV (Figure 7.1, Table 7.1). Perfusing with 8mM [Kl solution caused 
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a marginal reduction of mean LV CV to 85 ± 6% (p<0.05), whilst the RV remained 
unchanged at 112 ± 9%. This difference was not significant (#p = 0.09). 
7.3.2 Traditional CV measurements 
As clearly shown in figure 7.2A, there was a significant reduction in CV in the LV but not 
the RV after 6 minutes oflow-flow ischaemia. The LV longitudinal CV fell to 69 ± 8%* 
and the LV transverse CV reduced to 70 ± 1 %* (*p<0.05 vs. baseline). In comparison, the 
RV longitudinal CV was unchanged at 98 ± 2%, whereas the RV transverse CV was 
marginally reduced to 92 ± 3% (p<0.05). The reduction in the RV transverse CV was 
significantly less than the reduction in LV transverse CV (p<0.05). 
After 6 minutes of perfusion with 8mM [K+] solution neither the transverse CV nor the 
longitudinal CV were significantly changed in either ventricle (Figure 7.2B). In the LV, the 
percentage change of the longitudinal CV was 113 ± 8%, and the transverse CV was 99 ± 
5%. In the RV, the percentage change of the longitudinal CV was 117 ± 7%· and the 
transverse was 98 ± 5%. There was no significant difference between the percentage 
changes of longitudinal or transverse CV between the ventricles. 
7.4 Discussion 
This aim of this chapter was to investigate the role of LVIRV heterogeneity of CV in 
producing the observed DF heterogeneity in low-flow ischaemia and raised [K+]EC. To do 
this, CV was· assessed in VF (apparent CV) and during epicardial pacing (traditional CV). 
The CV values obtained in control during traditional CV measurements are in keeping with 
the current literature. Previous studies have measured the longitudinal CV in the rabbit as 
widely as 67 ± 4cmls (252) to 76 ± 11 cmls (253). This chapter's mean LV longitudinal CV 
. of 76 ± 3 cmls lies within this range. The mean LV transverse CV of 33 ± 3cm1s also 
compares well with previous measurements in rabbit of -36 cm/s (252, 253). 
The role of CV in VF is controversial. Theoretically, slowing of conduction has 
diametrically opposite effects on VF maintenance depending on whether the driving 
mechanism is "a mother rotor" or "multiple wavelets" (254). In their paper, Qu et a1. 
predicted that conduction slowing will stabilise a mother rotor and therefore convert VF to 
VT. The same level of conduction slowing was predicted to reduce the rate of wavelet 
annihilation, thereby prolong VF duration. 
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7.4.1 Apparent CV and traditional CV discrepancy 
Also controversial is the relationship between CV assessed in VF (apparent CV), and CV 
assessed during epicardial pacing (traditional CV). As explained fully in chapter 2.6, 
traditional measurements of CV limit the assessment to the epicardium, and allow 
assessment of conduction aniosotropy that arises from myofibril orientation. In contrast, in 
VF the spiral waves drift chaotically across the myocardial fibres and myocardial layers. It 
is interesting that such chaotic pathways give rise to baseline CV in LV of 36.5 ± 3.1 , 
which is close to baseline transverse CV in the LV of 33 ± 3cmls. This suggests that 
conduction across the fibres rather than along them has more influence in VF. 
A 6mllmin 
I 
~ 
~ 
"0 
o 
~ 
c 
o 
tl 
'" "C C 
o 
() 
Longitudinal 
LV RV 
Control Low-flow Control LOW-flow 
Longitudinal 
LV RV 
Control 8mM [K1 Control 8mM [K1 
I 
~ 
·u 
o 
~ 
c 
.9 g 1 
"C 
c 
o () 
Transverse 
LV RV 
* 
Control Low-flow Control Low-flow 
Transverse 
LV RV 
Control 8mM [K1 Control 8mM [K1 
Figure 7.2 Bar plot of absolute traditional CV.Panel A: CV in low-flow ischaemia. Low-flow 
ischaemia decreased both longitudinal CV* and transverse CV* (* p<O.05). Panel B: CV in 
SmM [K+]ec. In SmM [K+]ec neither the longitudinal CV nor the transverse CV were 
significantly altered, though there was a tendency for both to be increased. 
Despite this similarity between apparent CV and transverse CV by traditional 
measurements, these CV assessments responded differently to perfusion with 8mM [K+] 
solution. The apparent CV in the LV was reduced in low-flow ischaemia, and 8mM [K+] 
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solution. The traditional ev in the LV was reduced in low-flow ischaemia, but was 
unaffected by 8mM [K+] solution. 
One possible explanation for this disparity is the differences in the activation pathways 
between apparent and traditional ev (Figure 7.3). With epicardial pacing, the excitation 
travels outwards, through the epicardium, from the point of stimulation (Figure 7.3A). 
Beyond a certain distance, the epicardium starts to become activated from the underlying 
intramural myocardium (175). This produces artificially fast epicardial ev. This artefact 
can be avoided by measuring the ev closer to the activation point. In VF, the activations 
observed on the epicardial surface can arise from adjacent epicardium or from the 
underlying intramural myocardium (Figure 7.3B). Attempts to differentiate between these 
activation pathways from the optical action potential morphology has led to conflicting 
results (255-257). This, plus the ever-changing nature of the VF activations, means that at 
present it is not possible to determine the wavefront direction in VF. Therefore the 
apparent ev in VF could be influenced by electrophysiological changes of the underlying 
intramural myocardium, which would not influence the traditional ev. The intramural 
myocardium contains of a distinct population of cells known as "M cells". These M cells 
have unique electrophysiological properties (258, 259), and are effected differently from 
epicardial cells by drugs like quinidine (260). It is possible that these M cells undergo 
different e1ectrophysiological adaptations to raised [K+]EC. However, there is no evidence 
in the current literature for such differential M cell responses to raised [K+]EC. . 
Another possible explanation for the disparity between the apparent and traditional ev is 
the different activation rates ofVF and epicardial pacing. In VF, after 60 seconds the LV is 
activated at c.20Hz. This is equivalent to a BeL of 50s. Such short cycle lengths induce 
, " 
VF within seconds. Therefore it is not possible to ~ssess traditional ev at activation rates 
equivalent to those experienced in VF. At higher activation rates, the Na channels do not 
fully recover (261). One would predict that this relative inhibition of INa would reduce the 
apparent ev compared to the traditional ev. 
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Figure 7.3 Illustration of different pathways of epicardial activation. Panel A: Traditional CV 
- the activation wavefront changes from epicardial to intramural source. As the orientation 
of the activation changes, the epicardial CV changes (175). From the epicardial surface, the 
orientation of the underlying wavefront is not easily indiscernible (255-257). Panel B: 
Apparent CV - In VF, epicardial activity is chaotic. The activation could originate from 
intramural rotors or multiple epicardial wavelets. Here an intramural rotor is illustrated. At 
present it is impossible to differentiate the activation pathway from optical mapping of the 
epicardial surface. If raised [K+]EC affects intramural and epicardial conduction properties 
differently, this could explain the disparity between traditional and apparent CV. 
7.4.2 Traditional CV 
Previous research shows that as ischaemia evolves, CV is altered in a biphasic manner (for 
review see (249)). CV increases in the early stages of ischaemia. This increasing phase 
lasts for ~2 minutes, and is followed by a progressive decrease in CV. Therefore, at the 6 
minute time-point used in this chapter, one would expect the CV to be reduced compared 
to baseline. Indeed, this chapter demonstrated reductions in the L':. longitudinal CV and 
transverse CV, as assessed through epicardial pacing. However, in the RV, the longitudinal 
CV was unchanged after 6 minutes oflow-flow ischaemia, and the transverse CV was only 
marginally reduced. This differential reduction of CV in the LV compared to the RV 
during low-flow ischaemia could explain the heterogeneous DF reduction in LV in VF 
during low-flow ischaemia. Although several studies have suggested a relationship 
between DF and CV (67, 70, 189, 262,263), probably the most convincing study correlates 
the ECG DF to the rotation rate of the underlying epicardial re-entrant circuits (62). Here, 
Mandapati et al. showed that the evolving global ischaemia was associated with ECG DF 
reduction, and that this ECG DF reduction correlated with the decreasing rotational rate of 
optically imaged re-entrant circuits at that same time-point. 
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Whilst this chapter's results would support a causal role for CV heterogeneity in 
detennining the DF heterogeneity in low-flow ischaemia, they do not support a role for CV 
heterogeneity underlying the identical pattern of DF heterogeneity in raised [K+]EC. 
Assessments of CV by epicardial pacing failed to demonstrate any significant change in 
CV in 8mM [K+] solution. If anything, during perfusion with 8mM [K+] solution, there was 
a tendency for the longitudinal and transverse CV to increase in both ventricles. Previous 
experimental and computer studies show a complex relationship between conduction 
velocity and [K+]EC (218, 250). Elevating the [K+]EC above 5mM results in progressive CV 
increases until a peak is reached at around 8 - 9mM. Elevating the [K+]EC above this results 
in slowing of conduction. At c.12mM [K+]EC the CV falls below baseline levels. Therefore, 
this chapter's demonstration of a trend towards increasing CV in 8mM [K+]EC is in keeping 
with the current literature. Since the LV DF was significantly reduced in 8mM [K+]EC, CV 
reduction cannot be an underlying cause for DF reduction. This conclusion is supported by 
previous reports indicating a lack of correlation between CV and DF (241). 
134 
8 Changes in the amplitude of the VF signal with 
time 
Jane C. Caldwell, 2006 Chapter a, 135 
8.1 Introduction 
In VF during low-flow ischaemia, the DF of the ECG and psECG decrease with time 
(Chapter 3). As previously discussed in chapter 1.1.1.4, both clinical (24, 29) and animal 
studies (30, 33) show that the decrease in ECG frequency is accompanied by a reduction in 
the amplitude of the ECG signal. In ischaemia during regular pacing, there is a reduction in 
amplitude of the action potential (AP) (140, 214,228,238,264). This amplitude reduction 
is thought to result from multiple electrophysiological alterations in response to several 
metabolic components. The precise contributions of each of these are uncertain. However, 
it is possible that the fall in VF amplitude may arise from the same phenomenon. 
The alterations in ECG amplitude in VF during full perfusion have not been evaluated. 
Therefore the contribution of VF itself to the amplitude decline is not known. Also 
unknown is whether the decrease in amplitude in non-perfused VF is homogeneous across 
the ventricles, or whether there is LVIRV heterogeneity, in a similar fashion to LVIRV 
hetereogeneity of DF (Chapter 3). Finally, the contribution of hypoxia, acidic pHEC and 
raised [K+]EC to the amplitude decline in VF is not known. 
This chapter investigates the time-course and spatiotemporal distribution of the amplitude 
changes in VF during full perfusion (control) and low-flow ischaemia (6ml/min perfusion). 
Having established this, the contribution of the principal ischaemic components to the 
amplitude changes and their spatiotemporal distribution will be investigated. 
8.2 Methods 
The amplitude of the ECG and optical signals during VF was measured using the data sets 
of chapter 3 & 4 as outlined in chapter 2.5.2. Briefly, locally developed software (Dr F. L. 
Burton) filtered the signal (polynomial subtraction, low (3Hz) and high pass (50Hz) 
filters), identified the peaks as points of changed dV/dt direction, and then calculated the 
peak-to-peak amplitude. The mean peak-to-peak amplitude was calculated for each ECG 
and optical recording during VF. 
Owing to biological variation, the absolute ECG amplitude varied between preparations. 
For optical signals, this was further compounded by differential illumination within the 
recording field. At the centre of the optical field, the confluence of the 4 light sources led 
to greater intensity of illumination than at the periphery. To remove both biological and 
technical sources of variation, the VF amplitude was assessed by fractional change in the 
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individual preparations. Whilst it was possible to measure the ECG amplitude in sinus 
rhythm, it was not possible to measure the optical signal amplitude due to motion artefact. 
For consistency, the fractional changes in both ECG and optical amplitudes were 
calculated using the peak-to-peak VF amplitude immediately after induction as a baseline. 
Comparisons between experimental conditions were made using the mean fractional 
change over the 7 - 9 minute time interval and the single time-point of 480s. Significance 
testing with ANOV A showed identical significances for both the 7 - 9 minute time interval 
and the single 480s time-point. Therefore only the 7 - 9 minute time interval data are 
detailed to allow comparison with the micro electrode data (Chapter 9). 
Owing to the variable location of the LV/RV boundaries within the area of interrogation, 
the amplitude change in each ventricle was derived from the same standardised 3 x 3 
pixels as used to calculate mean ventricular DF in chapters 3 & 4. As the standardised LV 
and RV pixel squares were equidistant from the central point of illumination, differential 
photobleaching was assumed to be negligible. Significance between the ventricles was 
compared by paired t-test, whilst significances between different parameters were 
compared using ANOV A. 
After initial loading, the fluorescent emission of voltage-sensitive dyes can be affected by 
variables other than the membrane potential. These variables include dye concentration 
(i.e. washout), dye intemalis~tion to the inner leaflet of the cell membrane and dye 
photobleaching (156, 265). A progressive change in any of these variables could result in 
optical amplitude decline. To investigate the effect of these uncontrollable variables, the 
spontaneous degradation in the optical amplitude was investigated in non-VF preparations, 
using optical recordings were made by Dr N. Walker for the purpose of examining LV. 
, . 
restitution. These long-term recordings were ideal. for examining the change in signal 
amplitude with time. For this purpose signals were re-analysed in terms of amplitude 
changes with time. In these experiments, 3J.LM cytochalasin D was administered as per 
chapter 7.2, to reduce motion artefact. This allowed accurate measurement of AP 
amplitude during atrial pacing. As ventricular heterogeneity was not the focus of these 
protocols, the position of the LVIRV boundary was extremely variable and eccentric. This 
made selection of standardised 3 x 3 pixel squares in both ventricles impossible, and so the 
mean ventricular percentage amplitude changes cannot be reported. 
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8.3 Results 
8.3.1 VF amplitude in control conditions 
The induction of VF did not alter the ECG amplitude consistently. Compared to the 
amplitude in sinus rhythm, on VF induction individual preparations experienced either (i) 
an increase in ECG amplitude (as occurred in 21 of the 51 protocols, 41 %), or (ii) a 
decrease in ECG amplitude (as occurred in the other 30 protocols, 59%). For all 
preparations the mean fractional change in ECG amplitude on inducing VF was 1.3±O.2 
(range 0.6 - 2.4), which was not significant. As VF continued, the ECG amplitude 
decreased (Figure 8.1A). Therefore, all changes were calculated as a fraction of initial VF 
amplitude, rather than a fraction of sinus rhythm amplitude. 
As shown in figure 8.lA, in VF during control conditions (40mVmin, n = 7), the ECG 
amplitude fell over the first 4 minutes (240s). After 4 minutes the ECG amplitude did not 
change greatly, but rather approximated around a steady state value of -55% of baseline. 
Comparing the changes of ECG amplitude with that of ECG DF showed reciprocal 
patterns (Figure 8.1 C). In VF during full perfusion, the ECG DF increased to a peak at 3 
minutes (21 Os), before slightly slowing to a steady state by 4 minutes (Chapter 3.3.1). 
During VF in control conditions, the psECG amplitude declined more markedly than the 
ECG amplitude over the first 4 minutes to --45% (Figure 8.1 B). After 4 minutes, the 
psECG amplitude continued to decline, but at a slower rate. This slower decline was 
almost parallel to that observed in RA pacing (Figuie 8.2). 
Spatiotemporally, the reduction in optical amplitu4e was not homogeneous across the 
anterior surface of the heart (Figure 8.1 D). Rather, there was a more profound amplitude 
reduction in the LV than the RV (Table 8.1). This LV/RV heterogeneity in' amplitude 
reduction was not observed during regular atrial pacing. Figure 8.2A shows that during RA 
pacing (n = 4), the psECG amplitude declined in a more linear fashion. Using Origin 7.0 
(OriginLab Corporation, MA, USA), the data was fitted to y = mx + c. Superimposing this 
best-fit line onto the psECG amplitude time-course during fully perfused VF, demonstrated 
a good fit for the slower amplitude reduction that occurred after 5 minutes. This suggests 
that the continued slow reduction in psECG amplitude is consistent with dye degradation. 
Indeed, correcting the psECG amplitude for dye degradation resulted in identical fractional 
changes to those in the ECG amplitude (Figure 8.2B). During RA pacing, the fractional 
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reduction in optical signal amplitude was homogeneous across the area of interrogation 
(Figure 8.2e). This suggests that signal degeneration occurs in a homogeneous fashion 
within the ventricles. 
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Figure 8.1 Amplitude and OF changes during VF under control conditions (n = 7). Panel A: 
Plot of changes in ECG amplitude with time. The mean fractional change in ECG amplitude 
was calculated using ECG amplitude immediately after VF induction as baseline. The ECG 
amplitude decreased for the first 4 minutes (arrow = 240s). After this the ECG amplitude 
stabilised at a level of -55%. Panel B: Plot of change in psECG amplitude with time. Again 
there was an initial period of marked amplitude reduction over the first 4 minutes (arrow). 
By this point the psECG amplitude had reduced to -45%. After this the psECG amplitude 
continued to decrease but at a slower rate. This continued amplitude reduction could be 
explained by dye degradation (Figure 8.2). Panel C: Plot of changes in ECG OF with time. 
The rapid decrease in amplitude coincided with the initial increase in OF (arrow = 240s). 
After this both amplitude and OF stabilised. Panel 0: Colour map of the fractional change in 
amplitude in each pixel at 480s. The optical signal amplitude has decreased more markedly 
in the LV than in the RV (dotted white line = LV/RV boundary, white squares = standardised 
areas for determining mean ventricular fractional changes). 
Amplitude Control Low O%P02 pH6.7 pH6.3 8mM lOmM 
(%) flow IC K + 
LV 33±5** 32±3 27+6*** 45+8 20+6*** 60+15 86+13 
RV 63±8** 49±9 59±11 *** 56+5 55+4*** 100+15 91 +16 
Table 8.1 Percentage change in VF amplitude in LV and RV. In control, pH 6.3 and 0%P02, 
the LV amplitude experienced more profound amplitude reductions than the RV ('"*p<0.01, 
***p<0.001). Experimental protocol results for fractional change in optical amplitude in the 
LV can be divided into 2 groups: - (i) LV amplitude reduction that was equivalent to control -
pH 6.7, pH 6.3, low-flow ischaemia and 0% P02, and (ii) LV amplitude reduct ion that was less 
than control - raised [K+]EC' This only reached signif icance in 10mM (p<0.05). The fractional 
change of amplitude in the RV was similar in all protocols. 
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Fi ure 8.2 ff ct f dy d gr d tlon n optical signal amplitude. Panel A: Plot of change in 
psECG amplitude with time during atrial p c lng nd during VF In control conditions. In RA 
paced hearts, the psECG amplitude decreased in a more linear fashion. This amplitude 
reduction is probably due to a combination of dye washout, internalisation and 
photobleaching. The superimposed red line is the best linear fit (y = mx + c) d termlned 
by Origin 7.0. In VF, th P ECG amplitude decreased rapidly until 240s (arrow), and then 
decreased more slowly. This secondary phase of amplitude decline runs almost parallel to 
the best-fit line of the amplitude changes during right atrial pacing. Panel B: Plot of 
amplitude changes in ECG and corrected psECG. The psECG was corrected for dye 
degradation using the linear fit equation from panel A. The changes in ECG and corrected 
psECG amplitude overlap. This suggests that the secondary decline 'in the psECG is due to 
dye degradation. Panel C: Colour map of the fractional change in amplitude during RA 
pacing after 480s. In RA pacing, the optical signal amplitude was only marginally reduced. 
This optical amplitude reduction occurs homogeneously across the area of interrogation. 
8.3.2 VF amplitude in low-flow ischaemia 
In figure 8.3 , the ECG and psECG show similar patterns of amplitude change in VF during 
the low-flow ischaemia. On reducing the flow rate to 6ml/min, there was an immediate 
increase in the ECG and psECG amplitude that reached a peak at 120s. This amplitude 
increase coincided with an initial decline in ECG DF (Figure 8.3C). Optical mapping at 
this 120s time-point showed an increase in the LV amplitude (Figure 8.3D). 
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Figure 8.3 Amplitude changes during VF in low-flow ischaemia (n =,.1) and hypoxia (n = 6). 
Panel A: Changes in ECG amplitude with time. In low-flow, the ECG amplitude increased 
until 120s (black arrow). After this, the amplitude steadily declined. Although the amplitude 
reduction tended to be greater than control, this was not statistically significant over the 7 -
9 minute assessment interval. During hypoxia, the ECG amplitude declined in a manner 
indistinguishable from control until 4 minutes (magenta arrow = 280s). After this the ECG 
amplitude continued to decrease but did not become significantly different from control 
amplitude change. Panel B: Changes in psECG amplitude with time. With the exception of 
the initial amplitude increase immediately on flow reduction, the psECG amplitude changed 
in a similar manner in both hypoxia and low-flow ischaemia, and was indistinguishable from 
psECG amplitude changes in control conditions. Panel C: Changes in ECG OF with time. 
The transient increase in ECG and psECG amplitude from 60 - 120s coincided with a 
marked decrease in OF (arrow). Panel 0: The colour-coded map displays the fractional 
change in optical VF amplitude in each pixel. This map illustrates the typical findings at 
120s during low-flow ischaemia (black arrow in panels A - C). This shows that the LV 
amplitude was increased compared to the baseline optical amplitude taken immediately 
after VF induction (white dotted line = LV/RV boundary). 
After the peak at 120s, the ECG and psECG amplitudes decreased in a near linear fashion 
until the protocol end at 600s (Figures 8.3A & B). Although after 120s in low-flow 
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ischaemia the ECG amplitude continued to decline, over the assessment interval of 7 - 9 
minutes the mean fractional change in ECG amplitude in VF during low-flow ischaemia of 
0.38 ± 0.04 was not significantly different from that in control conditions of 0.57 ± 0.06. 
The psECG amplitude declined steadily in a manner that is indistinguishable from the 
control. Over the 7 - 9 minute period, the mean fractional change in psECG amplitude of 
0.35 ± 0.04 was not significantly different from that in control of 0.37 ± 0.04. 
In low-flow ischaemia, the spatiotemporal distribution of the fractional amplitude change 
at 480s was also not significantly different from control, although there was a tendency for 
a greater reduction in RV optical amplitude (Figure 8.4 (i), Table 8.1). 
8.3.3 VF amplitude in hypoxia 
The initial progression of ECG VF amplitude in hypoxia was indistinguishable from 
control (Figure 8.3A). In both, there was an initial rapid decrease in amplitude for 4 
minutes. After this the curves diverged, as hypoxia was associated with continued 
rediuction of ECG amplitude to 0.47 ± 11, whereas the ECG amplitude in control 
conditions stabilised to 0.57 ± 0.06. This divergence did not result in a significant 
difference between the ECG amplitude reductions during VF in hypoxia compared to that 
during control. 
The psECG amplitude in VF during hypoxia showed no divergence from the amplitude 
changes of VF during control conditions (figure 8.3B). Over 7 - 9 minutes the psECG 
amplitude in hypoxia fell to 0.4 ± 0.07 compared to the control psECG amplitude reduction 
of 0.37 ± 0.04. 
The spatiotemporal distribution of the amplitude change during hypoxia was 
indistinguishable from control with a similar degree of LV and RV amplitude reduction 
(Table 8.1, Figure 8.4(i». 
8.3.4 VF amplitude in acidic pHEC 
As is clear from figure 8.5, in VF during acidicpHEc there was great variability in the ECG 
amplitude changes. However, over the 7 - 9 minute assessment period, the ECG 
amplitudes stabilised at 0.71 ± 0.1 in pH 6.7 and 0.55 ± 0.08 in pH 6.3. Neither of these 
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Figure 8.4 Colour-coded maps of fractional change in optical signal amplitude during VF. 
These maps show typical spatiotemporal distribution of amplitude change during VF at 
480s. The changes are expressed as a fraction of the corresponding site's amplitude 
immediately after VF onset. The arrangements fall into 2 groups compared to control VF 
(Figure 8.1C): - (i) Similar or slightly greater reduction in VF amplitude - low-flow, hypoxia 
and acidic pHEC ' (ii) Lesser reduction in VF amplitude with no significant change in LV or RV 
amplitude - raised [K+]EC' (White dotted lines = LV/RV boundary, white squares = 
standardised areas to determine ventricular optical amplitude). 
The psECG amplitude showed less variability in VF during acidic pHEC. Although the 
psECG amplitude fell less in pH6.7 to 0.54 ± 0.06, this was not significantly different 
Jane C. Caldwell , 2006 Chapter 8, 143 
from the control reduction of 0.37 ± 0.04 (Figure 8.5). For pH 6.3, the psECG amplitude 
decline to 0.4 ± 0.04 was also indistinguishable from that of control. 
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Figure 8.5 ECG and psECG amplitude during VF in acidic pHec. Panel A: Changes in ECG 
amplitude with time - Although highly variable, neither pH 6.7 (n = 8) nor pH 6.7 (n = 7) 
altered the amplitude reduction compared to control. Panel B: Changes in psECG amplitude 
with time - again the amplitude reduction at both pH levels was not significantly different 
from control. 
Looking at the spatiotemporal distribution of the amplitude changes, the LV amplitude 
followed a similar pattern to the ECG and psECG amplitudes. Although pH 6.7 tended to 
produce lesser reductions in the LV amplitude, this was not significant (Figure 8.4(i), 
Table 8.1). At pH 6.3, there was a non-significant tendency for the LV amplitude to be 
reduced greater than in control. The RV amplitude changes were not significantly different 
from control at either pH (Figure 8.4(i), Table 8.1). 
8.3.5 VF amplitude in raised [KfJEC 
During VF in raised [K+]EC, the ECG amplitude initially decreased to a trough of 0.77 ± 
0.09 in 8mM [K+]EC and 0.49 ± 0.04 in 10mM [K+]EC at 21 Os (Figure 8.6A). This was not 
significantly different from the fractional change of 0.62 ± 0.05 in control conditions at 
the same time-point. Similarly, the psECG amplitude decreased to a trough of 0.67 ± 0.08 
in 8mM [K1Ec and 0.60 ± 0.04 in 10mM [K1 Ec at 180s(Figure 8.6B). Again neither of 
these reductions were significantly different from the fractional psECG amplitude change 
in control conditions of 0.49 ± 0.03. After the respective troughs, there was a steady 
increase in ECG and psECG amplitude in both raised [K+] solutions. In 8rnM [K+] 
solution, the ECG amplitude had increased to 1.05 ± 0.13 at 7 - 9 minutes. This was 
significantly different from the control ECG fractional change of 0.57 ± 0.06 (**p<O.Ol). 
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The psECG amplitude increased to 0.78 ± 0.09 in 8mM [K+] solution compared to the 
change in control of 0.37 ± 0.04 (***p<O.OOI). In 10mM [Kl solution, the ECG 
amplitude increased to 0.87 ± 0.15, which was not significantly from control. However, 
the psECG increased to 0.94 ± 0.09*** that was significantly different from control 
(***p<O.OOI). Neither the ECG nor the psECG amplitude changes were significantly 
different in 8mM [K+] solution compared to 10mM [K+] solution. 
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Figure S.6 ECG and psECG amplitude during VF in SmM (n = 6) and 10mM (n = 5) [K+] 
solutions. Panel A: Changes in ECG amplitude with time - in raised [K+]ec the ECG 
amplitude decreased until 210s (arrow). After 210s, the ECG amplitude increased in both 
SmM** and 10mM [K+]ec (**p<0.01). Panel B: Changes in psECG amplitude with time -
Similar patterns of amplitude change was observed in psECG as ECG. An initial decrease in 
amplitude to 1S0s (arrow), was followed by steady increases in both SmM*** and 10mM*** 
[K+]ec (***p<0.001). Panel C: Changes in ECG OF with time - In raised [KJec the period of VF 
amplitude decline was associated with increasing OF (till arrow). The rising amplitude 
thereafter was associated with decreasing OF. 
The amplitude changes were almost reciprocal to the fractional changes in ECG DF in 
raised [K+] EC. The initial fall in amplitude was associated with the initial increase in DF 
(Figure 8.6C). The following increase in amplitude was associated with decreasing DF. 
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In raised [K+]EC, the spatiotemporal amplitude alterations were also different from those 
observed during VF in control conditions (Table 8.1 , Figure 8.4(ii)). At 480s, the RV 
amplitude was maintained in both raised [K1Ec protocols. At 480s in 10mM [K+]EC, the 
LV amplitude had decreased to a lesser extent than in control (p<0.05) or in 8mM [K1Ec 
(p<0.00 1) (Table 8.1). 
The spot analysis at 480s does not give a full impression of the spatiotemporal changes of 
optical amplitude that occurred during VF in raised [K+]EC. Looking at the fractional 
change maps each minute reveals that the RV amplitude was essentially unchanged 
throughout the 8mM and 10mM [K1Ec protocols (Figure 8.7), whereas the LV amplitude 
declined until 240s (Figure 8.7B), before increasing (Figure 8.7C). This progression is 
similar to that observed in the psECG amplitude (Figure 8.6B). 
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Figure B.7 Spatiotemporal progress ion of amplitude during VF in BmM [KJ solution. Panel 
A: Os - As the amplitude changes were normalised to the amplitude at Os, this colour map is 
uniform = 1. Panel B: - 240s - the LV amplitude has reduced, whereas the RV remains 
largely unchanged. Panel C: - 480s - the LV amplitude has increased compared to 240s 
(panel B). Again the RV amplitude was largely unchanged. 
B.3.6 Relationship between amplitude and DF 
The above results suggest that during VF, an inverse relationship exists between the 
amplitude changes and the changes in DF. For example, in control, hypoxia and acidic 
pHEC, the increasing DF was associated with decreasing ECG and psECG amplitudes. 
Whereas in raised [K+]EC, and transiently in low-flow ischaemia, the decreasing OF was 
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associated with an increase in VF amplitude. To investigate this relationship further, the 
ECG and psECG fractional amplitude changes and fractional DF changes were plotted as 
scattergrams, and fitted with y = mx + c using Origin 7.0 (Figure 8.8). For control, 
hypoxia, acidic pHEc and raised [K+]EC, the individual scattergrams displayed negative 
correlations between the fractional changes in VF amplitude and DF (data not shown). 
Combining these protocols into a single scattergram for ECG (Figure 8.8A) and psECG 
(Figure 8.8B) confirmed the inverse relationship. The more complex temporal changes that 
occur during VF amplitude in low-flow ischaemia did not correlate negatively with VF DF 
(Figures 8.8C & D). 
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Figure 8.8 Scattergrams of fractional change in VF amplitude against fractional change in 
VF OF. Panel A: ECG - Scattergram of the fractional change of ECG amplitude against the 
fractional change of ECG OF during control, hypoxia, acidic pHec, raised [K+lec and selected 
points during low-flow ischaemia ( . = low-flow 60 - 120s only). This shows an inverse 
relationship between fractional changes in amplitude and OF during VF. Panel B: psECG -
the similarly created scattergram for psECG also demonstrates an inverse relationship 
between amplitude and frequency ( . low-flow ischaemia). Panel C: ECG in low-flow 
ischaemia. This scattergram of the fractional change in ECG amplitude vs. fractional change 
in ECG OF in VF during low-flow ischaemia contains data of all time-points. The more 
complex temporal changes in VF amplitude that occurs during low-flow ischaemia results in 
a direct relationship between amplitude and frequency. Panel 0: psECG in low-flow 
ischaemia demonstrates a similar direct relationship to the ECG (Panel C). 
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8.4 Discussion 
The aim of this chapter was to study the global and spatiotemporal changes in VF 
amplitude with time during full perfusion and low-flow ischaemia, and to examine the 
contribution of hypoxia, acidic pHEC and raised [K+]EC to these changes. 
8.4. 1 VF amplitude in control conditions 
In VF during fully perfused control conditions, the amplitude of the ECG decreased in a 
non-linear fashion. An initial period of rapid amplitude reduction was followed stabilsation 
at -55% (Figure 8.IA). The ECG gives a global assessment of the electrical activity of the 
heart, and as such a reduction in its amplitude could represent (i) a homogeneous decrease 
in the amplitude of the electrical activations across the heart, (ii) heterogeneous changes or 
(iii) no real decrease in the amplitude of the electrical activations, but rather an increase in 
electrical disorganisation, as is known to occur in fully perfused VF (266). With increased 
disorganisation, the local electrical vectors will increasingly oppose each other, and will 
therefore reduce the electrical amplitude measured at a global level. 
The reduced electrical co-ordination of VF compared to sinus explains the immediate 
reduction in the ECG amplitude on VF induction that occurred in 59% of experiments. 
Less clear is the reason for the increase in ECG amplitude at induction that occurred in the 
other 41 % of experiments. In sinus rhythm, hearts were compressed in an attempt to 
eliminate motion artefact from the optical signals (Chapter 2.4). In the hypo-contractile 
state of VF lesser degrees of compression were required to do this. The greater 
compression required in sinus rhythm was produced by greater_ displacement of the· 
chamber's back piston (Figure 2.2), and resulted in a physical movement of the heart 
relative to the fixed wall-mounted ECG electrodes. This tended to move the heart out of 
the line of the fixed electrodes, and so may explain an artificial increase in ECG amplitude 
on VF induction, as lesser degrees of compression kept the heart more in-line with the 
fixed ECG electrodes. 
Although the psECG is also a global measure of electrical activity, its amplitude change is 
derived from the amplitude changes recorded in each of the 252 photodiodes. Each 
photodiode records the electrical activity from a small epicardial area (0'8 mm x 0·8 mm). 
Therefore, vector alignment does not influence the amplitude of the optical signals in VF. 
As the psECG amplitude decreased in a similar non-linear manner as the ECG amplitude, 
this would suggest that the ~ecrease in the electrical activation amplitude was real (Figures 
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8.1A & B). Although there were differences between the ECG and psECG amplitude 
changes, with the psECG experiencing a more profound initial amplitude reduction, and 
continuous slower amplitude decline, these differences could be accounted for by dye 
degradation (Figure 8.2). 
Optically mapping VF during control conditions revealed that the reduction in activation 
amplitude was heterogeneous with more profound amplitude reduction in the LV than the 
RV (Figure 8.1 C). The ventricular nature of this heterogeneity in amplitude reduction is 
reminiscent of the LVIRV heterogeneity in DF, where in control conditions the LV DF 
increased, whilst the RV DF remained unchanged (Chapter 3). The proposed mechanism of 
DF heterogeneity (Chapter 3.4.3) may also explain the LVIRV heterogeneity in VF 
amplitude changes. The greater LV-to-RV expression of Kir2.x results in a greater 
magnitude of IKI within the LV, allowing faster frequencies to develop (63, 190). This 
greater magnitude of IKI will oppose INa to a greater extent. If the INa magnitude is the same 
in both ventricles, the greater IKI magnitude in the LV will result in lower levels of 
depolarisation on activation in the LV compared to the RV (i.e. a lower systolic 
depolarisation). To date there is no evidence to support this hypothesis. 
Another possible mechanism for the LV/RV heterogeneity in amplitude changes is 
differential perfusion of the LV compared to the RV. Studies in dogs (199) and rats (200) 
have shown differences in the control of the vascular tone in the right and left coronary 
arteries. In the dog, Quail et al. demonstrated lesser degrees of vasodilatation in the left 
then the right coronary arteries in response to increased aortic pressure (199). During VF in 
control conditions, the perfusion rate was maintained at 40ml/min. However, the aortic 
pressure tended to increase from -4OmmHg in sil'l:us rhythm to -50mmHg immediately. 
" 
after VF induction (as these values were not recorded, no further analysis is possible). 
Therefore, during VF in control conditions, one would predict.lesser vasodilatation of the 
LV vascular bed. Such lesser vasodilatation could produce a relative ischaemia in the LV 
compared to the RV. 
In VF, the rapid activation rates lead to enhanced energy consumption (267, 268). In the 
presence of localised ischaemia, this enhanced energy consumption could outstrip energy 
production, and result in the loss of maintenance of membrane ionic gradients. Under such 
circumstances, the resting (diastolic) membrane potential becomes depolarised (81, 140). 
Such diastolic depolarisation could reduce the optical amplitude by (i) reducing the 
excursion to AP plateau and (ii) by reducing the number of active Na channels, and thus 
the magnitude of INa (269). 
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Optical mapping detects relative changes in fluorescence, and therefore indicates relative 
changes in membrane potential. The absolute membrane potential cannot be inferred. 
Therefore, it is impossible to distinguish by optical mapping between amplitude reductions 
secondary to diastolic depolarisation from reductions due to reduced systolic 
depolarisation. Such differentiation requires measurement of the absolute transmembrane 
potential, as can be achieved with floating microelectrodes (Chapter 9). 
8.4.2 VF amplitude in low-flow ischaemia 
As outlined in this chapter's introduction, both clinical (19, 24, 29) and animal studies (30, 
33) have shown a reduction in ECG amplitude during VF when cardi~c perfusion is not 
maintained. Similarly, this chapter demonstrates a reduction of ECG and psECG 
amplitude in VF during low-flow ischaemia. However, on reducing the perfusion rate, the 
ECG, psECG and LV optical amplitude transiently increased (Figure 8.3). Two possible 
explanations for this initial increase in amplitude are: -
(i) Hyperpolarisation - as discussed more fully in section 8.4.4 below, low levels of 
intracellular acidosis hyperpolarise the resting membrane potential (219). Such 
hyperpolarisation should increase the amplitude of VF activations, as tended to occur in pH 
6.7 (Figures 8.4 & 8.5, Table 8.1). In no-flow ischaemia, the myocardial pH decreases in 
an exponential fashion with time (270). Thus any hyperpolarisation will be transient, as the 
pH falls to levels that depolarise the resting membrane potential (219). 
(ii) Increased electrical co-ordination - in global ischaemia, VF becomes more co-
ordinated (36, 62, 271, 272). Such co-ordination c~)Uld give rise to an apparent increase in 
" 
amplitude. This increased co-ordination could have been caused by raised [K+]EC, which 
will be discussed more fully in section 8.4.5. 
Following this transient increase, the ECG, psECG and LV amplitudes declined steadily 
(Figure 8.3). However, each of these amplitude reductions differed in their relationship to 
the relative VF amplitude changes in control conditions. For instance, in control conditions 
the ECG amplitude stabilised at 4 minutes, where the ECG amplitude in low-flow 
continued to decrease. This is in keeping with the continuous reduction of AP amplitude 
that occurs in ischaemia during!:fegular pacing (140,214,228,238,264). More difficult to 
explain is the equivocal effect of low-flow ischaemia on the amplitude reduction of the 
psECG and LV optical signals compared to control. One possible explanation is the effect 
of the signal-to-noise ratio on lower amplitude optical signals. In optical mapping, the 
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signal-to-noise ratio depends on many factors from magnification (see Chapter 1.3.5) to 
dye degradation (150). In a given optical system, the signal-to-noise ratio is fairly stable 
over time, experiencing only a slow exponential decline with a time constant in the order 
of 75 minutes (273). Even with a stable signal-to-noise ratio, the artefacts are greater in 
lower amplitude than higher amplitude signals. In VF, the amplitude of the optical signal 
markedly decreased, with psECG amplitude falling to <45% after 5 mins. At such low 
levels of absolute change in fluorescence, the greater effect of signal noise could obscure 
any true difference in psECG and LV amplitude in low-flow ischaemia compared to 
control. 
8.4.3 VF amplitude in hypoxia 
Although solutions were changed after 60s of VF, the 90% transition did not occur at the 
heart until 180s (Figure 4.1). At this point, in contrast to VF in low-flow ischaemia, there 
was no initial increase in ECG or psECG amplitude on lowering the P02. Instead, during 
hypoxia there is a steady decline in both the ECG and psECG amplitudes (Figure 8.3). 
Possible explanations for this difference are: - (i) lack of hyperpolarisation - unlike 
acidosis, reductions of the intracellular P02 are not associated with a transient 
hyperpolarisation phase (202, 204, 211), or (ii) lack of increased organisation - as shown 
in figure 4.2, neither the ECG nor psECG DF changed dramatically on application of 
hypoxia. This would suggest that in hypoxia, VF remained rapid and disorganised. 
As with VF in low-flow ischaemia, during hypoxic VF the ECG amplitude did not 
stabilise, but continued to decline. Also similar to low-flow ischaemia, the psECG and LV 
amplitude reductions in VF during hypoxia were inqistinguishable fl:om control. Again the . 
greater influence of noise on the lower amplitude signals could be obscuring further 
amplitude reductions. 
As discussed in chapter 4.4.3, previous research into the effects of hypoxia on the resting 
membrane potential and AP amplitude have shown variable results. The major source of 
this variation appears to relate to each study's method of perfusing their preparation, and 
the inherent effect on K+ accumulation and [K+]EC, rather than the level of P02. For 
example, in continuously superfused cellular preparations, K+ could not accumulate and 
the diastolic potential and AP amplitude remained virtually unchanged during an hour of 
hypoxia (202). Similarly, in Langendorff-perfused whole heart (204) and papillary muscle 
preparations (203, 214) at 5mM [K+]EC, after 10 minutes of hypoxia the diastolic 
membrane potential depolarised by <2m V, and the AP amplitude remained virtually 
Jane C. Caldwell, 2006 Chapter 8; 151 
unchanged. In contrast, in regional hypoxia in Langendorff-perfused pig hearts Morena et 
al. documented -10m V diastolic depolarisation, and moderate amplitude reduction for any 
given [K+]EC (211). 
So in fully perfused, hypoxic VF in the Langendorff-perfused rabbit heart, one would 
expect only a marginal increase in [K+]EC compared to control. It is uncertain if such small 
increases in [K+]EC would be sufficient to partially depolarise the membrane, and therefore 
reduce the VF amplitude. This could not be investigated by floating microelectrode, as 
preparations were continuously superfused in this apparatus and the bathing solution was 
open to the room enviroment (Chapter 9). 
8.4.4 VF amplitude in acidic pHEC 
As with dominant frequency (Chapter 4.4.2), the relationship between VF amplitude 
change and extracellular pH is complex. In this chapter, there was a trend for both ECG 
and psECG amplitude to be conserved during perfusion at pH 6.7 in compared to VF in 
control conditions. No such trend was observed at pH 6.3. A similar pattern was observed 
for the LV optical amplitude; at pH 6.7, the LV amplitude tended to be decreased by a 
lesser extent than control, whereas at pH 6.3 the LV amplitude reduction tended to be 
greater. Neither of these changes reached significance. 
As outlined in chapter 4.4.2, individual studies have shown acidic pHEc to depolarise the 
resting (diastolic) membrane potential over a range of pHs from 6.0 - 6.7 (218, 220, 221, 
274). Such depolarisation would reduce the amplitude of the VF activations. In contrast, 
Sato et al. demonstrated a small hyperpolarisation of the diastolic potential at pH >6.0, and . 
, . 
depolarisation at pH <6.0 (219). Hyperpolarisation should increase the amplitude of the VF 
activations, and therefore may account for the non-significant increases in the ECG, 
psECG and LV amplitudes in pH 6.7 in this chapter. Depolarisation of the diastolic 
potential in acidic pHEc is thought to result from extracellular K+ accumulation secondary 
to inhibition of IKI by acidosis (222). The relationship between IKI and pH is biphasic 
(219). Low levels of acidification (pH 7.2 - 6.0) enhance the current, whereas higher levels 
(PH 6.0 - 5.0) inhibit it (219). Thus low levels of acidification would be expected to 
hyperpolarise the diastolic potential, and higher levels depolarise it. In VF, the ongoing 
metabolic stress could produce greater acidification than that predicted by solution 
imposition alone. Hence it is possible that the pH 6.7 solutions could enhance IKI. 
hyperpolarise the diastolic membrane potential, and thus conserve the VF amplitude. 
Whereas pH 6.3 solutions could inhibit IKI. depolarise the diastolic potential, and thus 
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equal or enhance the amplitude reduction. Therefore, as with frequency, IKI could explain 
the complex, but subtle effects of acidic pHEC on the activation amplitude in VF. 
As discussed in section 1.2.3, the reduction of pHEC during VF in low-flow ischaemia is 
not clear from the current literature. Complete ischaemia in sinus rhythm can reduce the 
intracellular pH to 6.78 at 10 minutes (79), whereas in VF supported by CPR, that at best 
gives perfusion at 25% of the normal flow (17), the pHEC dropped to 6.38 at 11 minutes 
(80). Therefore, it is conceivable that the pH fell to 6.3 during low-flow ischaemia, where 
perfusion was 10% of control flow rate. This would suggest that acidic pHEc, as well as 
hypoxia, is contributing to the decline in VF amplitude in low-flow ischaemia. As before, 
this could not be investigated by floating micro electrode, as preparations were 
continuously superfused and the bathing solution was open to the room enviroment 
(Chapter 9). 
8.4.5 VF amplitude in raised [K'')EC 
As discussed above, the 90% changeover in solutions did not occur at the heart until 180s 
(Figure 4.1). ECG, psECG and LV amplitudes decreased progressively until -180s in VF 
during raised [K+]EC. After -180s, the ECG, psECG and LV amplitudes increased (Figures 
8.6 & 8.7). This amplitude augmentation runs contrary to the theoretical expectations as 
explained below. 
In theory, raising the [K+]EC from 5.5mM to IlmM will depolarise the resting membrane 
potential from -82m V to -64m V. Experimental data confirms this membrane 
depolarisation; using microelectrodes in whole heart (81, 214) and cellular (202) 
preparations, raising [K+]EC to 11 mM depolarised the membrane by "around 26m V. In these 
studies, as the resting (diastolic) membrane potential became less negative, the AP 
amplitude was reduced (81, 202). Thus one would predict that raising [K+]EC during VF 
would depolarise the diastolic potential and reduce the activation amplitude. 
The observed increase in VF amplitude coincided with a reduction in ECG, psECG and LV 
DF. This suggests that as the frequency of the activations decreased, the electrical activity 
in VF became more organised, and hence the amplitude of the global measurements 
increased as the local electrical vectors reinforced each other. Such increased organisation 
need not be associated with an actual increase in amplitude at the cellular level. Such 
dissociation between cellular and global amplitudes could explain the apparent 
contradictory findings of increased activation amplitude in VF during raised [K+]EC. The 
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lack of an increase in action potential (AP) amplitude at the cellular level was confirmed 
by recording the absolute membrane potential in VF during raised [K+]EC using floating 
micro electrodes (Chapter 9.3). 
8.4.6 Relationship 
amplitude 
between frequency, organisation and 
In all VF protocols, including low-flow ischaemia from 60 - 120s, the ECG and psECG 
amplitudes were inversely related to the relative DF (Figure 8.8). So as the ECG and 
psECG DF increased, the VF amplitude declined, whereas a decrease in DF was associated 
with an amplitude increase. 
As explained above, in control conditions VF becomes more disorganised with time (266). 
Therefore the constituting electrical vectors of the ECG should increasingly oppose each 
other, and reduce the global electrical amplitude of the VF activations. This vector 
explanation cannot account for the reduction of amplitude of the psECG. The LVIRV 
heterogeneity of the amplitude decline would also suggest a true reduction in cellular AP 
amplitude, which was confirmed by micro electrode (Chapter 9.3). One would predict a 
similar finding during VF in hypoxia and acidic pHEC. Unfortunately this could not be 
verified by microelectrode as the solution bathing the region of epicardial impalement was 
open to the air. 
Previous studies have shown AP amplitude to decrease in low-flow ischaemia (140, 228, 
238, 264) and raised [K+]EC (81, 202, 214). The investigations in this chapter showed an 
initial or persistent increase in ECG and psECG amplitude during VF in low-flow 
. 
ischaemia and raised [K+]EC. Once again, a possible explanation for the increase VF 
amplitude on the ECG is increased co-ordination of the electrical activity, allowing local 
electrical vectors to reinforce, rather than oppose each other. Indeed, increased co-
ordination of electrical activity in VF during ischaemia is well documented (36, 62, 271, 
272). 
A similar concept may explain the observed increase in psECG and LV optical AP 
amplitude during VF in low-flow ischaemia and raised [K+]EC. In optical mapping, the 
signal from a single pixel represents the summation of the activity of the hundreds of cells 
(153). For this reason, the upstroke of the optical AP is slower than that. of a glass 
micro electrode AP in the same area (153) (Figure 1.16). In VF, as the DF falls, the 
activation wave progresses across the myocardium more slowly (70, 263, 275). Thus 
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within a pixel, a greater number of the cells will reach peak activation and peak 
fluorescence at the same time. This more synchronised activity will produce an increase in 
fluorescence amplitude, which may not be associated with a true increase in cellular 
electrical amplitude. Indeed microelectrode impalement failed to show an increase in 
amplitude at the cellular level during VF in raised [K+]EC (Chapter 9.3). 
8.4.7 Conclusion 
During VF in control conditions there was a reduction in the activation amplitude, which 
probably reflects a decline in membrane excursion at the cellular level. This amplitude 
reduction in is probably enhanced by low-flow ischaemia as suggested by the ECG, but not 
in the more noise-sensitive psECG. Both hypoxia and pH 6.3 also tended to enhance the 
ECG amplitude reduction compared to control. Although raised [K+]EC increased the 
activation amplitude during VF, this could be due to enhanced synchronisation. Thus a 
combination of hypoxia and acidosis, and even raised [K+]EC, are probably involved in the 
amplitude reduction ofVF during low-flow ischaemia. 
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9 Membrane potential during VF 
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9.1 Introduction 
The experimental results from chapters 3 - 8 have suggested a series of questions 
concerning the electrophysiology ofVF. These questions were: -
(i) In VF during control conditions, the ECG, psECG and LV optical AP amplitude 
decreased with time (Chapter 8). The reduced activation amplitude could be due to 
depolarisation of the diastolic membrane potential, reduction in the systolic potential, or a 
combination of both. Transmembrane recording of the membrane potential during VF in 
control conditions will help elucidate the relative contributions of changes in the diastolic 
and systolic potential. 
(ii) During VF in low-flow ischaemia and raised [K+]EC, there was either a transient or 
persistent increase in the ECG, psECG and LV optical AP amplitude (Chapter 8). 
Theoretically, neither of these conditions should increase the activation amplitude during 
VF. Therefore the amplitude increase could be artificial and due to increased alignment of 
the local electrical vectors as the electrical activity becomes more co-ordinated. 
Transmembrane recordings of the membrane potential during VF in low-flow ischaemia 
and raised [K+]EC will detect whether or not a real increase in the AP amplitude occurs at 
the cellular level. 
(iii) During VF in low-flow ischaemia (Chapter 3) and raised [K+]EC (Chapter 4), the LV 
dominant frequency (DF) slowed, whilst the RV DF remained unchanged. This LVIRV DF 
heterogeneity was shown to be associated with differential elevation in the LV activation 
threshold compared to the RV (Chapters 5 -7). The hypothesis was raised that the increase 
. 
in activation threshold resulted from depolarisation of the diastolic membrane potential 
leading to a partial inhibition of INa. Transmembrane recordings of the membrane potential 
will show if the diastolic membrane potential depolarises during VF in low-flow ischaemia 
and raised [K+]EC. 
To address these issues the absolute meIIlbrane potential was measured by floating 
micro electrode during VF in control conditions, low-flow ischaemia and raised [K+]EC. 
9.2 Methods 
Hearts were prepared as per chapter 2.8. Briefly, hearts were Langendorff-perfused, had an 
LV balloon inserted, and then were placed in a chamber adapted for microelectrode 
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impalement of the LV surface. These adaptations included boring a 0.5cm diameter hole in 
the Plexiglas front-plate, and adding a 2nd supporting column to allow the chamber to be 
held horizontally as well as vertically. Borosilicate glass microelectrodes were filled with 
2M KCI and the tips mounted onto silver chloride-coated silver wire to give a total 
resistance of 20 - 25MQ. Signals were recording via a dual microprobe Model 750 
amplifier (WPI, Sarasota, FL), before being stored digitally at either 1 or 10 kHz. The 
electrical apparatus was calibrated at the start of each day. 
Prior to VF induction, the baseline transmembrane potential was recorded during RV 
pacing at BCL 18Oms. Typical baseline signals are shown in figure 9.1 A. Hearts were 
burst paced into VF, and fresh impalements were achieved approximately every 30s. 
Figure 9.1B shows a typical transmembrane recording during VF. For 60s the heart was 
perfused in standard Tyrode's solution at 40mllmin in all protocols. After 60s, perfusion in 
standard Tyrode's solution at 40ml/min was maintained in control protocols. In 
experimental protocols either the perfusion rate was decreased to 6ml/min (low-flow 
ischaemia) or the solution [K+] was increased to 8mM. After approximately 600s in VF, 
hearts were defibrillated by intra-aortic injections of 2M [KCI] solution. 
A B 
-400ms 
Figure 9.1 Sample mlcroelectrode recordings. Panel A: l V impalement during baseline 
pacing at Bel = 180ms. Panel B: lV impalement during VF. -
Signals were analyzed offline for amplitude and frequency changes using FFT (Chapter 
2.5). Signals were converted to absolute membrane potentials using that day's calibration 
curve. Peaks were identified in Origin (Originlab corporation, USA), and the mean 
diastolic and systolic membrane potential calculated for each impalement. As the precise 
time of impalement could not be strictly controlled, values were collated into time bins and 
expressed for the time period in a horizontal step-wise graph. As with ECG and psECG 
amplitude, significant changes in membrane potential were assessed over the 7 ~ 9 minutes 
time interval. Systolic and diastolic potentials at 7 - 9 minutes were compared using the 
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paired t-test to baseline membrane potentials during control pacing (BCL 180s) in same 
heart. Comparisons between protocols were performed by repeated ANOV A. 
Using dyes and spectrophotometry, the 90% transition time for washing in different [K+] in 
this set-up was estimated (Figure 9.2). The electrophysiology set-up used for floating 
microelectrode work had a larger dead space than the optical system, hence the transition 
between solutions was not as swift, and 90% transition was achieved after 220s. Therefore, 
the 90% transition time for [K+] was after 280s ofVF. 
90% transition 
............ J 
0.5 
o.o'+--
o 60 120 180 240 300 360 420 480 540 600 
Time(s) 
Figure 9.2 Transition time to wash In different [K1 solutions In the mlcroelectrode set-up. 
This was assessed using dyes and absorption spectrophotometry. 
9.3 Results 
As shown in figure 9.3, during VF in control perfusion, low floW ischaemia and 8mM 
[K+]EC, the changes in DF with time from transmembrane recordings of the LV epicardial 
surface were similar to the DF changes of the psECG. In 8mM [K+]EC, the later decrease in 
. . 
DF recorded from micro electrode as compared to psECG can be explained by the greater 
delay till 90% solution transition of 280s in microelectrode compared to 150s for optical 
mapping. 
During VF in control conditions, the diastolic membrane potential at 7.- 9 minutes of -65 ± 
3m V was not significantly different from the diastolic potential during baseline pacing of 
-72 ± 4mV (Figures 9.4 & 9.7). In contrast, as shown in figure 9.4, the maximum systolic 
membrane potential sharply decreased on VF induction, and continued· to decline 
throughout the period ofVF. By the 7 - 9 minutes assessment point, the maximum systolic 
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potential had reduced to -24 ± 5m V, which was significantly lower than the maximum 
systolic potential at baseline of 18 ± 3mV (p<O.OOOI, Figure 9.7). Compared to baseline 
pacing, the peak-to-peak amplitude at 7 - 9 minutes was significantly reduced to 47 ± 6% 
(p<O.OOI). However, using the peak-to-peak amplitude on VF induction as baseline, the 
AP amplitude reduction was only to 86%. Approximately 15 minutes after defibrillation, 
the amplitude was re-assessed at BCL 180ms. This showed full recovery of amplitude 
(Figure 9.4). 
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Figure 9.3 Dominant frequency during control, low-flow Ischaemia and BmM [Kjec. Panel A: 
Mlcroelectrode OF. As with psECG there was (I) an Increasing OF In control VF, (II) a 
decreasing OF in low-flow Ischaemia and (iii) a decrease after an Initial delay with BmM 
[Kjec. Panel B: psECG OF. The progression patterns are similar to those observed by 
mlcroelectrode. The notable exception Is the more Immediate decrease In OF In BmM [Kjec. 
This Is due to the shorter time to reach 90% solution transition In the optical apparatus. 
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Figure 9.4 Membrane Potential during baseline pacing at Bel 180ms (Pace 180) and VF in 
control conditions. Immediately after VF induction, there was a decrease in amplitude 
mainly due to a more negative maximum systolic potential. The systolic potential continued 
to become more negative with time. In contrast, the diastolic potential remained unchanged. 
Post VF, the systolic potential recovered to pre-VF levels after -15 minutes. The grey square 
indicates the 7 - 9 minutes time interval used for statistical comparisons. 
In VF during low-flow ischaemia the maximum systolic potential dropped to the more 
negative value of -19 ± 8m V immediately after VF induction (Figure 9.5). After this the 
maximum systolic potential stabilised. By the 7 - 9 minutes assessment point the 
maximum systolic potential of -10 ± 8m V was significantly different from that during 
baseline pacing of 13 ± 4mV (p<0.05). The diastolic potential of -68 ± 3mV was not 
significantly different from the baseline pacing potential of -76·' ± 2mV. Compared to 
baseline pacing, the VF peak-to-peak amplitude was significantly reduced to 66 ± 12% at 7 
- 9 minutes (p<0.05). Thus there was no evidence of peak-to-peak amplitude increase 
during low-flow ischaemia. Again, the peak-to-peak amplitude during pacing at BCL 180 
returned to the pre-VF level after ~ 15mins. 
In VF during low-flow ischaemia, neither the maximum systolic nor the diastolic potential 
was significantly different from VF under control conditions at 7 - 9 minutes (Figures 9.5 
&9.7). 
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Figure 9.5 Membrane Potential during baseline pacing in control conditions (Pace 180) and 
during VF in low-flow ischaemia. Immediately after VF induction, the maximum systolic 
potential became more negative. The diastolic potential remained unchanged. After 15 
minutes recovery time, the systolic potential returned to baseline values. 
During VF in 8mM [K+]EC, the maximum systolic potential dropped to the more negative 
value of -24 ± 5mV on VF induction (Figure 9.6). However, as figure 9.6 demonstrates, 
both the maximum systolic and the diastolic membrane potential gradually depolarised as 
VF continued in 8mM [K+] solution. By 7 - 9 minutes, the maximum systolic potential of 
-14 ± 4m V was significantly different from that during baseline pacing of 4m V ± 4 
(p<0.05). By 7 - 9 minutes the diastolic potential had depolarised to -55 ± 8m V in 8mM 
[K+]EC. This was significantly depolarised compared to the bas~Jine resting membrane 
potential during pacing of -80 ± 5m V (p<0.05). Although the absolute diastolic potential of 
-55 ± 8mV during VF in 8rnM [Kl solution was not significantly different from that of the 
absolute diastolic potential of -65 ± 3m V during VF in control conditions, the relative 
change in the diastolic potential of ~25m V compared to ~ 7m V in control was significantly 
different (p<0.001 , Figure 9.7). 
Compared to baseline pacing, the peak.-to-peak. VF amplitude at 7 - 9 minutes was 
significantly reduced to 49 ± 6% (p<0.001). Comparing the peak.-to-peak. amplitude at 7 -
9 minutes to the peak.-to-peak. amplitude immediately after VF induction, the amplitude 
was reduced to only 93%. There was no evidence of any increase in AP amplitude during 
VF in raised [K+JEc. 
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Figure 9.6 Membrane potential during baseline pacing in control conditions (Pace 1BO) and 
during VF in BmM [K+] solution. Immediately on VF induction there was a drop in the 
maximum systolic potential to more negative values, while the diastolic potential remained 
unchanged. On increasing [K+]EC the diastolic potential depolarised. There was a tendency 
for systoliC potential to depolarise in raised [K+]EC. At no point did the peak-to-peak 
transmembrane potential show an increase in VF amplitude. 
In summary, therc was significant reduction in the transmembrane peak-to-peak AP 
amplitude during YF in low-flow ischaemia, raised [K+]EC and control conditions, as 
shown in figure 9.7. The amplitude reductions were due to variable combinations of 
depolarisation of the diastolic membrane potential and more negative maximum systol ic 
membrane potentials. In control conditions, the amplitude reduction was primari ly due to 
the more negative maximum systolic potentials. In 8mM [K+]EC, depolarisation of the 
diastolic membrane potential was more important. VF in low-flow ischaemia showed the 
smallest amplitude change and both processes appeared to be of equal importance. 
9.4 Discussion 
The aim of this chapter was to answer three specific questions by intracellular recordings: -
(i) Is the amplitude reduction in control VF due to depolarisation of the resting (diastolic) 
membrane potential or reduction in the maximum systolic potential? (ii) Is the apparent 
amplitude increase in VF in low-flow ischaemia and raised [K+]EC due to a real increase in 
the AP amplitude at the cellular level or is it a phenomenon of increased electrical co-
ordination? (iii) Does the resting membrane potential depolarise in VF during low-flow 
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ischaemia and raised [K+]EC, and thus support the hypothesis of increased activation 
threshold due to partial inhibition of INa secondary to diastolic membrane depolarisation? 
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Figure 9.7 Plot of mean membrane potential and amplitude change at 7 - 9 minutes with 
respect to baseline pacing at Bel 180s. In control conditions, there was a dramatiC 
reduction In the maximum systolic potential during VF. The maximum systolic potential was 
also reduced In low-flow Ischaemia and raised [K+]EC, but not to the same extent. In raised 
[K+]EC, diastolic depolarlsatlon was observed. In all protocols there was a significant 
reduction In amplitude compared to baseline pacing. 
9.4.1 Reduced systOlic depolarisation in VF during control 
conditions 
Transmembrane recordings during VF in control conditions confirmed that a reduction in 
AP amplitude occurs, and showed this to be due to reduced systolic depolarisation rather 
then to diastolic depolarisation. The reduction in LV AP amplitude to 86% recorded during 
VF was less than the reduction to 33% measured optically. Correcting the LV optical data 
for dye degradation results in a lesser reduction of VF amplitude in the LV to 54%; this is 
in the same order as the reduction in ECG amplitude to 55%. So although there was a 
reduction in activation amplitude at the cellular level, this cannot explain all the amplitude 
reduction of ECG and optical recordings. In the ECG, this discrepancy may arise from 
increasing global disorganisation during VF (2~6). 
The same explanation may also explain the discrepancy with the optical recordings. As 
explained fully in chapter 1.3.5, optical signals are influenced by a greater number of cells 
than transmembrane recordings from microe1ectrode impalement. This is why the upstroke 
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velocity of optical AP is slower than the corresponding micro electrode AP as shown in 
figure 1.16. As the AP propagates across the _lmm2 of epicardium recorded by the 
photodiode, there is a delay in the activation time of each cell. During regular pacing in 
control conditions, the average of the transverse and longitudinal velocity was -50cmls 
(chapter 7.3 .2). This creates an approximate 2ms spread of activation times across the pixel 
area (Figure 9.8A). This spread of activation acts to reduce the upstroke velocity. 
However, due to the AP plateau, the amplitude is not reduced. In contrast, in VF the 
apparent conduction velocity in control conditions of -35cm!s creates a greater spread of 
activation times across the pixel of3.5ms (Figure 9.8B). This, combined with the change in 
activation morphology, would be predicted to result in a reduction in amplitude compared 
to microelectrode recordings. So theoretically, a change in the local synchrony of 
activation could also affect the optical amplitude. 
9.4.2 No amplitude increase in low-flow ischaemia or raised [K'JEC 
In contrast to the amplitude of the ECG, psECG and optical signals in the LV pixels 
(Chapter 8.3), transmembrane recordings did not demonstrate a transient or persistent 
increase in the activation amplitude in VF during low-flow ischaemia or raised [K+]EC' 
This is in keeping with previous research (81, 140), and supports the hypothesis outlined in 
chapter 8.4.6, that the increased ECG, psECG and LV optical signal amplitudes were due 
to increased electrical co-ordination of the myocytes at slower activation frequencies. 
9.4.3 Diastolic depolarisation in raised [K''jEC 
In keeping with previous research (81), thi$ chapter demonstrated significant . 
. 
depolarisation of the diastolic membrane potential during VF in raised [K+]EC. This 
supports the hypothesis that the relative elevation of the LV activation threshold in raised 
[K+]EC is due to partial inhibition of INa through depolarisation of the diastolic'membrane 
potential. The presence of differential diastolic depolarisation in the LV compared to the 
RV in raised [K+]EC was not examined because of technical constraints. Clearly, 
demonstration of differential LV/RV diastolicdepolarisation would support the hypothesis 
more strongly. Potential ways to address this deficit are discussed in chapter 11.4.1. 
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Figure 9.8 Illustration of earliest and latest activation within a single pixel in regular pacing 
and VF. Panel A: During regular pacing. (i)Transmembrane AP - assuming a CV of 50cm/s 
across the -1mm2 pixel, the maximal delay between the first and last activation would be 
approximately 2ms. This delay is illustrated here. One can appreciate how such a delay will 
result in slowing of the optical AP upstroke as shown in (ii), but will have minimal effect on 
amplitude as the signals largely overlap. Panel B: During VF. (i)Transmembrane AP - the 
reduced CV of -35cm/s has increased the maximal delay to -3.5ms. This increased delay, 
with the changed activation morphology, now allows little overlapping of the earliest and 
latest activation. This could explain the greater reduction of signal amplitude recorded 
optically, as shown in (ii). 
The lack of significant depolarisation in low-flow ischaemia is not in agreement with 
previous studies (140), and may be due to technical issues. For example, there was 
constant superfusion of the impalement surface to allow electrical continuity with the 
ground reference electrode. This superfusion probably washed away the cellular K+ efflux, 
thereby preventing significant K+ accumulation and consequent depolarisation. Without 
this superfusion, K+ would be predicted to accumulate and so depolarise the diastolic 
potential. Such depolarisation would be expected to inactivate INa, reduced AP upstroke 
velocity and raise the AP activation threshold. As superfusion does not prevent the 
accumulation of K+ within the deeper myocardium layers, these tissues will undergo 
diastolic depolarisation, and thereby result in the reduced LV DF that was observed on 
microelectrode impalement ofVF during low-flow ischaemia. 
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10 Minimum defibrillation energies 
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10.1 Introduction 
As outlined in sections 1.1.1.4 & 1.2.2.3, over the last couple of decades it has been well 
established that longer duration out-of-hospital arrests are associated with lower frequency 
content of the ECG, and diminished defibrillation success (6, 23, 32, 33,276,277). More 
recently, animal and clinical studies have shown that CPR prior to defibrillation attempts 
increased the ECG Dominant Frequency (DF) (24, 278, 279), and improved defibrillation 
success (9, 12, 13,280-282). This suggests that ischaemia increases the energy required to 
defibrillate successfully, known as the defibrillation threshold (DFT), and that partial 
reversal of ischaemia by CPR reduces the DFT. 
Paradoxically, experimental assessments ofDFT, rather than rates of defibrillation success, 
have not demonstrated an increase in DFT under ischaemic conditions. In VF during low-
flow ischaemia, the DFT was not increased in rabbits (283), and the related parameter of 
the Minimum Defibrillation Energy (MDE) was reduced in swine (73). Supporting these 
experimental results, computer modelling has predicted a fall in the upper limit of 
vulnerability (ULV) in global ischaemia (284, 285). As explained in chapter 1.2.3, the 
ULV of a preparation is the highest shock strength that induces VF. The close inter-
relationship between the ULV and DFT is well established (120, 286, 287). 
In this thesis, hearts were defibrillated after 600s of VF. This chapter reports the 
defibrillation energies required to terminate VF in the protocols outlined in chapters 3 & 4. 
Thus this chapter documents the energies required to successfully defibrillate VF during 
control, low-flow ischaemia, acidic pHEc, hypoxia 'and raised [K+]EC conditions, and in the 
unperfused 8-week infarct model hearts. As discussed more fully in lYhapter 1.2.2, owing to 
the probabilistic nature of defibrillation (122), accurate DFT determination requires several 
short runs of VF defibrillated by an up-down protocol (123). Such lengthy processes 
cannot be performed in longer periods of VF. Therefore in this thesis, the more 
straightforward estimate ofMDE was determined (73). 
10.2 Methods 
Hearts were prepared as per chapters 3 & 4, and defibrillated as outlined in chapter 2.4. 
After 600s, hearts were defibrillated using an external cardiac defibrillator (Ventak ECD 
2815, CPL, St Paul's, MN, USA) delivering shocks via custom-made stainless steel 
paddles that are shown in diagrammatic form in figure 10.1, and in photographic form in 
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figure 2.2A. The orientation of the electrode polarity was kept constant, and as the 
defibrillation paddles cradled the heart to reduce motion artefact, the distance from the 
epicardial surface was constant. The paddles were fixed with respect to the frontplate and 
the area of optical interrogation (Figure 10.1). As the interrogation area was standardised 
using the left anterior descending artery (LAD) on the anterior surface as a landmark, the 
paddle position on the heart was relatively constant. 
As detailed in table 10.1, only certain energies could be administered by the Ventak ECD 
defibrillator. The defibrillator setting indicated the level of potential energy the capacitor 
was charged to. As capacitors always leak prior to discharge, the energy delivered across 
the heart was never 100% of the potential energy. The actual voltage applied by a certain 
charge depends on the resistance in the system. The resistance of the apparatus was fixed 
for all experiments, and therefore the resistance of the heart was the only variable. The 
degree of variation in heart resistance was negligible (heart resistance = 48 ± 0.50). The 
defibrillator measured the system resistance, and calculated the peak voltage and energy 
supplied. 
Interrogation 
area 
Aortic 
Cannula 
Paddles 
Figure 10.1 Diagram of the defibrillation set-up. The paddles were fixed In 2 dimensions, 
with only be moved towards or away from the heart possible. As in all experiments the area 
of Interrogation was standardised to the L WRV border using the LAD as a landmark, the 
position of the paddles with respect to the heart was also consistent. 
The first shock administered was at the lowest defibrillator setting of 0.11. Inbuilt 
programming prevented administration of biphasic shocks at 0.1 J. If defibrillation failed, 
the shock strength was repeatedly increased to the next defibrillator energy setting until 
defibrillation was successful. The maximum shock strength applied was 5J (Table 10.1). 
This terminal shock strength was chosen as shocks >5J were (i) virtually never successful 
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and (ii) when they were successful, they were associated with a pennanent increase in the 
perfusion pressure of>80 mmHg. Such perfusion pressures indicated a level of preparation 
degradation that was incompatible with further experimentation (chapter 2.1). The strength 
of shock that successfully defibrillates the heart by such a step-up protocol is known as the 
MDE (73). To control for any confounding influence of preparation degradation, equal 
proportions of 1 st and 2nd runs were perfonned for each protocol. 
Energy setting (J) Mean volta~e ± SD ill Mean energy ± SD (J) Waveform 
0.1 38 ± 1.5 0.098 + 0.004 Monophasic 
0.3 61 ± 1.8 0.298 ± 0.006 Biphasic 
0.5 79±2.9 0.477 + 0.008 Biphasic 
0.8 99 ±3.9 0.759 + 0.013 Biphasic 
1.0 111 + 3.8 0.960 + 0.015 Biphasic 
2.0 155 +4.7 1.895 + 0.039 Biphasic 
3.0 189 + 7.9 2.836 + 0.055 Biphasic 
4.0 217 + 6.9 3.778 + 0.061 Biphasic 
5.0 244±7. 4.705 + 0.092 Biphasic 
Table 10.1 Energy settings of Ventak ECD and the corresponding voltage, energy and 
waveform delivered. 
Heterogeneity of repolarisation and refractoriness is thought to playa role in defibrillation 
outcome (275). In the chaotic activity of VF, with multiple wandering wavelets, it can be 
assumed that cells become activated as soon as their effective refractory period is 
complete. Using this assumption, electrical mapping studies of VF assessed epicardial 
refractoriness through the time intervals between VF activations (4, 46, 134, 135). Through 
these VF intervals (VFIs), the dispersion of refractoriness was assessed by their coefficient 
of variance. The DF of a pixel represents the predominant VFI in that pixel during the 
optical recording. Therefore in an attempt to assess the dispersion of refractoriness during 
VF, the coefficient of variance of the optical DFs was calculated. Fop each time interval the· 
standard deviation for the DF of the 252 individual optical signals was multiplied by 100, 
and then divided by the mean. The fractional change of the Coefficient ~f variance was 
detennined at 480s using the coefficient of variance immediately after VF induction as 
baseline. 
10.3 Results 
10.3.1 Minimum defibrillation energy (MDE) 
As shown in Figure 10.2, the mean MDE required to defibrillate VF in low-flow ischaemia 
of 93 ± 24V was not significantly different from that required in control conditions of 73 ± 
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9V. Similarly, the MOE in 8mM [K+] solution of 56 ± 3V was not significantly different 
compared to control (Figure 10.2). VF in 10mM [K+] solution spontaneously converted to 
a regular ventricular escape rhythm before 600s. 
In VF during 0% P02 and acidic pHEc, significantly stronger shocks were required to 
defibrillate VF compared to control and 8mM [K+]EC. In 0% P02 the MDE was 148 ± 21 V 
(**p<O.OI vs. control and 8mM [K+] EC), and in pH 6.7 the MDE was 177 ± 26V 
(***p<O.OOI vs. control and 8mM [K+]Ec)(Figure 10.2). 
In both pH 6.3 and unperfused 8-week infarct protocols, all hearts remained in VF after 5J 
shocks. In these protocols, application of shocks > 11 produced prolonged periods of 
asystole, after which the first electrical activity was VF. Successful defibrillation in these 
protocols required a combination of intra-aortic bolus injection of 2M [KCI] solution and 
5J shocks. 
10.3.2 OF and MOE 
To examine the relationship between MDE and the electrical activity, the MDE was plotted 
against the psECG DF immediately prior to defibrillation. It was not possible to calculate 
the concurrent ECG DF as the amplifier was disconnected during defibrillation. As shown 
in figure 10.3, there was no correlation between the MDE and the psECG OF. 
Control Low 
flow 
*** 
0% P02 pH 6.7 
Figure 10.2 Plot of mean MOE ± SE. The MOE was significantly raised by pH 6.7 and 0% P02 
when compared to control (**p<0.01, ***p<0.001). 
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Figure 10.3 Scattergram of psECG OF vs. MOE. The OF of the psECG was calculated 
immediately prior to defibrillation. Plotting psECG OF against the MOE determined at the 
same time shows no linear correlation. 
10.3.3 Coefficient of variance 
The coefficient of variance of the optical dominant frequency was calculated for each time 
interval. The coefficient of variance was not significantly different between the protocols 
immediately after VF induction (data not shown). As VF progressed, the coefficient tended 
to increase with time in all protocols except acidic pHEc, where it tended to remain 
constant. For clarity, in figure 10.4 only the data from control, low-flow ischaemia and pH 
6.7 conditions are plotted for the full time-course. There was no significant change in 
coefficient of variance as assessed by absolute values or by the fractional change in each 
heart (Figure 10.5). 
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Figure 10.4 The coefficient of variance of the optical OF. The coefficient of variance was 
calculated for the OF of all 252 optical signals. Although there was a tendency for the 
coefficient to increase in control and low-flow, and to decrease in pH 6.7, there was no 
significant difference as assessed at 480s. 
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Control Low-flow 8mM K' pH 6.7 
Figure 10.5 Mean fractional change in coefficient of variance. The coefficient of variance of 
the OF of the 252 optical signals was calculated for Os and 480s. For each protocol the 
fractional change from Os to 480s was calculated. There was no significant difference in the 
fractional change in coefficient of variance between any of the protocols. 
10.4 Discussion 
In this chapter, the mean MDE was not significantly altered by low-flow ischaemia or 
8mM [Kl solution compared to control. Instead, the MDE was significantly elevated by 
hypoxia and acidic pHEC. 
10.4.1 MDE in low-flow ischaemia 
Successful defibrillation requires a shock to homogeneously depolarize a sufficient mass of 
myocardium to stop the fibrillation wavefronts without launching new activation waves. 
Thus defibrillation fails because the shock that terminates fibrillation also reinitiates 
" 
fibrillation. Several different mechanisms leading to the reinitiation of VF have been 
proposed; from critical point re-entry (94, 104), through virtual electrodes (96) to Delayed 
After Depolarisations (DADs) (288). Along with the uncertainty surrounding the 
mechanism of defibrillation failure, there are equally conflicting views on the impact of 
ischaemia on DFT. To date, most investigators have concentrated on the effects of regional 
ischaemia on DFT. Different research groups have shown that occlusion of the LAD artery 
could increase DFT (289, 290), decrease DFT (291), or to have no effect on DFT (292), 
(293) such that even the size of the ischaemic area had no significant effect on DFT (294). 
In the small number of studies that examined the effect of global ischaemia on DFT, there 
was an equal range of findings. In the isolated swine heart, Barton et al. documented a 
decrease in MDE in prolonged low-flow ischaemia (73). In contrast, Cheng et al. 
demonstrated a wider window of vulnerability to shock-induced arrhythmia in isolated 
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rabbit hearts suggestive of a raised DFT (295). However, Behrens et a1. found that global 
ischaemia had no effect on DFT (283). 
10.4.1.1 Evidence for unchanged defibrillation energies in global 
ischaemia 
In this chapter, equivalent MDE were attained during VF in control conditions and low-
flow ischaemia with the flow rate at 15% of standard perfusion. This ':Ompares well to the 
only previous study of global low-flow ischaemia in isolated rabbit hearts (283). Behrens 
et al. found that the energy required to defibrillate control conditions of271 ± 33V was not 
different from the energy of 268 ± 42V that was required when the flow rate was reduced 
to 20%. The absolute energies required to defibrillate in both conditions were much higher 
than those documented in this chapter (control = 73 ± 9V, low-flow ischaemia = 93 ± 
24V). The higher absolute energy values in Behrens et al. are probably due to a 
combination of differences in (i) protocols, (ii) electrode arrangements and (iii) biphasic 
waveform characteristics. 
(i) Behrens et al. measured the DFT 50 by an up-down protocol. The hearts were made 
ischaemic for 10 - 15 minutes before several short periods of 5 - 10s of VF were induced 
and defibrillated. Due to the longer period of 600s of VF in ischaemia used in this thesis, 
such an up-down protocol could not be performed. Rather, the MDE was determined. 
(ii) Behrens et al. used parallel circular electrodes that were held 6cm apart and 
perpendicular to the long axis of the heart. Although the resistance was not stated, one 
would expect such an electrode arrangement to haye higher resistances than the cradling 
electrodes applied in this thesis. • 
(iii) Factors affecting the efficacy of biphasic waveforms are numerous and complex (for 
full summary see (296». These factors include waveform duration and shape (297, 298), 
tilt (299) and capacitor size (300). The Medtronic defibrillator used by Behrens et al. had a 
smaller 120~ capacitor compared to the 140fl,F capacitor of the ECD used in this chapter. 
This smaller capacitor gave a waveform duration of 5ms compared to the 14ms waveform 
duration in this current study. 
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10.4.1.2 Evidence for decreased defibrillation energies in global 
ischaemia 
Using isolated pig hearts, Barton et al. observed that lower energies were required to 
defibrillate VF during perfusion at 10% standard rate compared to perfusion at standard 
rate (73). Barton et al. also observed that the ECG DF decreased during VF in low-flow 
ischaemia. They hypothesised that the slower ECG DF in low-flow ischaemia represented 
more organised myocardial electrical activity, and that this more organised activity could 
be defibrillated more easily, hence the reduction in MDE. Three computer simulations 
support this hypothesis. 
The first of these simulations used the bidomain model of human atrial tissue (301). Here, 
Plank et al. calculated that higher energies would be required to defibrillate increasing 
levels of fibrillation complexity. By increasing the spatial heterogeneity of the acetyl 
choline dependant potassium channel they controlled the degree of wavebreak of a single 
spiral rotor. As the degree of wavebreak increased, the energy predicted to terminate the 
arrhythmia also increased. 
The second simulation supporting the hypothesis of an inverse relationship between 
electrical complexity and the defibrillation energy was performed using the Auckland 
model of canine ventricles (302). Here, Hillebrenner et al. predicted that multiple scroll 
waves would require higher energies to be successfully defibrillated than a single scroll 
wave. 
The third supporting simulation examined the effect of complete global ischaemia on the 
ability to induce arrhythmia in the bidomain model of the canine" ventricle (284). Here, 
Rodriguez et al. predicted the lowering of the UL V in total global ischaemia compared to 
control conditions. As previously explained, the UL V and DFT are known to be intimately 
related (120, 286, 287). Thus predicting a lowering in ULV also implies a lowering of the 
DFT (284). 
The observations and simulations of reduced defibrillation energy were derived from larger 
hearts compared to those used in this thesis or in Behrens et al. It is therefore possible that 
the reduced defibrillation energies are an indirect feature of the greater myocardial mass. 
For instance, although Barton et al. (73) and Behrens et al. (283) both increased shock 
strength by 50V increments, the greater resistance of the larger swine heart of 840 would 
reduce the concurrent increase in current and power associated with this voltage increase. 
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As discussed more fully later, in this chapter, there was no correlation between the rate of 
electrical activity and MDE (Figure 10.3). 
10.4.1.3 Evidence for Increased defibrillation energies in global 
ischaemia 
There is no direct assessment of DFT or MDE that demonstrates an increase in global 
ischaemia. However such a result could be implied from the optic~ mapping study by 
Cheng et al. using isolated rabbit hearts immobilised by BDM (295). Here Cheng et al. 
demonstrated an increase in the dispersion of repolarisation times, 20 minutes after the 
perfusion rate was reduced to 25%. Concurrent with this increased dispersion, they 
demonstrated an increased window of vulnerability to shock-induced arrhythmia. This 
means during low-flow ischaemia VF could be induced by a monophasic countershock at 
more points of the AP than in control. The resultant VF spontaneously defibrillated in all 
control protocols, whereas defibrillation shocks were required to convert VF in ischaemic 
conditions. The applicability of this study to this chapter is difficult as: - (i) the percentage 
flow reduction was much lower in this thesis, (ii) the duration of ischaemia was twice as 
long as that used in this thesis and (iii) the use ofBDM can in itself increase the window of 
vulnerability as subsequently demonstrated by the same group (ISS). 
10.4.2 MDE in hypoxia 
During hypoxia, increased energies were required to defibrillate VF compared to control 
conditions. To date only a few studies have investigated the effects of hypoxia on the 
required defibrillation energy. Of these studies, one canine study showed that hypoxia. 
" lowered the DFT from 83 ± 49J in control to 58 ±.28J (p<0.01) (294), whereas another 
canine study showed no affect of hypoxia on DFT (303). These studies were performed on 
in situ hearts with CPR support during VF. Thus any hypoxia-induced K+ efflux would 
partially accumulate (214), reduce the potassium equilibrium potential, depolarise the 
diastolic membrane potential, and therefore lower the defibrillation threshold (304). In the 
Langendorff-perfused rabbit heart extracellular K+ would not be expected to accumulate. 
Indeed, the lack of difference in hypoxia compared to control in either the VF frequency 
(Chapter 4) or VF amplitude (Chapter 8) supports this prediction. 
In the absence of K+ accumulation, it is difficult to predict the effect of hypoxia on 
defibrillation energies. Some effects of hypoxia would tend to increase the required energy, 
whereas other effects would tend to decrease it. In the Langendorff-perfused guinea pig 
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heart, Salama et al. showed an increase in the regional dispersion of repolarisation during 
hypoxia and hypothermia (305). The association of increased dispersion of repolarisation 
with increased defibrillation energies is well documented (295, 306, 307). In contrast, 
hypoxia has been shown to abolish DADs (308), which have been proposed as a source of 
VF reinitiation (288). By abolishing these spontaneous calcium releases, hypoxia could 
reduce the tendency for reinitiation of VF, and thus increase than chance of successful 
defibrillation. 
10.4.3 MOE in acidic pHEC 
Acidic pHEc increased the energies required to defibrillate VF compared to control 
conditions. As with hypoxia, previous research into the effects of acidic pHEc on required 
defibrillation energy is limited and conflicting. Kerber et al. failed to show any change in 
DFT with either respiratory or metabolic acidosis (309). However, they only reduced the 
arterial pH to 7.25. In contrast, a Chicago research group repeatedly demonstrated the need 
for more countershocks and greater total defibrillation energy in hypercarbic acidosis (310-
312). The arterial pH was reduced to pH 6.7 in all these studies. In this chapter, pH 6.7 
increased the MDE from 73 ± 9V to 177 ± 26V (p<O.OOI), and during pH 6.3, VF was 
resistant to defibrillation with shocks as high as 250V. In pH 6.3, shock strengths> 11 OV 
produced an isoelectric window longer than 20s. One would normally expect such a 
prolonged isoelectric window to be associated with successful defibrillation. However, in 
pH 6.3, the first activation after this window was VF. 
Acidic pH is well recognised for its arrhythmogenicity (for review see (213». As well as 
affecting the resting membrane potential, APD and activation threshold (discussed fully in ' 
. 
chapter 4.4.2), acidic pH can precipitate arrhythmias through (i) the triggered activity of 
EADs (313-315) and DADs (221, 308, 316), (ii) producing re-entrant susceptible 
substrates such as calcium (Ca2+) altemans (317, 318), (iii) CV slowing (218,31'9) and (iv) 
increased gap junction resistance (320-322). Several of these mechanisms have been 
associated with defibrillation failure. 
10.4.3.1 DAD and acidic pH 
DADs consist of transient diastolic depolarisations of the membrane that occur secondary 
to spontaneous release of Ca2+ from the sarcoplasmic reticulum (SR) (323), an~ are often 
associated with calcium overload of the SR (324). By reducing the Ca2+ load, and thus 
suppressing DADs, amiodarone can chemically defibrillate VF (325). Similarly, 
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defibrillation shocks that significantly reduce the SR Ca2+ load tend to be successful, 
whereas those that fail to reduce the SR Ca2+ load often fail to defibrillate (326). This has 
lead to the hypothesis that in unsuccessful defibrillation, VF is reinitiated by DADs from 
the Ca2+ overloaded SR. Evidence to support this comes from optical mapping of near-
DFT strength shocks (327). In this study, VF was shown to be reinitiated by focal activity 
after complete repolarisation. Subsequent experiments by the same group demonstrated 
improved defibrillation success and reduced DFT with the DAD inhibitor, flunarizine 
(288). Acidic pH has been shown to increase the frequency and amplitude of DADs (221, 
308). Thus one would predict that acidic pH should have the reverse effect to flunarizine, 
and therefore should reduce the success of defibrillation and increase DFT. 
10.4.3.2 Re-entry substrate and acidosis 
Re-entry is another important mechanism for reinitiating VF after unsuccessful 
defibrillation (l09). In order to sustain re-entry a tissue must provide (i) functional 
conduction block and (ii) large enough functional circuit to allow adequate repolarisation 
and re-activation (for review see (38». 
i) Functional conduction block - The first of these requirements may arise from altemans. 
By slowing Ca2+ recycling in the SR, acidic pH can produce both mechanical and Ca2+ 
altemans (317), which in tum can lead to altemans of the APD (328, 329). APD altemans 
can cause conduction block if the voltage oscillations are spatiotemporally out of phase; 
that is that adjacent areas having short and long APD on the same activation (330, 331). 
The inherent instability of such discordant altemans leads to functional conduction block, 
and thus re-entry (332). However, this does not take into account the voltage/Ca2+. 
interaction. To date, the role of the voltage/Ca2+ interaction in altemans has only been 
proposed by computer modelling (333). In this 'study, two contrasting voltage/Ca2+ 
interactions were proposed: - (a) Negative voltage/Ca2+ interaction - as shown in figure 
10.6, the greater amplitude Ca2+ transient predominantly inactivates L-type Ca2+ channel 
resulting in a shortened APD. (ii) Positive voltage/Ca2+ interaction - here the larger Ca2+ 
transient predominantly affects Na+-Ca2+ ex~hanger to prolong the APD (Figure 10.5). 
Positive interactions will tend to amplify changes in the system. Such a system is predicted 
to be less stable and more arrhythmogenic. It has yet to be established which type of 
voltage/Ca2+ interaction prevails in acidic pH. 
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(ii) Functional circuit - By slowing wave propagation, acidic pH allows re-entry to become 
established in smaller circuits. In acidic pH, AP propagation is slowed by a combination of 
INa inhibition (334) and increased gap junction resistance (320-322). 
Sarcolemma 
Figure 10.6 Voltage- Ca2+ interactions. A small amount of calcium enters the myocyte via the 
L-Type Ca2+ Channel (LTCC). This activates Ca2+-lnduced Calcium-Release (CICR) from the 
SR via the Ryanodine receptor (RyR). On relaxation, the released Ca2+ is either sequestered 
back into the SR via the Sarcoplasmic-Endoplamsic Reticulum Ca2+ ATPase (SERCA) or 
extruded out of the cell by+ ~a+-Ca2+ exchanger (NCX) with a reciprocal influx of Na+. ~he 
released Ca2 stops the Ca Influx by negative feedback on both L TCC and RyR. In negative 
voltage/Ca2+ interaction, the feedback inhibition of L TCC is greater than the influx of Na, so 
that a larger Ca2+ transient is associated with a shorter APD. In positive voltage/Ca2+ 
interaction, the Na influx via NCX predominates thus prolonging the APD (Adapted from 
(335». 
So in summary, despite conflicting evidence for the effect of acidic pH on defibrillation 
energy requirements, the electrophysiological effects of acidosis .support an increase in 
energy requirements. This is in keeping with the increased MDE produced by pH 6.7 and 
the defibrillation resistance of pH 6.3 demonstrated in this chapter. 
10.4.4 MDE in raised [K:1Ec 
Although there was no significant change of MDE in 8mM [K+] solution compared to 
control and low-flow ischaemia, there was a tendency towards reduction. Higher [K+] 
solutions resulted in spontaneous defibrillation to a regular ventricular escape rhythm 
before 600s. This suggests that the MDE was actually reduced and was not detected due to 
technical restraints. As outlined in section 10.2, the ECD could only deliver biphasic 
shocks >60V. Thus it was not possible to detect MDE below 60V. As the MDE for VF in 
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control conditions was 64 ± 2V, a significant reduction ofMDE by raised [K+]EC compared 
to control was impossible to detect. Previous clinical experience would support this 
conclusion. Prior to the invention of electrical defibrillators, chemical VF defibrillation 
was developed (163), and used in cardiac surgery (164). Indeed, this technique was been 
re-evaluated for use after coronary artery bypass surgery to prevent mechanical damage of 
the newly grafted vessels by the intra-thoracic defibrillator paddles (336). Previous animal 
research has also shown that raised [K+]EC lowers DFT (304). In this canine study, cardiac 
perfusion was maintained by cardiopulmonary bypass, and the [K+]EC raised by potassium 
chloride infusion. Babbs et al. demonstrated that the percentage reduction of DFT was 
linearly related to log[K+]Ec and the potassium equilibrium potential (EK)' This linear 
relationship supported their hypothesis that raised [K+]EC would reduce DFT by bringing 
the diastolic membrane potential nearer to the cellular firing threshold of -50 to -6OmV. 
Indeed, when the diastolic membrane potential was raised above the firing threshold to -
46m V by 16mM [K+]EC, Babbs et al. observed spontaneous defibrillation. 
The inverse relationship between [K+]EC and DFT only applies to global increases in 
[K+]EC. Regional increases in [K+]EC increases the DFT (306). This was hypothesised to 
arise from the increased heterogeneity of various electrophysiology parameters such as 
repolarisation, refractoriness and conduction velocity. 
10.4.5 MDE in infa~cted hearts during zero-flow ischaemia 
In zero-flow ischaemia, non-infarcted hearts spontaneously defibrillated from VF within 
240s (Chapter 3.3.1). In comparison, 8-week infarct hearts remained in VF for 600s, and 
were resistant to defibrillation. As with acidic pHEc, shocks> 1J pro~uced long isoelectric . 
gaps after which the first activation was VF. Two phenomena may contribute to this 
defibrillation resistance: - (i) electrophysiological consequences of border zone and scar 
tissue and (ii) increased heterogeneity secondary to cardiac failure. 
10.4.5.1 Electrophyslological consequences of scar tissue 
An important risk factor for sudden cardiac death from VF is the presence of an infarct scar 
(337). The myocardium at the interface of normal and scar tissue, which is commonly 
known as the border zone, undergoes extensive remodelling (for review see (338». Border 
zone remodelling involves fibroblast infiltration, disruption of the myofibril structure, and 
changes in the patterns of connexion expression (339-341). This border zone exhibits 
slower epicardial conduction velocities compared to the surrounding normal and infarcted 
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tissue (182), and has been linked to arrhythmogenesis in both dogs (342) and rabbits (343). 
Through electrical mapping, Peters et al. localised re-entrant circuits of VT to the border 
zone in 4-day infarct canine hearts (342). A similar localisation of shock-induced 
arrhythmias was demonstrated in 4-week infarct rabbit hearts with optical mapping (343). 
In this study, Li et al. demonstrated a higher UL V in infarcted compared to normal hearts, 
thus implying an increase in DFT. They also found that shock-induced VF was most 
commonly initiated by a break-excitation wavefront that originated within the border zone. 
Although such break-excitations can reinitiate VF after failed defibrillation, they do not 
explain this chapter's findings ofre-excitation after prolonged isoelectric windows (295). 
10.4.5.2 Electrophysiological heterogeneity in cardiac failure 
Distinct from the border zone, non-infarcted myocardium also undergoes remodelling (for 
review see (344». As they adapt to the relative increase in workload, the non-infarcted 
ventricular myocytes hypertrophy (345,·346), with the degree of hypertrophy dependent on 
the extent of the infarct (347). The electrophysiological properties in these hypertrophied, 
non-infarct myocytes are changed, with increased CV (252), prolonged APD (348) and 
altered Ca2+ transients (179). The evidence is conflicting as to whether or not these 
adaptations increase the electrophysiological heterogeneity across the heart. For example, 
in the rat the difference in APD and Ca2+ transients between myocytes from the RV free 
wall and septum was reduced, post infarction (349). In the rabbit however, the APD and 
Ca2+ transients were shortened in subendocardial myocytes, but prolonged in subepicardial 
and M-type myocytes (179). Also in the rabbit, Ng et al. used a combination of MAPs and 
the calcium sensitive dye Indo-l to show increased dispersion of APD and Ca2+ transient 
duration across the non-infarcted epicardial surface of 8-week infarct hearts compared to . 
, . 
equivalent regions in control hearts (180, 188). 
Increased epicardial APD dispersion is also a feature of non-infarct related heart failure. In 
canine tachycardia-induced cardiomyopathy, Pak et al. demonstrated increased 
repolarisation heterogeneity, and an increased incidence of malignant arrhythmias (350). In 
this model the DFT was also increased (351, 352). This suggests that the increase in 
defibrillation energies is not only due to the electrical consequences of the infarct. 
10.4.5.3 Cardiac dilation and defibrillation energy ~ 
The 8-week rabbit infarct model has an increased LV end-diastolic diameter (179-181). In 
theory, this increased cardiac volume associated with cardiac failure should affect the 
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minimum field strength for a given shock. The inverse square law dictates that the electric 
field intensity falls as square of the distance from the electrode increases. Indeed in cardiac 
tissue, the field strength does fall with distance (353) and cardiac dilatation increases DFT 
(354, 355). However, the long isoelectric window observed in the infarcted hearts after 
shocks > 11, suggests that the field strength was sufficient to inactivate all electrical activity 
including the area of minimum field strength. So although cardiac dilatation could explain 
an increase in defibrillation energy, it does not explain the immediate reinitiation ofVF. 
10.4.6 Lack of relationship between DF and MDE 
As discussed above, previous studies have suggested a correlation between the complexity 
of the electrical activity and the required defibrillation energy (73 , 284, 301 , 302). In 
contrast, clinical studies have shown that the slower electrical activity of more prolonged 
out-of-hospital arrests are associated with less successful defibrillation (6, 23, 32, 33, 276, 
277), and that partial restoration of perfusion increased the ECG DF (24, 278, 279) and 
improved defibrillation success (9, 12, 13,280-282). 
In this thesis, there was no correlation between the VF electrical activity as measured by 
the psECG DF immediately prior to defibrillation and the MDE. Indeed, the ischaemic 
components which increased MDE compared to control, namely hypoxia and acidic pHEc, 
did not change the ECG, psECG or LV optical DF compared to control (Chapter 4.3, 
Figure 10.7). In contrast, low-flow ischaemia and raised [K+]EC markedly slowed the ECG, 
psECG and LV optical DF, had no significant effect on the MDE. 
pH6.7 
*** 
pH6.7 
0% po, 0% po, 
SmM [1<1 SmM [1<1 
Low-flow Low-flow 
Control Control 
1 150 200 20 
MOE(V) ECG OF (Hz) 
Figure 10.7 Bar charts of MOE and ECG OF. Panel A: MOE is significantly raised by pH 6.7 
(***p<0.001 vs. control) and 0% P02 (**p<0.01 vs. control) but unaffected by low-flow 
ischaemia or SmM [KJ solution. Panel B: In contrast, the ECG OF was significantly reduced 
by low-flow ischaemia (***p<0.001 vs. control) and SmM [KJ solution (**p<0.01 vs. control) 
but unaffected by pH 6.7 or 0% P02• 
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The lack of correlation between OF and MOE is not surprising. As discussed above the 
success or failure of a shock is influenced by far more factors than the electrical co-
ordination at the point of defibrillation. Factors such as trigger potential (288), 
heterogeneity of refractoriness and conductivity all have roles to play in defibrillation 
failure (356). Thus relating MOE to OF is too simplistic. 
10.4.7 Coefficient of variation as measure of dispersion of 
repolarisation 
A key concept in defibrillation is the heterogeneity of repolarisation and refractoriness 
prior to defibrillation. Computer modelling has predicted that more complex electrical 
activity at the point of defibrillation will require greater shock strength to terminate the 
arrhythmia (301, 302). Previous studies have used the coefficient of variance of the 
ventricular fibrillation interval to assess the dispersion of refractoriness during VF (4, 46, 
135). By measuring the interval between VF activations, this method assumes that in VF, a 
cell will be activated as soon as its ERP is completed. Under the same principle, the OF 
should represent the predominant refractoriness within the 0.8 x 0.8mm epicardial surface 
the photodiode recorded from (Chapter 2.4). In an attempt to quantify the heterogeneity of 
the electrical activity in VF, the coefficient of variance for the optical DFs was calculated. 
This failed to show any significant change in electrical heterogeneity either between, or 
within protocols. 
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11 Synopsis 
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The main aim of this thesis was to identify the contributions of the principal metabolic 
components of ischaemia to the slowing of the electrical activity in VF, and to establish 
whether the same components were responsible for increasing the energy required for 
successful defibrillation. These investigations were performed on the isolated Langendorff-
perfused rabbit heart using a combination of optical mapping, MAP electrodes and floating 
microelectrodes. The main findings of this thesis were: -
(i) That there was LV/RV heterogeneity in DF during VF in low-flow.ischaemia, and that 
this pattern was most closely reproduced by raised [K+]EC, rather than hypoxia or acidic 
pHEC. 
(ii) That the electrophysiological mechanism underlying this ventricular heterogeneity was 
most probably a differential increase in the activation threshold in the LV compared to the 
RV. 
(iii) That there was LV/RV heterogeneity in activation amplitude in VF. 
(iv) That the ischaemic components that led to an increase in the required defibrillation 
energy did not slow the electrical activity in VF. 
11.1 Spatiotemporal heterogeneity in dominant frequency 
Previous research in VF has shown that the temporal changes in ECG frequency are 
dependant on the level of myocardial perfusion (30, 73). Similar dependence of the ECG 
DF on perfusion rate in the isolated rabbit heart was demonstrated in chapter 3. On . 
reducing the perfusion rate, the DF declined to a st~ady state value: The rate of ECG DF 
decline, and the steady state value acheived depended on the perfusion rate (Figure 3.1). 
Perfusion at 6ml/min was designated as low-flow ischaemia, as this was the lowest 
perfusion rate to reliably maintain VF for 600s. Examining the spatiotemporal distribution 
of the electrical activity, optical mapping revealed LVIRV heterogeneity in the DF, when 
the ECG DF was at steady state (480s). During control conditions, the LV DF increased 
with time and was also increased compared to the contemporous RV DF (Figure 3.4). In 
low-flow ischaemia, the LV DF decreased with time, whilst again the RV DF remained 
unchanged. 
On imposing individual metabolic components of ischaemia during VF, the ECG and 
psECG DF were not significantly altered by hypoxia or acidic pHEC compared to control 
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(Figures 4.2 & 4.3). In contrast, during VF in raised [K+]EC, the ECG and psECG showed a 
declining DF pattern that was indistinguishable from that of low-flow ischaemia (Figure 
4.5). Looking at the spatiotemporal DF organisation in VF, the DF pattern in hypoxia was 
indistinguishable from control (Figure 4.4), and the DF pattern in raised [K+]EC was 
indistinguishable from low-flow ischaemia. The DF pattern in acidic pHEc was different 
from both control and low-flow ischaemia, with the LV DF increasing to a lesser extent 
than in control conditions, and the RV DF now also increasing. 
Thus raising [K+]EC best reproduced the global and spatiotemporal frequency changes 
observed in VF during low-flow ischaemia. 
11.2 Electrophysiological mechanism of dominant 
frequency heterogeneity 
Four theoretical mechanisms were identified as potential sources of the spatiotemporal DF 
heterogeneity in VF during low-flow ischaemia and raised [K+]EC:- (i) differential 
prolongation of LV repolarisation; (ii) differential prolongation of LV post-repolarisation 
refractoriness; (iii) differential reduction in LV conduction velocity and (iv) differentially 
increase in LV activation threshold. 
11.2.1 (i) Prolongation of repo/arisatlon 
Repolarisation and refractoriness are interlinked phenomena. Only when the membrane is 
starting to repolarize from the action potential plateau does it start to gain the excitability 
of the relative refractory period. By prolonging the plateau phase, the absolute refractory 
period (ARP) is prolonged. In VF, it has been argued that a ventricular myocyte will be 
activated as soon as it is capable (4, 46, 357). Thus, by extending the ARP, the activation 
rate and the dominant frequency (DF) would be reduced. To explain the DF reduction in 
the LV, but not the RV, a differential prolongation of the LV APD would be required. 
Simultaneous measurements of LV and RV MAPD90 in control conditions showed no 
baseline differences. In low-flow ischaemia, neither the LV nor the RV MAPD90 were 
significantly altered. The tendency for the LV APD to be shorter than the RV APD in low-
flow ischaemia would be more in keeping with higher DF in the LV than the RV. In raised 
[K+]EC, both RV and LV MAPD90 were significantly shortened, but to similar degrees. 
Thus differential prolonged repolarisation cannot explain the LVIRV heterogeneity ofDF 
during VF in low-flow ischaemic or raised [K+]EC conditions. 
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11.2.2 (ii) Prolonged of post-repolarisation refractoriness 
In ischaemia, the ARP extends beyond AP plateau, and even full repolarisation (236, 237). 
This post-repolarisation refractoriness can be assessed by measuring the effective 
refractory period (ERP). If post-repolarisation refractoriness was differentially longer in 
the LV than the RV, this could explain its lower DF during low-flow ischaemia and raised 
[K+]EC. As discussed fully in chapter 6.4.1, the assessment of refractoriness in ischemia is 
difficult. Traditionally, ERP has been assessed by establishing the 'pacing threshold at 
intervals well beyond possible post-repolarisation refractoriness, setting the pacing 
stimulus at twice this voltage then, using an S1S2 protocol, identifying the ERP as the point 
of non-capture (239). Using this protocol, the baseline LV and RV ERP were not 
significantly different in control conditions (Figure 6.3), and were not significantly 
changed in either ventricle during low-flow ischaemia or raised [K+]EC. This result 
indicates that differential prolongation of the LV post-repolarisation refractoriness also 
cannot account for the LV IRV heterogeneity of DF during VF in low-flow ischaemic or 
raised [K+]EC conditions. 
11.3 (iii) Reduced conduction velocity 
The role of conduction velocity (CV) in VF is controversial. Computer modelling predicts 
opposite effects of conduction slowing on VF maintenance depending on whether the 
underlying mechanism is a "mother rotor" or "multiple wavelets" (254). On one hand 
conduction slowing will stabilise a mother rotor and convert VF to VT, whereas on the 
other hand slowed conduction will reduce the rate of wavelet annihilation and thereby 
prolong VF duration. Ischaemia alters CV in a temporally biphasic fashion. After onset of' 
ischaemia, the CV increases for -120s before progressively decreasing (205). In VF, the 
480s assessment point represents 420s in the experimental condition. Therefore at 480s in 
VF during low-flow ischaemia, the CV should be reduced. After 420s of low-flow 
ischaemia, both longitudinal and transverse CVs were reduced by -30% in the LV. 
However, in the RV, longitudinal CV was maintained, and transverse CV reduced to lesser 
degrees (-7%) (Figure 7.2). This differential effect may be the basis for the reduced DF in 
LV in low-flow ischaemia. However, in raised [K+]EC there was no change in CV, and 
therefore CV reduction cannot be a necessity for'the DF to be reduced in VF. 
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11.3.1 (iv) Raised activation threshold 
An action potential is triggered if the resting membrane potential depolarises above a 
certain threshold voltage and sufficient Na + current (INa) is activated to rapidly depolarise 
the membrane. This threshold voltage can be increased either by increasing the magnitude 
of the background outward current, or by reducing INa. In VF, the AP amplitude is highly 
variable. It is therefore conceivable that low amplitude activations from an area with a low 
activation threshold will not trigger activity in an adjacent region with a high activation 
threshold. For this reason, a differential increase in LV activation threshold could reduce 
the LV DF. 
During low-flow ischaemia and raised [K+]EC the activation threshold was increased in the 
LV compared to the RV (Figure 6.4). Previous research has documented raised activation 
thresholds in ischaemia (242, 242, 245, 246) and in raised [K+]EC (247). This increased LV 
activation threshold was associated with a slower MAP upstroke velocity in the LV 
compared to the RV, suggesting a reduction in the available Na+ channels or an increase in 
the background K+ currents (Figure 6.5). The association between reduced magnitude of 
INa, increased pacing threshold and reduced AP upstroke has previously been demonstrated 
in neural tissues (248). 
During VF in 8mM [K+] solll:tion, there was a significant depolarisation of the diastolic 
membrane potential (Figure 9.6). In contrast, the expected diastolic depolarisation in VF 
during low-flow ischaemia was not demonstrated (Figure 9.5). This lack of diastolic 
depolarisation may well result from the superfusion of the epicardial surface. This 
superfusion may have prevented any accumulation pf the ischaemic:related K+ efflux, and . 
thereby prevented any depolarisation secondary to increased [K+]EC. As superfusion cannot 
prevent the accumulation of K+ within the deeper myocardium layers, these tissues will 
undergo diastolic depolarisation. Such depolarisation will inactivate INa, reduce AP 
upstroke velocity, increase the activation threshold, and thereby reduce LV DF as was 
observed on micro electrode impalement ofVF during low-flow ischaemia (Figure 9.3). 
Bringing this evidence together has led to the unifying theory that the LV DF slowing in 
VF during low-flow ischaemia and raised [K+]EC is due to LV diastolic membrane 
depolarisation. This LV diastolic depolarisation causes partial inactivation of the INa, and 
thereby increases the LV activation threshold. In support of this theory, inhibition of INa 
has been shown to reduce ECG DF in VF (62). In this study, Mandapati et al. observed that 
when hearts in VF were perfused with the Na channel inhibitor, tetrodotoxin, the rotational 
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rate of re-entrant circuits was reduced and the internal core of the re-entrant circuits was 
enlarged. These changes were identical to those they observed in VF during ischaemia. 
11.3.1.1 Mechanism of ventricular heterogeneity - role of IK1? 
The ventricular nature of VF heterogeneity is not a new concept. Shortly after VF 
induction the electrical activity is more complex in the LV than the RV (358), with higher 
frequencies developing in the LV compared to the RV (192, 193). Optical mapping has 
demonstrated that the transition between the 2 regions is sharp (63). In this thesis similar 
sharp transitions were observed in all VF protocols. As discussed in 3.4.3.2, Warren et a1. 
proposed the LV/RV heterogeneity in VF during control conditions was due to the 
differential expression of Kir2.1 and Kir2.3 in LV myocytes compared to RV myocytes 
(190). This differential Kir2.x expression may also account for the differences in the LV 
and RV DF in VF during low-flow ischaemia and raised [K+]EC. 
In raised [K+]EC, the reversal potentials (Ek) of both Kir2.1 and Kir2.3 expenence a 
rightward shift to less negative voltages (226). Such alterations in Ek result in diastolic 
depolarisation of the cell membrane when [K+]EC is raised (202, 227). The greater LV 
Kir2.x expression would be predicted to cause greater diastolic depolarisation in the LV 
than the RV. A greater diastolic depolarisation in the LV would lead to greater INa 
inhibition, and therefore greater increases in the activation threshold in the LV than the 
RV. 
11.4 Amplitude changes in VF 
Both clinical (19, 24, 29) and animal (30, 33) studies have demonstrated that the activation 
amplitude of the ECG diminishes with time in non-perfused VF. In comparison there is no 
literature detailing amplitude changes in perfused VF. 
11.4.1 Control conditions 
Under control conditions, the VF ECG amplitude rapidly decreased over the first 4 
minutes, then stabilised at -55% of the initial Vf amplitude. This pattern closely mirrored 
the ECG DF frequency changes, where the DF increased over the first 3 minutes, before 
slightly slowing and stabilising at values greater than those immediately post VF induction. 
As the ECG is a global assessment of electrical activity, 2 possible processes could result 
in this frequency/amplitude relationship: - (i) the faster electrical activity could be more 
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dyssynchronous. In this scenario, local electrical vectors would increasingly oppose each 
other, and therefore reduce the global amplitude recorded; (ii) increasingly faster 
activations could start to impinge on the Na + channel recovery. This would result in lower 
numbers of Na+ channels opening, a lower INa magnitude, and thus lower activation 
amplitude (maximum systolic potential). 
In optical mapping, each photodiode records the electrical activity from an epicardial area 
of less than Imm2• Therefore the VF amplitude reduction to -45% of baseline observed in 
the psECG suggests a cellular amplitude reduction rather than a co-ordination 
phenomenon. Optical mapping also revealed a more pronounced reduction of LV than RV 
amplitude with the LV amplitude reducing to -33% of baseline. Transmembrane 
recordings from the LV epicardial surface confirmed an- absolute reduction in the AP 
amplitude during VF in control conditions but only to 86% of baseline amplitude. So the 
LV amplitude reduction in VF was probably due to a combination of reduced electrical co-
ordination and reduced INa magnitude. 
11.4.2 Low-flow ischaemia, hypoxia and acidic pHEC 
On flow reduction there was a transient increase in ECG, psECG and LV optical AP 
amplitude, which corresponded to the initial dramatic decline in VF DF. From this point 
onwards the ECG, psECG ~d LV optical AP amplitudes were indistinguishable from 
control conditions. The amplitude changes in hypoxic and acidotic conditions were also 
indistinguishable from control. 
11.4.3 Raised [K'JEC 
Exposure of VF to raised [K+]EC decreased the ECG, psECO and LV DF. These DF 
decreases were accompanied by increases in the corresponding amplitudes.' When this data 
was plotted alongside the DF and amplitude results from VF in control, hypoxic and acidic 
conditions, they all followed the same correlation, perhaps suggesting a similar mechanism 
of amplitude alteration. Transmembrane recordings of VF during raised [K+]EC 
demonstrated that the reduction of DF was associated with depolarisation of both the 
diastolic and maximum systolic membrane potentials. There was however no increase in 
the peak-to-peak amplitude of the membrane potential oscillations in VF during raised 
[K+]EC. Instead the tendency was for the peak-to-peak amplitude to be reduced. 
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Although each photodiode records from a small epicardial area «lmm2), and is therefore 
less influenced by the macroscopic VF organisation than the ECG, each photodiode is still 
affected by the activity of hundreds ofmyocytes. In VF, where there is no AP plateau, the 
peak-to-peak amplitude of the optical signal will be affected by the degree of intercellular 
electrical co-ordination, and thus the number of cells contributing to the signal. As the 
dominant frequency slows, the activation wave rotates around its spiral core more slowly 
(62). This allows greater degrees of intracellular electrical co-ordination to produce an 
artificial increase in the optical amplitude in VF during raised [K+]EC. 
11.5 Minimum defibrillation energy 
In order to successfully defibrillate VF a shock must (i) depolarise sufficient myocardium 
to disrupt the propagation of the fibrillation wavefronts and (ii) not produce new 
excitations that re-initiate VF (92). The mechanism of re-initiation is still unclear. This 
thesis examined the effect of low-flow ischaemia and its principal metabolic components 
on the minimum defibrillation energy (MDE) required to terminate VF. Whilst low-flow 
ischaemia (6ml/min) and raised [K+]EC (8mM) had no significant effect on MDE compared 
to control, lower perfusion rates and higher [K+] concentrations spontaneously converted 
VF in under 600s. This suggests that a true reduction in MDE by low-flow ischaemia and 
8mM [K+]EC was not detected due to technical issues such as the defibrillator programming 
prevented application of biphasic shocks <60V. In general, previous research supports the 
reduction of defibrillation energies in low-flow ischaemia (73, 284, 302) and raised [K+]EC 
(304). 
Spontaneous conversion did not occur in the 8-week infarct heart firilure model, even on . 
complete cessation of perfusion. In these protocols shocks> 11 OV completely abolished the 
electrical activity for over a minute. After this prolonged isoelectric window, the first 
activation degenerated into VF. This phenomenon probably results from a combination of 
the electrical consequences of scar tissue (182, 343) and the increased dispersion of 
refractoriness that occurs in heart failure of any origin (350-352). 
Decreasing the extracellular pH to 6.7 was associated with an increase in MDE. The well-
known arrhythmogenic properties of acidic pH are discussed in 1004.3. Such 
arrhythmogenic properties may account for the defibrillation resistance in pH 6.3, where 
despite prolonged iso-electric windows, the first activation degenerated into VF .. 
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During hypoxia, VF required more energy to be defibrillated successfully. The limited 
amount of previous literature shows hypoxia both increasing and decreasing the required 
defibrillation energy. Theoretical predictions of hypoxia's effect on defibrillation energies 
are difficult as hypoxia increases repolarisation heterogeneity (suggesting an increase in 
energy required) (305), and inhibits DADs (suggesting a decrease) (308). 
11.6 Future work 
11.6.1 Diastolic depolarisation 
The data in this study suggests that the spatiotemporal DF heterogeneity in VF during low-
flow ischaemia and raised [K+]EC results from the differential elevation of the LV 
activation threshold compared to the RV, and that this occurs secondary to differential 
diastolic depolarisation of the LV compared to the RV in these conditions. The differential 
increase in the LV activation threshold in raised [K+]EC was shown to be associated with 
diastolic depolarisation in the LV epicardium. However it was not shown that the LV 
underwent greater diastolic depolarisation than RV. Therefore an area of future work 
would be to study the effect of raised [K+]EC on the resting membrane potential in single 
cells isolated from the RV or LV. 
11.6.2 Heterogeneity of IK1 in rabbit 
This thesis also hypothesises that the differential elevation of the LV activation threshold, 
and the resultant spatiotemporal DF heterogeneity in VF during low-flow ischaemia and 
raised [K+]EC, could be secondary to a differential ventricular magnitude of IKI. In low-
flow ischaemia and raised [K+]EC, the extracellular accumulation of K+ results in a right-
ward shift of the IKI reversal potential (226), and thus depolarises the res~ing membrane 
potential. If this current has greater magnitude in LV than RV, then differential 
depolarisation of the resting membrane potential should occur. This hypothesis gains 
credence from work in guinea pigs (63, 190,224) which demonstrated a greater magnitude 
of IKI in LV compared to RV myocytes (63), and that this IKI heterogeneity was the result 
of increased expression of Kir2.x in the LV compared to the RV (190). This greater degree 
of background current produced faster LV' repolarisation, and thus allowed the 
development of higher DF in the LV compared the RV. Inhibiting IKI with BaCI abolished 
this ventricular DF heterogeneity (190). 
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At present there is no evidence to either support or refute ventricular heterogeneity of 
IKllKir2.x in the rabbit. The distribution of IKI magnitude has wide species variation; where 
the guinea pig has almost double the magnitude of IKI in LV compared to the RV myocytes 
(63, 190), the dog has equal magnitudes of IKI in both ventricles (229). Therefore the 
ventricular heterogeneity of IKI needs to be confirmed in the rabbit. This could be done 
through a combination of (i) patch-clamp experiments on isolated LV and RV myocytes, 
(ii) Using BaCI in whole heart preparations to assess its effect on the frequency 
heterogeneity, (iii) in situ hybridisation of Kir2.x (approaches have been made towards 
Prof. Mark Boyett for potential collaborations). 
11.6.3 Voltage - calcium interactions during VF in low-flow 
ischaemia 
The importance of voltage-calcium interactions in VF induction is increasingly being 
recognised (for review see (359)). Theoretically (360) and experimentally (361) 
spontaneous calcium release has been linked to the first wavebreak event that initiates VF. 
On top of this, evidence is emerging that positive voltage-calcium altemans is important in 
creating dynamic instability that may also precipitate VF (333, 335). The role of calcium in 
VF maintenance is supported indirectly by studies showing (i) conversion of VF to VT by 
blockade of L-type calcium channels (66, 362, 363) and (ii) the association of failed 
defibrillation with non-reversal of intracellular calcium overload (326). In contrast 
simultaneous recordings of voltage and calcium during perfused VF show a lack of any 
relationship between the 2 signals immediately after VF induction (216, 217). As yet the 
-
role of calcium in VF during ischaemia has not been examined. It is possible that during 
the slower voltage oscillations that occur in low-flow ischaemia and raised [K+]EC that' 
voltage and calcium oscillations could become fe-associated. This phenomenon could be 
examined in the VF model used in this thesis by imaging the calcium transient 
simultaneously with the membrane potential via a second photo diode array, a dichroic 
mirror and co-loading with Rhod 2AM (48). 
11.7 Clinical Relevance 
11.7.1 Reversal of hypoxia and' acidosis 
This thesis demonstrated that the minimum defibrillation energy required to successfully 
defibrillate prolonged episodes of VF was increased by hypoxia and acidosis. This would 
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suggest that directed reversal of these factors could enhance defibrillation success. More 
rapid reversal of hypoxia in the prolonged arrest scenario could be achieved by prioritising 
intubation, and ventilating with 100% 02 along with the initial CPR (75), rather than 
mouth-to-mouth ventilation which maximally provides 17% 02 (18). Such procedures 
would entail paramedic intubation, and require a high degree of training to ensure proper 
ET tube insertion (364). 
The reversal of acidosis with buffering agent has previously been attempted with variable 
success (365-367). This probably relates to the fact that in ischaemia, the acidosis is 
primarily an intracellular lactic acidosis, which buffers are less able to reverse (367). 
Therefore, establishing perfusion and maximising oxygenation are more likely to reverse 
this acidosis (17, 77). 
11.7.2 Antero-posterior vs. Antero-Iateral paddle position 
This thesis demonstrated that in VF during low-flow ischaemia the electrical activity was 
faster in the RV than the LV. This suggests that the RV acts as a primary driving force in 
VF during low-flow ischaemia, and that adequate coverage of the RV by the electrical field 
is a prerequisite for successful defibrillation. In human anatomy, the RV falls more within 
the electrical field of antero-posterior (AP) positioned paddles than those placed in the 
antero-Iateral (AL) position. The superior efficacy of AP over AL electrode placement in 
atrial fibrillation conversion has been shown in some studies (368-372) but not others (373, 
374). Another consideration is the aetiology of clinical VF; in this thesis VF was induced 
by burst pacing, whereas most clinical arrests occur in the context of ischaemiaireperfusion 
of myocardial infarction (5). Here the higher activity of the RV may.be irrelevant; 8-week . 
infarct rabbit hearts were resistance to defibrillation. even after prolonged abolition of all 
electrical activity. 
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Abstract 
Introduction: Studies of ventricular fibrillation (VF) show that the dominant frequency (DF) of the ECG . 
decreases as ischemia develops. The aim of this study was to examine the spatiote~poral organisation of the 
electrical activity associated with VF under ischaemic conditions. 
Methods and Results: Isolated rabbit hearts were Langendorff-perfused at 40ml/min with Tyrode's solution 
and loaded with RH237. Anterior epicardial optical action potentials were recorded with a photodiode array 
(252 sites, 15x 15mm). After 60s ofVF (induced by burst pacing), global ischemia was produced by low flow 
(6ml/min), or the solution changed to impose hypoxia (95% N2/5% CO2), acidic pHo (6.7, 80% 0 2/20% CO2) 
or raised [K+]o (8mM). DF of the optical signals was determined at each site. Conduction velocity (CV), 
action potential duration (APD90), effective refractory period (ERP), activation threshold, dV/d1max and 
membrane potential were measured in separate experiments during regular ventricular pacing. During VF, 
ischemia decreased the DF in the left ventricle (LV) (58±6%, p<O.OOl cf. baseline) but not the RV (93±5%). 
Raised [K+]o reproduced this pattern (LV DF: 67±12%, p<O.OOl; RV DF: 95±9%). LV DF did not decrease 
in hypoxia or acidic pHo. During ventricular pacing, ischemia decreased CV in the LV but not the RV. 
Raised [K+]o did not change CV in LV or RV. Ischemia and raised [Klo both shortened APD90. ERP was 
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not significantly altered, but LV activation threshold was increased by both ischemia and raised [K+]o, and 
was associated with decreased dV/dt.n.x, and diastolic depolarisation. 
Conclusions: These results suggest that during VF decreased ECG DF in global ischemia is largely due to 
elevated [K+]o affecting LV, rather than RV electrophysiology. Possible explanations for the reduced LV DF 
are diastolic depolarisation, reduced dV/dtroax and increased activation threshold. These parameters are 
unchanged in the RV during ischemia. 
Key words: Optical mapping, ischemia, ventricular fibrillation. 
Introduction 
In ventricular fibrillation (VF), the electrical activity of the ventricles is uncoordinated, resulting in loss of 
cardiac output and death unless corrective measures are undertaken'. VF is the major cause of sudden death, 
with an estimated annual European death rate of 123,0002. Regardless of the underlying mechanism of the 
electrical activity associated with VF ("mother rotor,,3 or "multiple wavelet'.4) , the result is high frequency 
deflections (3-5 Hz in humans) of the ECG5• This signal is thought to reflect oscillations of the ventricular 
membrane potentiaI6•7•8• The frequency of these oscillations is not uniform across the heart; higher 
frequencies are observed in the left ventricle (LV) than the right (RV)9.1O. 
Experimentally, myocardial perfusion can be maintained during VF. Under these circumstances, ECG 
frequency remains relatively constant". In contrast, when the heart was not perfused, ECG frequency 
decreases6 and the intervals between epicardial activations increase'2. This suggests that during VF, ischemia 
influences the electrical properties of the myocardium such that the rate of activation is reduced. The 
underlying cellular mechanism of this phenomenon is unknown. Recent work suggests that this ischemic 
frequency slowing occurs heterogeneously across the ventricles'3, the VF frequency being reduced more in 
the LV than the RV. The electrophysiological mechanism underlying this RV-LV heterogeneity is unclear. 
The primary metabolic consequences of ischemia are hypoxia: acidic pH and raised extracellular potassium. 
The aim of this study was to determine which of these components of ischemia are responsible for the 
. 
differential reduction in frequency between the LV and the R V. 
Methods 
Langendorf! perfusion 
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH Publication No. 85-23, revised 1996). Adult male New Zealand White 
rabbits (weight 3-3.5 Kg) were sacrificed by intravenous injection of 0.5 mVkg Euthatal (sodium 
pentobarbitone 200 mg/kg, Rhone M6rieux) with 500 IU of heparin. The hearts were rapidly excised and 
perfused in Langendorffmode with Tyrode's solution at 37°C (composition (mM): Na 134.5, Mg 1.0, K 5.0, 
Ca 1.9, C1I01.8, S041.0, H2P04 0.7, HC03 20, acetate 20 and glucose 50) pH 7.4 (95% O2 /5% O2). Hearts 
were perfused at constant rate (40ml/min) using a Gilson Minipuls 3 peristaltic pump. Perfusion pressure was 
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monitored with a transducer in the aortic cannula. 
Optical mapping 
The heart was placed in a custom-made Plexiglas chamber (Figure I). The chamber allowed control of 
bathing solution temperature, and recording of global ECG via wall-fixed electrodes. The heart was loaded 
with 100 ilL of the voltage sensitive dye RH237 (Molecular Probes), dissolved in DMSO (lmg/ml). Light at 
535±25nm (interference filter, Comar Instruments Ltd, UK) from four 75W tungsten-halogen lamps 
illuminated the anterior surface of the heart (see online Figure 1). Light emitted from the heart was collected 
using a camera lens (Nikon 85mm, NA 1'4), passed through a 695nm long-pass filter, and the image focused 
on a 16xI6 photodiode array (C4675-102, Hamamatsu Photonics UK Ltd). Each diode had a sensing area of 
0·95mmxO·95mm with a pitch (distance from centre to centre) of 1·1 mm. The image of the anterior region of 
the heart was focused on the array at x 1·2 magnification, each diode detected light from a 0'8mmxO'8mm 
area of epicardium and therefore the full array recorded from a 15xI5mm area. (Figure IA). Digitised data 
samples were stored on disk and analyzed using software written in IDL (Interactive Data Language, 
Research Systems Inc.). 
Studies during Ventricular Fibrillation 
VF protocol and analysis 
VF was induced by burst pacing (50Hz stimulation for 8s) via platinum hook electrodes placed in the RV. All 
hearts were perfused with normal Tyrode's solution at 40mllmin for the first minute of VF. During control 
protocols, 40mllmin perfusion was maintained. In experimental protocols, either the perfusion rate (global 
ischemia - 6 mllmin) or solution composition was altered at 60s. ECG and optical recordings were taken for 
4s periods. ECG was recorded every 30 seconds and optical measurements every minute. 
The peak (dominant) frequency (OF) was identified from power spectra of ECG and optical signals. 
Summing the power spectra from all 256 pixels gave a global or pseudoECG (psECG) power spectrum 
(Figure 1 B-D). The progressive changes in psECG DF were similar to ECG DF, so only the ECG DF is 
shown (Figure 2). Plots ofpsECG DF are shown in the online supplemental data (Online Figure 2). To assess 
ventricular heterogeneity the mean DF from a 3x3 pixel area in both LV and RV was calculated. The 
position of the RV-LV border was confirmed by dissection at the end of the experiment. 
Epicardial membrane potential measurements using a floating microelectrode 
Hearts were prepared as above, but without dye loading and with the additional insertion of an LV balloon to 
reduce motion. The hearts were placed in a chamber similar to that used for optical recording but adapted for 
microelectrode impalement of the LV surface by boring a 5mm diameter hole in the Plexiglas front-plate. 
The chamber was turned 90° to allow access to the surface of the heart with vertical microelectrodes. These 
were pulled from borosilicate glass (WPI, Sarasota, FL) using a P-97 FlaminglBrowning pipette puller 
(Sutter Instruments, Novato, CA) and filled with 2M KCI before the tips were mounted onto silver chloride 
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coated silver wire (total resistance 20-25MQ). Impalements were made into the epicardial LV surface and the 
membrane potential signals were recorded via Microprobe Model 750 (WPI, Sarasota, FL). Transmembrane 
recordings were taken during RV pacing with a basic cycle length (BCL) of lSOms, and during VF. Signals 
were also analyzed in the frequency domain as above. 
Components of ischemia 
In order to study the effects of individual components of ischemia on electrophysiological changes during 
VF, standard Tyrode's solution was adapted according to previous studiesl4,ls,16. Acidic pHo of 6.7 was 
produced by bubbling with 20% C02/S0% 0 214; hypoxia was produced by bubbling with 5% C02/95% N2 
mixturels; hyperkalemia was produced using SmM or lOmM [K+]oI6. 
Studies during ventricular pacing 
Conduction velocity protocol 
Hearts were prepared for optical voltage mapping as above, and the LV or RV was paced on the epicardial 
surface via bipolar stimulating electrodes. The hearts were paced at BCL 250ms, and the activation pattern of 
the LV and the RV under control conditions were recorded. To assist immobilization, hearts were perfused 
with 3J..IM cytochalasin D for 20 minutes before measurements were made. At this concentration, 
cytochalasin D has been shown in this preparation not to affect conduction velocityl7. Activation times were 
recorded at 6-7 minutes of either global ischemia (6mVmin) or raised [K+]o (SmM). 
Activation time was determined as the time of maximum upstroke (dV/dt max) of the optical signal18. Using 
locally developed software written in MATLAB (The MathWorks, In~., MA, USA), these times were used to 
calculate local conduction velocity (For details see online Figure 3). 
Refractory period measurements 
Monophasic action potentials (MAPs) were recorded using Franz contact catheters (Ag-AgCI electrode, 2mm 
diameter, Boston ScientificlEP Technologies, San Jose, CA, USA) placed against the LV and RV epicardial 
surface. LV and RV MAPs were recorded simultaneously. Using a distant RV epicardial bipolar stimulating 
electrode, steady-state restitution protocolsl9 were performed after 6 and 10 minutes of either 6mVmin low-
flow global ischemia or perfusion with SmM [K+]o. ERP was assessed by stimulating at twice diastolic 
threshold voltage through one contact electrode whilst recording MAPs at the other. The SIS2 protocol used 
consisted of S beats at BCL 300ms (SI) followed by shorter test stimulus (S2)' The initial S2 interval of 
150ms, was reduced by 2ms until capture no longer occurred (Figure 6A). Threshold voltages were also 
recorded. 
Statistical analysis 
Data are expressed as mean ± SEM. Significance testing with ANOV A, paired t-test or Wilcoxon matched 
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pairs were performed using Instat3 (GraphPad Software Inc., USA). For ECG and psECG progression data at 
480s were compared. 
Results 
Simultaneous EeG and Optical signals in VF 
Figure lA(i) shows a Langendorff-perfused rabbit heart in the optical mapping chamber. The superimposed 
grid represents the area of the myocardium recorded by the photodiode array (16xI6·elements). The anterior 
descending coronary artery that approximately delineates the RV-LV border is clearly visible. The two white 
squares are two 3x3 pixel squares placed in the RV and LV regions. Panel A (ii) is a typical record of 256 
optical action potentials recorded from the epicardial surface. Panel B is a typical ECG recording from an 
isolated heart in sinus rhythm (i) and VF (ii). Panel C shows a typicru, optical signal from an LV pixel in 
sinus rhythm (i) and VF (ii). Panel C (i) and (ii) shows records from a pixel situated in the R V region of the 
array. The VF activation rate is clearly higher in the LV than the RV. ECG and optical power spectra are 
shown in Figure 10. This shows the dominant frequency of the optical signals recorded from the LV region 
is higher when compared with signals from the RV region and with the ECG. 
Effects of perfusion rate on the dominant frequency 
Typically, the OF of the ECG shortly after induction was 12-13Hz. This value changed with time, depending 
on the experimental condition. The evolution of OF under control conditions (40mllmin perfusion) is shown 
in Figure 2A. Expressed relative to the OF at time zero, the ECG OF increased to a peak value over the initial 
180s (136±7%, p<O.OOI), before decreasing, and stabilizing at values higher than those observed at VF 
induction (123±7%, p<0.05). On reduction of the rate of perfusion, the ECG OF rapidly decreased and 
stabilized at a lower OF value by 420s. The rate of decline, and the final steady-state value, depended on the 
perfusion rate such that OF declined more quickly at lower perfusion rates and reached a lower steady-state 
value (Figure 2A). Similar time courses were observed for median frequency values of the ECG (results not 
shown). On complete cessation of perfusion, OF rapidly decreased but the VF converted to a more regular 
rhythm within 240s in all hearts. Restoring perfusion resulted in spontaneous conversion to sinus rhythm. 
~uring perfusion at 4mllmin, 5 out of 9 hearts underwent spontaneous conversion. VF was maintained for 
periods longer than 720s during perfusion at 6mllmin and did not spontaneously convert to sinus rhythm. 
Optical psECG recordings showed similar OF changes to those observed with the ECG (Online Figure 2A). 
LV-RV differences in VF dominant frequency. 
The geometry of the heart prevents simultaneous recording of the optical signals from the entire epicardial 
surface of the LV and RV with a single camera. Therefore a region of the heart was chosen that spanned the 
LV-RV border on the anterior surface of the heart. From the optical map of this area, two standardized 
3x3mm regions in the LV and RV were examined. To ensure that the difference observed from these two 
regions was representative of teach ventricle, measurements of OF were made whilst imaging an area fully 
within the LV or the RV (Online Figure 4). The OF maps indicate that the values of OF are homogeneous 
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over individual ventricles. Comparing the DF of two standardized 3x3mm regions within one ventricle 
(region I and 2) showed no significant differences. The mean DF during normal perfusion VF increased to 
134±7% in region 1 of the LV and to I46±IO% in region 2. In the RV, the mean DF increased to II2±7% in 
region 1, and I08±I% in region 2. These data suggest that the optical signals from an area spanning the LV-
RV border represent the activity in both ventricles. 
Measurements from the area spanning the LV-RV border indicate that the spatial distribution ofVF dominant 
frequency was not homogeneous (Figure 3 & Table 1). DF increased in the LV during standard perfusion, 
whereas in the RV DF was only marginally increased (LV vs. baseline, 162±13%, p<O.OOl; RV vs. baseline, 
116±4%, p=NS; LV vs. RV p<O.OOl). This LV-RV dispersion developed progressively over 480s in all 
hearts. In contrast, during low-flow global ischemia at 6 rnVmin, there was a marked reduction of LV DF, but 
no significant change in the RV (LV, 58±8%, p<O.OOI; RV, 94±7%, p=NS; LV vs. RV p<O.OI). 
Effect of acidic plio 
Perfusion with Tyrode's at pH 6.7 inhibited the initial increase in ECG DF (Figure 2B) and psECG DF 
(online Figure 2B). Instead there was a more gradual increase in DF to steady state values, which were not 
significantly different from control. 
Perfusion with acidic solution altered the spatial distribution of the DF values (Figure 3, Table 1). At 480s, 
the LV DF increased to a lesser extent than that observed with normal Tyrode's (PH 7.4, 162±13%; pH 6.7, 
141±7%, p<O.Ol). Whereas the RV DF increased to values significantly higher than control (PH 7.4, 
116±4%; pH 6.7, 135±6%; p<O.Ol). These changes produced an absolute DF value in the LV (-20Hz) after 
480s that was not significantly diffe~ent from that in the RV (-18Hz, Figure 3 and Table 1). In separate 
experiments, the effects of higher PC02 (lower pH) were examined. Perfusion with 50% CO2 (PH 6.3) had 
similar effects to those seen at 20% CO2 (PH 6.7) (results not shown). 
Effect of hypoxia 
The global measures of frequency (i.e. ECG and psECG) showed that DF in hypoxia was not significantly 
different from control at 480s (Figure 2C, online Figure 2C). The spatial heterogeneity was also 
indistinguishable from control (Figure 3 and Table 1). 
Effect of elevated [KJo 
Raised [K+]o had a profound effect on ECG DF and psECG DF (Figure 2D, online Figure 2D). Th~ time 
course and extent of the changes in DF were similar in 8mM and 10mM [K+]o, but spontaneous conversion 
occurred in 75% of experiments using lOmM [K+]o, and 20% using 8mM. In the presence of raised [KJo the 
spatial characteristics of VF were indistinguishable to those observed in 6rnVmin global ischemia; DF was 
decreased more in the LV than RV (LV 67±4%, p<O.OOl; RV 95±3%, p < 0.001; LV vs. RV p<O.OOl; Figure 
3, Table 1). 
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Epicardial transmembrane potential in VF 
Figure 4A(i) shows a typical transmembrane potential recorded with a floating microelectrode on the LV 
epicardial surface of a Langendorff-perfused rabbit heart. Figure 4A(ii) shows the transmembrane potential 
recording from the same area after VF induction. The averaged signals of membrane potential from the 
epicardial surface of the LV revealed a similar OF progression to those of ECG and psECG under control 
conditions, low-flow ischemia and 8mM [K+] (Figure 4B). Under control conditions, the diastolic membrane 
potential during VF was not significantly different from pre-VF values (BCL 180ms, -72±4mV; VF, 
-65±3mV). In contrast, the maximum systolic membrane potential decreased in VF (BCL 180ms, 18±4mV; 
VF, -24±5mV, p<O.OI). Systolic and diastolic membrane potentials during low-flow ischemia were not 
significantly different from control. Perfusion with 8mM [K+]o during VF depolarized the diastolic 
membrane potential (BCL 180ms, -80±5mV; VF, -55±8mV; p<O.05). 
Electrical properties of the myocardium during ventricular pacing 
Both low-flow global ischemia and raised [K+]o reduced VF frequency in the LV. Potential mechanisms 
include changes in: (i) conduction velocity, (ii) refractory period or (iii) excitability of the ventricular 
myocardium. Conduction velocity cannot be measured accurately during VF in the intact LV, owing to the 
unknown contribution of transmural versus trans-epicardial activation. The refractory period and excitability 
also cannot be measured directly during VF. We therefore undertook further experiments during regular 
ventricular pacing to investigate whether low-flow ischemia or elevated [K+]o induced changes in conduction 
velocity, repolarization, refractoriness or excitability of sufficient magnitude to account for the observed 
changes in OF in the LV and RV. 
Conduction velocity 
After 6-7 min of low-flow global ischemia there was a significant reduction of both longitudinal and 
transverse velocity in the LV (longitudinal 69±8%, p<O.05, transverse 70±1 %, p<O.05, n=4; Figure 5). The 
RV longitudinal velocity was unchanged (98±2%), but the 'transverse velocity "was reduced by a small 
amount (92±3%, p<O.05). The reduction in the transverse velocity was significantly less in the RV than the 
LV (p<O.05). 
After 6-7 min perfusion with 8mM [K+] neither LV nor R V conduction velocities were significantly changed, 
though there was a tendency for all velocities to increase (n = 4, Figure 5). 
Action potential duration, refractory period and 'excitability measurements 
The observed interventricular differences in OF may be due to a difference in repolarization and/or 
refractoriness of the myocardium. Prolongation of the LV APO or ERP relative to the RV could explain the 
slower OF observed in the LV. MAP090 and ERP were assessed during low-flow ischemia or elevated [K+]o 
as outlined in the Methods. Under control conditions, LV and RV MAP090 were not significantly different 
(Figure 6B). In low-flow ischemia, MAP090 tended to shorten in LV and lengthen in the RV, but these 
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alterations were not significant. Elevated [K+Jo caused both LV and RV MAP090 to decrease significantly 
compared to control values (p<O.OI)(Figure 6.B). The percentage change was not significantly different 
between the ventricles (LV 93±3%, RV 92±1 %). 
As the mean data show (Figure 6C), there was no significant difference between LV and RV ERP in control 
conditions. Neither low-flow ischemia nor elevated [K+Jo had a significant effect on LV or RV ERP as 
assessed at the standard pacing threshold (diastolic threshold x2). However, the voltage threshold for pacing 
the LV was increased by both low-flow ischemia and elevated [KJo' This effect was not evident when 
stimulating the RV (Figure 60). This differential effect occurred both for low-floW global ischemia (LV, 
x3.5±1.3; RV, x1.2±O.5; p<O.05) and elevated extracellular [K+J (LV, x2.6±O.5; RV, x1.3±O.3; p<O.05). One 
of the causes of an elevation of threshold could be inactivation ofNa + channels responsible for phase 0 of the 
action potential. Consistent with this explanation was the differential reduction of the maximum upstroke 
velocity (dV/dt max) of the MAP recording in the LV but not the RV (Figure 6E), in both low-flow ischemia 
(LV, 44±1O%, p<O.05; RV, 97±19%) and elevated [K+Jo (LV, 39±IO%,p<O.05; RV, 90±22%). 
Discussion 
This study shows that the reduction in the dominant frequency (OF) of the ECG during low-flow global 
ischemia is due to reduced OF in the LV but not the RV. The reduced OF is reproduced by raising [K+Jo and 
not by the reduction of P02 or extracellular pH. 
The reduction in dominant frequency of the ECG reflects decreased activation rates of the myocardium as 
indicated by the optical and microelectrode recordings. Theoretically, several mechanisms could be 
responsible for the decrease the frequency of activation: (i) reduced conduction velocity; (ii) prolongation of 
the action potential; (iii) prolongation of post-repolarization refractoriness; (iv) raised voltage threshold for 
activation. 
Reduced conduction velocity 
The role of conduction velocity (CV) in VF is controversial. Theoretically, slowing of conduction has 
diametrically opposite effects on VF maintenance depending on whether the driving mechanism is a "mother 
rotor" or "multiple wavelets,,2o. Conduction slowing stabilizes the mother rotor and converts'VF to VT, 
whereas slowed conduction reduces the rate of wavelet annihilation thereby prolonging VF duration2o. The 
biphasic nature of ischemia-induced alterations in CV is well documented (for review see21). Initially after 
the onset of ischemia, CV increases (~2 minutes) and then decreases again. Thus at 6-7 mins (the time point 
used in this study), conduction velocity would be expected to be lower. In the ventricular pacing experiments, 
both longitudinal and transverse velocity were reduced in the LV by ~30%. In the RV, longitudinal velocity 
was maintained and transverse velocity reduced to a much lesser degree (~7%). Therefore, this differential 
effect may be the basis for the reduced OF in LV in low-flow global ischemia. However, no change in CV 
was observed in elevated [KJo despite the decreased OF observed in the LV. This is in keeping with previous 
observations that CV slowing in ischemia was not solely due to [KJo accumulation22, and shows that a 
reduction in CV is not a prerequisite for reduced OF in VF. 
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Previous experimental and modeling studies show a complex relationship between conduction velocity and 
[Kio23.24. Elevation above 5mM results in increasing velocities to a peak at around S-9mM. At 
concentrations above -SmM conduction velocity decreases, at [K+]o of -12mM, velocity falls below control 
values23. Since DF slowed at these [K+]o values, a mechanism other than reduced CV would appear to be 
responsible. Such a lack of correlation between CV and DF has been demonstrated in atrial tissue25. 
Prolongation of repolarization 
Repolarization and refractoriness are interlinked phenomena. By prolonging the plateau phase, the effective 
refractory period (ERP) is also prolonged. In VF, it has been argued that a ventricular myocyte is reactivated 
as soon as it is excitable26. Therefore, extending the ERP would reduce the activation rate and the dominant 
frequency (DF). To explain a DF reduction in the LV, but not the RV, a differential prolongation of the APD 
would be required. We did not consider it feasible to measure APD during VF, because of the variation in 
morphology and diastolic potential (Figure 4). Measurements of APD using MAP recordings during 
ventricular pacing showed that on average there were no differences in APD between LV and RV. 
Furthermore, APD did not change significantly during low-flow global ischemia. Thus prolonged 
repolarization and therefore ERP cannot be used to explain reduction of DF in LV under low-flow 
conditions. Furthermore, elevated [K+]o mimicked the change in DF in both LV and RV but did not prolong 
the APD; instead elevated [K+]o reduced APD equally in both LV and RV by -10%. 
Prolongation of post-repolarization refractoriness 
In ischemia, the ERP may extend beyond full repolarization27.28.29. If post-repolarization refractory period 
was differentially longer in the LV, this could explain its lower DF during low-flow ischemia and raised 
[K+]o. As discussed by Opthof et al. the assessment of refractoriness in ischemia is difficult12. Traditionally, 
ERP has been assessed by establishing the pacing threshold at intervals well beyond possible post-
repolarization refractoriness, setting the pacing stimulus at twice this voltage then, using an S 1 S2 protocol, 
identifying the ERP as the point of non-capture30. Using this protocol failed to reveal any significant change 
in ERP in either LV or RV (Figure 6C). This is consistent with the reported lac~ of relationship between ERP 
and DF in canine atria25 and indicates that prolonged ERP cannot account for the decreased DF in low-flow 
global ischemia. 
Raised threshold for activation 
An increase in LV threshold for activation could reduce DF by increasing the time between repetitive 
activation of the myocardium. The threshold voltage can be increased either by increasing the magnitude of 
the background outward current or by reducing sodium current (INa)' 
In this study we observed a differential increase in LV threshold voltage, as represented by the increased 
pacing threshold during low-flow global ischemia and elevated [K+]o. Such raised voltage thresholds have 
been observed by others, both during ischemia31.32.33 and in the context of elevated [K+]o34. In the MAP 
experiments described in the current study, slower MAP upstroke was associated with this higher stimulation 
threshold, suggesting a reduction in the available Na+ channels or increased background K+ currents. The 
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association between reduced magnitude of INa, increased pacing threshold and reduced AP upstroke has been 
demonstrated in other tissues3s. Interestingly, these changes had no affect on conduction velocity. A similar 
dissociation between the degree of activation of INa and CV has not been shown directly in cardiac tissue. 
However, previous studies have shown a lack of correlation between maximum AP upstroke velocity and 
conduction velociryls.23. 
Past research recording transmembrane potentials during ischemia8 and raised [K+]oI6 showed depolarization 
of diastolic membrane potential. In the present study in VF there was a significant depolarization of the 
diastolic membrane potential when perfusing with increased [K+]o. Our lack of demonstration of significant 
changes in diastolic potential in low-flow ischemia could be due to perfusion with normal Tyrode's solution 
in the volume adjacent to the epicardial surface. This may have limited the increase in [K+]o in the 
epicardium during low-flow global ischemia, thereby preventing significant depolarization. As superfusion 
would not prevent the accumulation of K+ in the deeper myocardial layers, diastolic depolarization should 
occur within these tissues during ischemia. Such depolarization would be expected to inactivate INa, reduce 
AP upstroke velocity, and thereby result in the observed slowing of dominant frequency. 
Thus we hypothesize that global ischemia and raised [K+]o cause diastolic membrane depolarization, which 
causes partial inactivation of the INa, and thereby increases the activation threshold voltage. In support of this 
hypothesis, inhibition of INa caused a reduction in DF 36. This study showed that perfusing hearts with low 
concentrations of tetrodotoxin caused reduced rotational rate of re-entrant circuits and enlargement of their 
internal core, in a manner identical to that observed in non-perfused hearts. 
Mechanism of ventricular heterogeneity - role of [KJ? 
Ventricular heterogeneity of VF is not a new concept. Higher frequencies develop in the LV compared to the 
RV shortly after VF induction1o• Optical mapping has demonstrated a sharp transition between the 2 regions9• 
Similar sharp transitions have been observed in low-flow global ischemia and elevated [K+]o in the present 
study. In a previous publication, the source of this heterogeneity was thought to be the differential expression 
ofKir2.1 and Kir2.3 in LV myocytes compared to RV myocytes37• The differential expression of Kir2. 1 and 
. . 
Kir2.3 may also be the basis of the differences between LV and RV reported in this study. However, 
differences in the expression of other ion channels between LV and RV have been noted in a varitye of 
species38•39; these too may contribute to the differences in the DF obserVed in perfused and low-flow global 
ischemia. 
Conclusion 
During VF in low-flow global ischemic conditions there is decrease in the dominant frequency ofVF in the 
LV. This study shows for the first time that raised [K+]o, and not low P02 or acidic pHo alone, are responsible 
for this effect. This study also demonstrated that the insensitivity of the RV to raised [K+]o was the basis for 
the observed DF heterogeneity in previous research. The underlying electrophysiological mechanism is 
unknown, but the data suggests that raised activation threshold in the LV, and not the RV, is the cause. This 
indicates that intrinsic electrophysiological differences between the LV and RV may be responsible for 
dramatic differences in the VF dominant frequency during low-flow ischemia. 
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Figure I Panel A: (i) Langendorff-perfused rabbit heart in optical mapping chamber. The superimposed grid 
represents the area of the myocardium (16 x 16 pixel) visualised by the photodiode array. Panel A (ii) 
optically recorded action potentials (pacing cycle length 300ms). Panel B: ECG recording during (i) sinus 
rhythm and (ii) ventricular fibrillation (VF). Panel C: optical pixel recordings "from: (i) the LV in sinus 
rhythm, (ii) the LV in VF, (iii) the RV in sinus rhythm and (iv) the RV in VF. Panel D: superimposed power 
spectra of ECG [B(ii)], LV [C(ii)] and RV [C(iv)] signals in VF. 
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Figure 2 Progressive changes of ECG DF during VF. ECG dominant frequency (DF) are shown under a 
range of conditions. Panel A: at varying perfusion rates. Panel B: reduced extracellular pH (pH 6.7). Panel C: 
hypoxia. Panel D: raised extracellular [K+]. 
40ml/min 6ml/min pH 6.7 
10 15 20 25 
Figure 3 Dominant frequency maps. Spatial distributions of DF are demonstrated using by a colour code 
scale from 8-30Hz. Snapshots of typical DF distribution are shown at VF onset (Os) and after 480s. The LV-
RV border is indicated by a dotted white line. Maps are shown under the flowing conditions: Control 
(40ml/min) ; Low-flow global ischemia (6mllmin); Acidic pH (pH 6.7; 20% CO2, 80% 0 2); Hypoxia (0% 
P02 : 5% CO2, 95% N2) ; Raised K+ (8mM). 
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Figure 4 Measurements of transmembrane potential in VF. Panel A: Transmembrane potential recording 
from anterior LV epicardial surface during: (i) RV paced at BCL of 180ms and (ii) in VF. Panel B: Plot of 
OF progression as assessed from transmembrane potential recordings during VF in control (40mVmin), low-
flow global ischemia and 8mM [K+]o. Panel C: Above: LV DFs under control conditions (co) and during 
low-flow global ischemia and 8mM [K+]o. Below: Mean diastolic potential (bottom) and systolic potential 
(top) during RV pacing and VF (7-9 minutes). 
B (i) 
,00 
l eo 
f I. 
~ 
~ .. 
~ 
~ 20 
0 
U 
LV 
* 
co low BmM 
flow K' 
(ms) 
RV 
co low 8mM 
!low K-
(ii) LV 
co low BmM 
flow tr 
RV 
eo low 8mM 
!low tr 
Figure 5 Conduction Velocity Panel A: Typical LV isochronal activation maps during epicardial stimulation 
in control conditions (co) (i) and after 6-7 mins low-flow global ischemia (ii). Panel B: (i) Mean longitudinal 
CV; (ii) mean transverse CV. * indicates significant difference from control (p<O.05). 
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Figure 6 MAP studies Panel A: Two superimposed LV MAP recordings S, and S2 stimuli are indicted by 
arrows: black line is a control trace (BCL 300ms); grey line is record in response to an S2 stimulus 140ms 
after Sl. Panel B: mean APD90 of LV and RV under control (co), low-flow global ischemia (6mllmin) and 
raised [Klo (8mM). Panel C: mean ERP of LV and RV. Panel D: Fractional change of threshold voltage 
required to capture the respective ventricle at BCL 300ms. Panel E: Percentage change in upstroke velocity 
of MAP under low-flow global ischemia (6mllmin) and raised [K+] 0 (8mM). * indicates significant 
difference from control (p<O.05). 
Tungsten-halogen lamp 
RH237 
Online Figure I Optical Mapping Set-up Diagrammatic representation of optical mapping apparatus. Only 2 
Tungsten lamps are shown for clarity. The second pair of lights was parallel such that the 4 lights formed a 
square around the heart. Light was shone through 535±25nm interference filters and recorded after filtering 
through a 695nm long-pass filter. 
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Online Figure 2 Progression of psECG OF in VF Panel A: progression during differing perfusion rates. 
PseudoECG OF during 40mllmin and 6mllmin protocol (p<0.005). Panel B: progression under reduced 
extracellular pH (pH 6.7) compared to control (pH 7.4). Panel C: ps ECG OF progression during hypoxia 
compared to control. Again this global assessment showed no significant difference of OF in hypoxia 
compared to control. Panel 0: psECG# progression with raised extracellular [KJ compared to control. OF is 
profoundly reduced compared to control (#p<0.05). This assessment of global OF progression was 
indistinguishable from 6mllmin low-flow global ischemia. 
(ms) 
Figure 3 Conduction Velocity Conduction velocity measurements can be contaminated by intramural 
conduction or close pacing stimulus. Thus, to ensure the correct evaluation of conduction velocity, both 
transverse and longitudinal velocities were assessed using several different methods: (i) Circular method: CV 
was measured around a circle centred on the stimulation point *. A radius of 5nun was chosen to avoid the 
central area of instantaneous activation and more remote areas where transmural conduction can produce 
spuriously elevated values. Peak velocity was identified and the angle of the axis of fastest (longitudinal) 
conduction measured. CV at 90° to this axis (transverse) was also measured, yielding an estimate of 
conduction anisotropy. (ii) Linear method, using isochronal activation maps, CV was calculated along a 
straight line from the pacing site through the fastest advancing point of the wavefront. Longitudinal CV was 
determined as the value of the low plateau velocity between the peaks of stimulus artefact and intramural 
conduction. Transverse velocity was similarly assessed on a perpendicular line. Both methods produced 
similar results . 
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40ml/min Sml/min 
13Hz 
12Hz 
14Hz 
11Hz 
1Hz 
23Hz 
20Hz 
Online Figure 4 Ventricular Heterogeneity. The discrete LV-RV nature of the OF heterogeneity was 
demonstrated by rotating the heart and recording just from the LV or RV. Illustrated are typical OF maps at 
480s at 40ml/min control perfusion. No frequency alteration was observed on moving further into the LV or 
RV. Within the same ventricle statistics on mean DF were performed on two sets of 3x3 pixels. These sets 
were located at sites on the array identical to those used in standard experiments. There was no difference in 
OF between these sites at 480s (LV I - 24.4±2.7, LV 2 - 27.6±3.6, RVI 12.2±0.65, RV2 11.7±0.1). 
Dominant frequency of VF (Hz) 
Time Os 480s 
Site LV RV LV RV 
40ml/min (n=7) 16.7 ± 1.4 13.4 ± 0.9 26.1 ± 1.9*'" 15.6 ± 1.3" 
6ml/min (n=7) 15.2 ± 1.0 13.4 ± 0.9 8.6 ± 1.0*'" 12.3 ± 0.84" 
8mM K+(n=5) 16.5 ± 1.9 13.0 ± 0.7 9.2 ± 1.0 ," 12.5 ± 1.5" 
Hypoxia (n=5) 14.7 ± 1.0 12.4 ± 0.5 21.9 ± 1.0 ' " 14.7 ± 0.9" 
pH 6.7 (n=7) 15.4 ± 1.3 13.5 ± 1.0 20.0 ± 1.2 17.8 ± 1.1 
Table 1 Mean ventricular OFs calculated using 3x3 pixels. * indicates significant differences of VF OF, Os 
vs. 480s *p<O.OI , ** p<O.OOOI. # indicates significant LV-RV differences at 480s p<O.OO1. 
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